Enzymatic production of hyaluronan oligo- and polysaccharides by Kooy, F.K.
Enzymatic production of hyaluronan 
oligo- and polysaccharides
Floor K. Kooy
Thesis Committee
Thesis supervisors
Prof. dr. G. Eggink
Professor of Industrial Biotechnology
Wageningen University
Prof. dr. ir. J. Tramper
Professor of Bioprocess Engineering
Wageningen University
Thesis co-supervisor
Dr. ir. C.G. Boeriu
Senior scientist at Food and Biobased Research
Wageningen University
Other members
Prof. dr. M. M. Palcic  Carlsberg Laboratory, Denmark
Prof. dr. ir. G.W.K. van Dedem Delft University of Technology
Prof. dr. ir. M.H. Zwietering  Wageningen University
Dr. W.J.H. van Berkel  Wageningen University
This research has been conducted under the auspices of the Graduate School VLAG.
Enzymatic production of hyaluronan 
oligo- and polysaccharides
Floor K. Kooy
Thesis
submitted in fulfillment of the requirements for the degree of doctor
at Wageningen University
by the authority of the Rector Magnificus
Prof. dr. M.J. Kropff
in the presence of the 
Thesis Committee appointed by the Academic Board
to be defended in public
on Friday 18 June 2010
at 11.00 a.m. in the Aula.
Floor K. Kooy
Enzymatic production of hyaluronan oligo- and polysaccharides,
176 pages.
PhD thesis, Wageningen University, The Netherlands (2010)
With propositions and summaries in Dutch and English
ISBN: 978-90-8585-648-1


Contents
1 Introduction            9
2 Controlled enzymatic hydrolysis of polymeric hyaluronan for production 
of monodisperse low molecular weight hyaluronan oligosaccharides     19
3 Quantification and characterization of enzymatically produced hyaluronan 
 with fluorophore-assisted carbohydrate electrophoresis (FACE)     35
4 Biosynthesis of hyaluronan: Structural/functional evidence for two separate
 oligosaccharide binding sites of Pasteurella multocida hyaluronan synthase   55
5 Kinetic analysis of β1,3-glucuronyl transferase and β1,4-N-acetylglucosamine
 transferase activities in Pasteurella multocida hyaluronan synthase    83
6 General discussion         99
References        135
Summary         153
Samenvatting        159
Acknowledgements        165
About the author        171
CHAPTER 1
Introduction
10
Hyaluronan: a versatile molecule
Hyaluronic acid, better known as hyaluronan, is a linear glycosaminoglycan composed of repeating 
units of β4-glucuronic acid (GlcUA)-β3-N-acetyl-glycosamine (GlcNAc) disaccharides (see Figure 
1). Hyaluronan is ubiquitously distributed in vertebrate tissues in varying concentrations and with 
molecular weights generally ranging from 105 to 107 Da. High concentrations are found in umbilical 
cord, in synovial fluid between joints, skin, and in vitreous body of the eye (see Table 1). Rooster combs 
contain the highest concentrations of 7500 μg hyaluronan/g ever reported for animal tissues (Laurent 
et al. 1992).
The stiffness of the hyaluronan chain promotes 
an extended random coil conformation, occupying 
large molecular domains. Under physiological 
conditions, hyaluronan is negatively charged, 
attracting large amounts of water and forming 
a highly viscous gel. Its viscoelastic properties 
vary under pressure; water removal from the 
gel is gradually restored after the release of 
pressure (Fraser et al. 1997). Due to this variable 
viscoelasticity, hyaluronan offers lubrication for the 
joints and acts as a shock-absorber. Hyaluronan is 
an essential component of the extracellular matrix, 
creating a flexible and protective layer between 
different tissues. 
Besides the important structural function, 
hyaluronan is also involved in influencing cell 
responses during embryonic development, healing 
processes, inflammation and cancer. Depending 
on the type of tissue, different hyaluronan 
concentrations and molecular weights evoke 
different cell responses (Stern et al. 2006). In 
general, high molecular weight hyaluronan inhibits 
cell differentiation, while it promotes cell proliferation. During embryonic development, proliferating 
cells shed their hyaluronan-rich environment through hyaluronidase, an enzyme that hydrolyzes 
hyaluronan, to be able to differentiate into various tissues. However, elevated hyaluronan production 
or failure of hyaluronan degradation induces the development of cancer (Stern 2008). Interactions 
between hyaluronan and hyaluronan binding-protein CD44 promote drug resistance in a variety of 
cancer cell types. In contrast, small hyaluronan oligosaccharides ranging from 6 to 18 saccharide 
Organ or fluid Human
Umbilical cord 4100
Synovial fluid 1400-3600
Dermis   200
Vitreous body   140-338
Brain     35-115
Thoracic lymph       8.5-18
Aqueous humor       0.3-2.2
Urine       0.1-0.3
Lumbar CSF       0.02-0.32
Plasma (serum)       0.01-0.1
Table 1.   Normal concentrations (μg/g) of hyaluro-
nan in various organs. Adapted from (Fraser et al. 
1997).
Figure 1.   Repeating unit of hyaluronan.
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residues have been shown to slow down growth of several tumors in vivo and the influence of various 
chemotherapeutic agents can be enhanced by hyaluronidase treatment (Toole et al. 2008). 
Another instructive example of different roles played by hyaluronan of varying chain lengths is in 
wound healing (Stern et al. 2006). In the earliest phase of wound healing, hyaluronan of 1000 to 5000 
saccharide residues accumulate at the injured site through the production of platelets and bind fibrinogen 
to form clots. These anti-angiogenic and immunosuppressive polysaccharides facilitate access for 
neutrophils to remove dead tissue or bacteria. In the next phase, hyaluronan fragments of 1000 to 
1250 saccharide residues accumulate and induce the expression of inflammatory cytokines, signaling 
molecules that can interact with receptors of the surrounding cells. Next, hyaluronan oligosaccharides 
in the range of 6 to 20 saccharide residues induce the formation of new blood vessels. In the final phase 
of wound healing, hyaluronan oligomers of 6 to 20 saccharide residues stimulate fibroblast proliferation 
and the synthesis of collagen.
Of course, such a versatile molecule as hyaluronan is interesting for numerous pharmaceutical and 
cosmetic products. The largest application for hyaluronan is replacing the vitreous fluid that is lost during 
eye surgery such as cataract surgery or lens implementation (Kogan et al. 2007). Supplementation 
of hyaluronan into the synovial fluid is known to relieve pain in osteoarthritic patients and its effect 
can be prolonged through the use of cross-linked hyaluronan with slower degradation characteristics 
(Allison et al. 2006). The viscoelastic and space-filling properties of hyaluronan affect the thickness 
and viscosity of vocal folds, essential for the use of voice, and injured vocal folds can be repaired by 
injection of cross-linked hyaluronan. Slightly cross-linked hyaluronan is used to fill facial wrinkles and 
scars through injection, and more recently is also applied in anti-aging crèmes for its moisturizing 
properties (Kogan et al. 2007). Hyaluronan is used as an anti-adhesive film after abdominal surgery, 
as a protective compound to promote wound healing and as a hydrophilic coating on medical devices 
to improve biocompatibility and reduce fouling. Preliminary studies show promising results in the use 
of hyaluronan in tissue engineering. For instance, cartilage regeneration is stimulated through the 
incorporation of hyaluronan in polymer scaffolds on which chondrocytes are cultivated (Allison et al. 
2006). Other potential applications can be found in controlled drug release, in targeted drug delivery 
and in cancer treatment (Allison et al. 2006; Toole et al. 2008). 
Since the molecular weight of hyaluronan is crucial to its application, controlling the hyaluronan 
chain length and product distribution, also called polydispersity, is the main concern in hyaluronan 
production processes. In general, biological functions of high molecular weight hyaluronan are less 
sensitive to the exact length of the individual hyaluronan chain then in the case of small oligosaccharides. 
Therefore, synthesis of small oligosaccharides of one desired chain length, called monodisperse, is 
essential for certain applications. Based on these different biological roles, we use in our studies the 
term ‘oligosaccharide’ for chains consisting of up to 100 sugar residues and ‘polysaccharide’ for chains 
above 100 sugar residues.
Introduction
12
  Schedule 1.    Important events in research on hyaluronan production.
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History of hyaluronan production
With the years, several different techniques have been developed to obtain hyaluronan. The general 
outline of these developments and the most important events in hyaluronan production are shown in 
Schedule 1. In the beginning, hyaluronan was attained through extraction from animal tissues. The 
first patent in hyaluronan history was for a noninflammatory hyaluronan product with molecular weight 
of 750.000 Da and above, obtained from rooster combs (Balazs 1979). The product, Healon, was 
developed to supplement the loss of vitreous body fluid during eye surgery and was an immediate 
success after its introduction in 1982. Interestingly, the product’s early success was thanks to its use 
in curing joint inflammations in race horses and the demand for Healon exceeded the supply to a great 
extent (van Brunt 1986). 
Today, hyaluronan attained from animal tissues is still an important resource for commercial 
products, but, due to technical limitations and increased product legislation, other production processes 
are now preferred. One of the major problems in extraction processes is the inevitable hyaluronan 
degradation, caused by the presence of hyaluronidase in animal tissues and by the harsh extraction 
conditions, such as grinding, acid treatment, and repeated extraction with organic solvents (Ignatova 
et al. 1990). Extraction protocols have been improved over the years, but are still hampered by the 
low natural concentrations, the molecular weight and its polydispersity in animal tissues. The potential 
risk of contaminants, such as proteins and viruses, require additional separation steps to get a product 
legally approved. All in all, production of hyaluronan with high molecular weight through bacterial 
fermentation is slowly replacing the extraction processes.
After the discovery of hyaluronan in animal tissues, a small number of microbial pathogens, namely 
group A and C streptococci and Pasteurella multocida (Kendall et al. 1937; Carter et al. 1953; MacLennan 
1956), were identified that showed the capacity to produce hyaluronan. These microorganisms use 
hyaluronan to encapsulate their cells, which forms a perfect disguise from the animal defense system 
and facilitates the adhesion and colonization of bacterial cells (DeAngelis 1999a). 
In the early developmental stages of bacterial fermentation, traditional techniques, such as culture 
media (van de Rijn et al. 1980), cultivation conditions (Johns et al. 1994; Kim et al. 1996; Armstrong et 
al. 1997) and strain improvement (Kim et al. 1996; Stahl 2000), have been used to increase hyaluronan 
yield and quality. Soon, hyaluronan yields reached their practical limit of 6-7 g/l causing mass transfer 
limitations because of the high viscosity of the fermentation broth (Chong et al. 2005). After that, 
research focused on the improvement of product quality through controlling hyaluronan molecular 
weight, which will discussed in greater detail in Chapter 6.
A major breakthrough in hyaluronan production research was the identification of the genes 
involved in biosynthesis of hyaluronan and one of the sugar nucleotide precursors, which offered 
new possibilities in hyaluronan production (Wessels et al. 1991; Dougherty et al. 1992; DeAngelis 
et al. 1993a). The identified has operon could now be used to overexpress hyaluronan synthase, 
the enzyme that polymerizes UDP-glucuronic acid (UDP-GlcUA) and UDP-N-acetyl-glucosamine 
Introduction
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(UDP-GlcNAc) into hyaluronan, in recombinant hosts. From then on, new production processes have 
been in development, such as bacterial fermentation using safe recombinant hosts (DeAngelis et al. 
1993a; Widner et al. 2005) or in vitro synthesis using isolated hyaluronan synthases (De Luca et al. 
1995; DeAngelis et al. 2003). 
State-of-the-art production techniques
Depending on the type of product, high molecular weight hyaluronan with narrow polydispersity or 
small hyaluronan oligosaccharides of only one chain length, called monodispers, are required. Both 
types of hyaluronan products ask for a completely different approach of production.
For production of hyaluronan of high molecular weight, bacterial fermentation provides the highest 
hyaluronan yields with the opportunity to control the molecular weight distribution. Companies that 
already produce hyaluronan through streptococci fermentation are, for instance, Q-Med (Uppsala, 
Sweden), Lifecore Biomedical (Chaska, U.S.A.), and Genzyme (Cambridge, U.S.A.). Fermentation 
processes with recombinant hosts, instead of using the original, pathogenic bacteria, are more 
frequently used, since endotoxin and exotoxin contamination is prevented and a wide array of tools 
for genetic manipulation is available for metabolic engineering to optimize the molecular weight. The 
first company that achieved hyaluronan production in a heterologous hosts is Novozymes (Bagsvaerd, 
Denmark) using Bacillus subtilis as host (Widner et al. 2005). These production processes provide 
acceptable hyaluronan yields, but are still improved to obtain products with high molecular weight and 
narrow polydispersity.
Monodispers hyaluronan oligosaccharides can be produced through controlled addition or 
degradation using enzymatic or chemical methods. For instance, well planned one-pot strategies with 
activated saccharide building blocks and deprotection steps are capable to chemically synthesize 
hyaluronan oligosaccharides with 6 or 7 sugar residues (HA6 and HA7) without purification steps 
between elongations (Huang et al. 2007; Dinkelaar et al. 2009). Even-numbered and odd-numbered 
oligosaccharides up to HA9 with, respectively, GlcUA or GlcNAc at the reducing end were obtained 
in milligram quantities through degradation steps with  hyaluronidase and β-glucuronidase combined 
with anion exchange chromatography (Blundell et al. 2006). Chapter 2 of this thesis describes how 
experimental conditions can be used to control hyaluronidase degradation. A successful method to 
produce monodispers hyaluronan oligosaccharides on mg-scale is developed by the group of DeAngelis 
using two mutants of P. multocida hyaluronan synthase (PmHAS) to control single step elongations of 
hyaluronan oligosaccharides (DeAngelis et al. 2003). However, production on a larger scale has not 
yet been achieved.
As pointed out above, hyaluronan chain length can be completely controlled  in in vitro synthesis, 
whereas sugar nucleotide regeneration, necessary to supply the substrates for hyaluronan production, 
is accounted for in in vivo synthesis by the bacterial cells. Although the commercial production processes 
Chapter 1
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for high molecular weight hyaluronan and monodispers hyaluronan oligosaccharides are different, in 
both cases it is the enzyme hyaluronan synthase (HAS) that elongates the sugar nucleotide precursors 
into hyaluronan. 
Hyaluronan synthases
Since the discovery of the first gene encoding hyaluronan synthase in S. pyogenes (SpHAS) (DeAngelis 
et al. 1993a), similar hyaluronan synthases have been identified in mammals (e.g. humans (HsHAS) 
and mice (MmHAS)), in frogs (XlHAS), in certain bacteria (S. equisimilis (SeHAS) and S. uberis 
(SuHAS), and even in a virus that infects algae (CvHAS). All of these enzymes belong to the Class 
I HAS enzymes (Weigel et al. 2007), based on high sequence similarity, predicted topology as an 
integral membrane enzyme, and predicted structure (see Table 2). After the growing hyaluronan chain 
is released from the enzyme, further elongation is not possible. This type of elongation mechanism is 
called processive polymerization and is one of the main characteristics of Class I HAS enzymes.
In fact, the only enzyme that is capable of elongating hyaluronan oligosaccharides into long 
polysaccharides is PmHAS (DeAngelis 1999b), the single member of Class II (see Table 2). The ability 
to bind, extend and release oligosaccharide chains makes single step elongations possible, as was 
shown by DeAngelis using two PmHAS mutants that could either elongate GlcNAc or GlcUA to the 
growing chain (DeAngelis et al. 2003). Another advantage above Class I enzymes is that PmHAS can 
be expressed as a soluble enzyme (e.g. residues 1-703) by removing the putative membrane domain 
at the C-terminus. For these two reasons, PmHAS was selected to study in our research group.
Kinetic studies of Class I enzymes to clarify the elongation mechanism are challenging to accomplish 
due to enzyme instability and the inability to use hyaluronan oligosaccharides as a substrate. So far, for 
Introduction
Class I
Class IIReducing Nonreducing
Members SpHAS, SeHAS, 
SuHAS (MmHAS, 
HsHAS)
XlHAS1 (CvHAS) PmHAS
Predicted topology Integral membrane Integral membrane Peripheral 
(or soluble)
No. of GT-A fold domains One One Two
No. of UDP-sugar sites Unknown Unknown Two
No. of HA polymer sites Unknown Unknown Probably two
Hyaluronan chain growth Reducing end Nonreducing end Nonreducing end
Intrinsic polymerization Processive Processive Nonprocessive
Table 2.   Hyaluronan synthase classification system as proposed by (Weigel et al. 2007). Assignments in 
parentheses require further confirmatory studies.
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Class I enzymes it is unclear how the substrates are elongated and in which way the molecular weight 
of hyaluronan can be controlled. For PmHAS, it has been shown that the first elongation steps are very 
slow, and that using templates, which are short oligosaccharides, increases the enzyme activity rates 
and decreases product polydispersity (Jing et al. 2004). However, the exact elongation mechanism is 
unknown.
Research aim
The main question, important for both in vivo as in vitro hyaluronan synthesis, is how the molecular 
weight of hyaluronan can be controlled using HAS enzymes. This thesis will try to answer this 
question from a biochemical perspective. The aim of this thesis was to gain more knowledge on the 
polymerization mechanism of PmHAS using kinetic and structural studies. The focus was especially on 
how these results can be used to control the polymerization reaction.
Thesis outline
Since hyaluronan product distribution could be narrowed using templates, our first aim was to understand 
the influence of hyaluronan oligosaccharides on PmHAS polymerization. Chapter 2 describes the 
preparation of hyaluronan templates ranging from HA4 to HA10 through stepwise hyaluronan cleavage 
by hyaluronidase. Experimental design studies using pH, enzyme concentration and reaction time as 
parameters were applied to increase the concentration of one of the hydrolysis products. In this way, 
hyaluronidase cleavage could be controlled to obtain higher amounts of HA4, HA6 or HA8. 
To be able to follow all oligosaccharide products formed during PmHAS polymerization, HA4 
templates were labeled with a fluorescent tag, purified and characterized as substrate for PmHAS. 
Labeled products were separated on TBE 20% polyacrylamide gels using gel electrophoresis and 
quantified using image analysis tools. Chapter 3 describes this fast, simple and sensitive fluorophore-
assisted carbohydrate electrophoresis (FACE) assay. 
In Chapter 4, the oligosaccharide binding sites of both transferase domains are investigated by 
assessing the influence of hyaluronan oligosaccharides on PmHAS polymerization. Kinetic studies 
of single step elongations of hyaluronan oligosaccharide from HA4 to HA9 indicated two separate 
oligosaccharide binding sites of different lengths based on differences in the specificity constant. This 
was confirmed by the structural model of PmHAS that was built using the crystal structure of K4CP 
chondroitin polymerase. The effect of two separate oligosaccharide binding sites on polydispersity was 
demonstrated by PmHAS polymerization reactions using fluorophore-labeled HA4.
In Chapter 5, initial velocity studies of single-step elongations were carried out for both PmHAS 
transferase domains by varying the concentrations of HA oligosaccharide and UDP-sugar independently. 
Chapter 1
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The combined results from statistical model discrimination and dead-end inhibition studies indicate 
that both transferase domains elongate through a sequential mechanism, most likely an ordered one. 
Structural similarities with glycosyltransferases of GT-A fold showed two flexible loops that probably 
changes its conformation upon binding the sugar nucleotide, after which the oligosaccharide binds and 
is elongated. 
Chapter 6 discusses how molecular weight can be controlled in hyaluronan production using 
bacterial fermentation and in vitro synthesis with hyaluronan synthases. Various topics are addressed 
including the effect of culture conditions and substrate availability on molecular weight and how this can 
be related to the characteristics of hyaluronan synthases. Moreover, prospects on increased PmHAS 
performance and integrated processes of in vitro hyaluronan synthesis are explored.
Introduction
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Controlled enzymatic hydrolysis of 
polymeric hyaluronan for production 
of monodisperse low molecular weight 
hyaluronan oligosaccharides 
Access to defined hyaluronan (HA) oligosaccharides is crucial both for unravelling biological functions of hyaluronan as well as for developing production methods for hyaluronan with defined chain length and low polydispersity. Here we report the results of a study focused on 
the development and optimization of an enzymatic method for the manufacture of HA oligosaccharides. 
Response surface methodology was used to investigate the effect of three selected parameters on the 
production of low molecular weight hyaluronan oligosaccharides (HA templates, n = 4, 6, 8, and 10) by 
hydrolysis of hyaluronan using ovine testicular hyaluronidase. These parameters were pH, the enzyme/
substrate ratio and reaction time. Empirical models were elaborated for the yield of each individual 
target HA oligosaccharide using a central composite design. The conditions have been found that 
allow selective production with high yield of either short hyaluronan oligomers (HA ≤10) or longer 
oligosaccharides (HA > 10). Preparative enzymatic hydrolysis of hyaluronan under optimum conditions 
resulted in high amounts of the target HA oligosaccharides (n = 4, 6, 8 and 10), which were separated 
by flash-chromatography. These isolated oligosaccharides were characterized by a combination of 
anion exchange chromatography and matrix-assisted laser desorption/ionization mass spectrometry 
with time-off-flight analysis. The HA oligosaccharides produced by this method were monodisperse 
compounds with purity above 98 %. 
Floor K. Kooy, Gerard Boswinkel, Eric Boer, Johannes Tramper, Gerrit. Eggink, Carmen G. Boeriu. 
(Submitted for publication)
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Chapter 2
Introduction
In the past years, the interest for production of low molecular weight hyaluronan (HA) oligosaccharides 
has increased significantly. The intensification of research on HA oligosaccharides is a direct result 
of the distinct biological activities observed for HA oligosasccharides and HA polysaccharides. HA 
tetrasaccharide (HA4) and hexasaccharide (HA6) were shown to induce complete and irreversible 
maturation of human dendritic cells via Toll-like receptor-4 (Termeer 2000; Termeer et al. 2002), 
due to specific binding. Increased levels of interleukin-12 were released by some leukocytes upon 
stimulation with HA oligomers (Jobe 2003). Stressed synovial cells were found to suppress cell death 
upon treatment with HA4, in a canine arthritis model (Xu 2002). HA oligosaccharides have been shown 
to inhibit tumor growth in vivo (Zeng et al. 1998) and to promote angiogenesis (West et al. 1985; 
Rahmanian et al. 1997). Hyaluronan oligosaccharides have also been used in functional and structural 
studies of HA-binding proteins, to elucidate protein-HA interactions and to characterize binding sites in 
cartilage proteoglycans components (Hardingham et al. 1973; Hascall et al. 1974; Seyfried et al. 2005b) 
and in the link modules of the human tumor necrosis factor-stimulated gene-6 (TSG-6) and leukocyte 
homing receptor, CD44 (Tammi et al. 1998; Kahmann et al. 2000; Lesley et al. 2000; Mahoney et al. 
2001b). 
To unambiguously relate a measured biological activity to a unique structure, it is essential to use 
well-characterized and analytical grade oligosaccharide preparation of defined size in both biological 
and structural studies. Various methods for the production and purification of HA oligosaccharides have 
been reported. Most applied methods involve hydrolysis of high molecular weight hyaluronan using 
hyaluronidase, an endohydrolase belonging to the glycoside hydrolase (GH) family 56. This enzyme 
randomly cleaves β-(1,4)-N-acetylhexosamidine linkage along the polymer chain, resulting in complex 
mixtures of even-numbered oligosaccharides ranging from tetramers to bigger than HA30. Purification 
of defined HA oligomers from these mixtures was achieved by size exclusion chromatography 
(Hardingham et al. 1973; Hascall et al. 1974; Tammi et al. 1998) and/or ion exchange chromatography 
(Holmbeck et al. 1993; Toffanin et al. 1993; Almond et al. 1998; Tammi et al. 1998; Lesley et al. 2000; 
Mahoney et al. 2001a) and reverse-phase ion-pair high performance liquid chromatography (Cramer 
et al. 1991). The low yields obtained and the extensive purification required has limited the application 
of these methods.
In 2004, the synthesis of polydisperse hyaluronan oligosaccharides by elongation of HA4 
with UDP-glucuronic acid (UDP-GlcA) and UDP-N-acetylglucosamine (UDP-GlcNAc) using the 
Pasteurella multocida hyaluronan synthase (PmHAS) was reported (Jing et al. 2004). A new method 
was developed for the production of monodisperse hyaluronan oligosaccharides with defined length 
using two recombinant single action glycosyltransferases, a glucuronic acid transferase and an 
N-acetylglucosamine transferase obtained by mutagenesis of PmHAS (DeAngelis et al. 2003). Using 
a dual-enzyme reactor strategy with stepwise addition of the two sugar nucleotide monomers, UDP-
N-acetylglucosamine and UDP-glucuronic acid, DeAngelis and co-workers succeeded to synthesize a 
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HA22 by elongation of a HA tetrasaccharide acceptor (DeAngelis et al. 2003). In principle, this method 
allows the controlled synthesis of hyaluronan oligosaccharides of any desired length, the final size of 
the oligosaccharide depending on the number of sugar addition steps employed, but the use of a HA 
template with the size of at least tetramer as acceptor is compulsory. 
In our studies on the synthesis of hyaluronan oligosaccharides we have shown that under kinetic 
controlled conditions, a recombinant PmHAS enzyme is able to synthesize defined HA oligosaccharides 
with low polydispersity by elongation of a HA4 acceptor with UDP-GlcNAc and UDP-GlcA, respectively 
(Kooy et al. 2009b). Moreover, kinetic characterization of the PmHAS enzyme indicated that the 
addition of HA4 (i.e. two disaccharide units in length) templates increases the reaction rate compared 
to de novo synthesis using only UDP-sugars, but longer oligosaccharides with three (HA6) and four 
(HA8) disaccharide units in length were preferred (Kooy et al. 2010).
Chemical synthesis of these oligosaccharide building blocks for hyaluronan synthesis is possible. The 
largest HA oligosaccharides synthesized are tetra-, penta- and heptasaccharides having a glucosamine 
reducing end (Dinkelaar et al. 2009) and a hexasaccharide (HA6) containing a methoxyphenyl group 
at the reducing end (Halkes et al. 1998). Although feasible, chemical synthesis of HA oligosaccharides 
is difficult and involves multiple protection/deprotection and purification steps in order to ensure the 
stereo- and regioselectivity of the glycosidic linkage, resulting in very low product yields. Therefore, 
chemical synthesis is limited to short oligomers. 
The only route that might afford an easy and simultaneous production of hyaluronan templates 
HA4, HA6 and HA8 seems to be the digestion of polymeric hyaluronan by testicular hyaluronidase, 
but this requires optimization of the reaction to increase the yield and to narrow the range of molecular 
weight of target oligomers. 
Here we describe the optimization of the reaction parameters that affect the enzymatic hydrolysis 
of hyaluronan by hyaluronidase. Our objectives were to understand the effect of relevant reaction 
variables (i.e. pH of the medium, enzyme concentration and reaction time) on the molar conversion 
of hyaluronan and to identify the optimum conditions for the highest yield of low molecular weight HA 
templates HA4, HA6, HA8 and HA10, while minimizing the production of oligosaccharides larger than 
HA10. We applied statistically based experimental design and response surface methodology (RSM) 
for empirical model building and exploitation.   
   
Experimental procedures
Materials and methods
Hyaluronidase (EC 3.2.1.35) type V, from sheep testes, with an activity of 2660 units/mg solid and the 
sugar nucleotides UDP-GlcA and UDP-GlcNAc were obtained from Sigma-Aldrich (Zwijndecht, NL). 
Hyaluronic acid from Streptococcus equi sp. (Mw = 1.2 * 106 Da, protein < 1%, solubility in water of 5 
mg/ml) was obtained from Fluka. Analytical grade hyaluronan tetra-, hexa-, octa- and decasaccharides 
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were obtained from Hyalose (Cambridge, USA). Maltodextrins (mass range 250-2500 Da) were from 
Avebe, Veendam, The Netherlands). PmHAS (purified) was provided by Schering-Plough (formerly 
Organon N.V., Oss,  The Netherlands). All other chemicals were of analytical grade.
Hyaluronan hydrolysis (experimental design)
Reactions were carried out in batch mode in a 24-tubes carrousel (GreenHouse PlusTM Parallel 
Synthesizer, Radleys Discovery Technology) with controlled temperature, cooling and magnetic stirrer. 
20 mg of polymeric HA was dissolved at a concentration of 5 mg/ml (4 ml in total) in digest buffer (0.1 
M citric acid/0.2 M Na2HPO4 buffer of pH ranging from 2.4 to 7.6) and the mixture was thermostated 
at 37 °C under moderate stirring. The reaction was initiated by the addition of appropriate amounts of 
hyaluronidase to achieve a final enzyme concentration in the reaction mixture ranging from 126.8 to 
473.2 units/per mg hyaluronan. The reaction mixture was incubated at 37°C for a time (t) in the interval 
1.6 to 22.4 h. At each time point, the reaction was quenched by boiling for 10 min. Control reactions 
without enzyme were carried out under identical conditions. Samples were analyzed by HPAEC-PAD and 
the identity of the products was determined with MALDI-TOF-MS. Standard HA4, HA6, HA8 and HA10 
oligosaccharides were used as reference. Quantitative analysis of each size-uniform oligosaccharide 
obtained was performed by weight. The results are given as relative percentage yield.
High performance anion exchange chromatography 
High Performance anion exchange chromatography (HPAEC) was performed using an ICS-3000 Ion 
Chromatography HPLC system equipped with a CarboPac PA-1 column (4 x 250 mm) in combination 
with a CarboPac PA guard column (4 x 25 mm) and a pulsed electrochemical detector in pulsed 
amperometric detection (PAD) mode (Dionex, Sunnyvale, USA). A flow rate of 1.0 ml min-1 was used 
with the following gradient 0-45 min at 0-500 mM sodium acetate in 20 mM NaOH, 45-46 min at 20-150 
mM NaOH, 46-49 min at 150 mM NaOH.
Analysis of the reaction products by MALDI-TOF MS
After incubation, the composition of the reaction mixture was determined by Matrix-Assisted Laser 
Desorption-Ionisation Time Of Flight Mass Spectrometry (MALDI-TOF-MS) using an Ultraflex 
workstation (Bruker Daltonics, Germany) equipped with a 337 nm laser. The mass spectrometer was 
operated in the positive mode and calibrated with a mixture of maltodextrins (mass range 250-2500 
Da), from Avebe, Veendam, The Netherlands). Ions were accelerated with a 25 kV voltage after a 
delayed extraction time of 200 ns. Detection was performed after using the reflector. The lowest laser 
intensity needed to obtain a good quality spectrum was applied. The samples were 10 times diluted in 
the matrix solution (10 mg of 2,5-dihydroxybenzoic acid (DHB) in water ) and for analysis 2 µl of the 
mixture was transferred to a MALDI sample plate and dried under a stream of warm air.
Chapter 2
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Design of experiments 
The following three parameters were varied: pH (x1), the ratio enzyme to substrate hyaluronan (x2) and 
time of experiment (x3). The settings of the different parameters were determined for all input variables 
from preliminary screening experiments and from data reported in literature. The response variables 
studied in this chapter are the molar yields of the HA di-, tetra-, hexa-, octa- and decamers and the yield 
of HA oligomers larger than decamer. We have used a central composite design, which is especially 
useful in the case of potential complex processes and when the response is non-linear. Additional 
observations in the so-called “star-points” were done to estimate quadratic effects. Table 1 shows the 
minimal (-1), the central point (0) and the maximal (+1) values used for each parameters, as well as the 
star points (-2) and (+2). Six replicates were run at the central point and all statistical experiments were 
performed in random order to avoid bias.
 
The response variable is modelled by a quadratic model given as:
                  (1)
where Y is the response variable, β0 is the intercept, β1 to β33 the regression coefficients and x1 to x3 
are the predictors or independent variables. Specific for the experiments in this article: Y = yield of 
oligosaccharide HAn, x1 = pH, x2 = the ratio enzyme to substrate hyaluronan and x3 = reaction time, 
expressed as total enzyme activity used per mg of hyaluronan substrate (units/mg) 
The estimation of the regression coefficients is done by least squares regression. We applied the 
so-called Mallow’s Cp criterion for model selection. This criterion compromises the fit of the model to 
the response variable with as little as possible regression coefficients in the model. This is done to 
avoid overfitting, i.e. the modelling noise (of experiment) in the model. 
Visualisation of the response surface was done in the mathematical software package Matlab. We 
have chosen for 3D plots of two explanatory variables at three different levels of the third explanatory 
variable. The figures consist out of 4 sub-figures: one visualizes three different levels of a third 
explanatory variable in one plot, the other three sub-figures plot the surfaces separately. 
Table 1.    Setting levels of each input variable.
Parameter Unit Levels
-2 -1 0 +1 +2
pH (x1) 2.4 3.5 5.0 6.5 7.6
Enzyme/HA ratio (x2) Unit/mg 126.8 200.0 300.0 400.0 473.2
Time (x3) h 1.6 6.0 12.0 18.0 22.4
Production of monodisperse HA oligosaccharides by controlled hydrolysis
24
Preparation, purification and characterization of monodisperse HA oligomers
Hyaluronan (200 mg) was dissolved at a concentration of 5 mg/ml total volume 40 ml) in the reaction 
buffer of pH 5 and incubated at 37°C for 2 h. To this, ovine testicular hyaluronidase (15.1 mg, 40000 
U, 200 units/mg HA) was added and the mixture was incubated at 37°C for 18 h. The progress of the 
reaction was monitored by thin layer chromatography (TLC) using silica gel plates in eluens, containing 
n-butanol, acetic acid, and water in a ratio of 1.5:1:1, respectively. The silica gel plates were developed 
using 10 % H2SO4 in methanol spray and heated for 10 minutes at 105°C.  End point was assessed by 
HPAEC-PAD. When the reaction reached the desired conversion, it was stopped by boiling for 10 min, 
freeze-dried and stored at -20°C. The HA oligomers were purified by flash column chromatography, 
using a mixture of n-butanol : acetic acid : water of 3 :1 :1, at a flow rate of 20 ml/min, and samples 
of 8 ml volume were collected. Separation of HA oligomers was monitored by TLC and representative 
samples were analyzed by MALDI-TOF-MS. Samples containing defined size oligosaccharides were 
pooled together, dried and further characterized  by HPAEC-PAD and MALDI-TOF-MS. 
The isolated HA4, HA6 and HA8 were tested as substrate for PmHAS in one step-elongation 
reaction with either sugar nucleotides UDP-GlcUA and UDP-GlcNAc using the method of our other 
studies (Kooy et al. 2010). The HA4 was evaluated as template for the enzymatic synthesis of larger 
hyaluronan oligomers in reaction with equimolar mixture of UDP-GlcUA and UDP-GlcNAc as described 
in (Kooy et al. 2009a).
Results and discussion
Optimization of the reaction conditions for production of HA oligosaccharides.
Hydrolysis of polymeric hyaluronan with testicular hyaluronidase generally results in complex mixtures 
of HA oligosaccharides with broad size distribution. Isolation of a targeted HA size requires demanding 
chromatographic steps and low product yields are generally obtained. Production of the HA tetramer 
(HA4) by extensive digestion of hyaluronan with a large excess of hyaluronidase has been reported 
(Blundell et al. 2006), but to our best knowledge, no optimized methodologies have been developed 
for the production of HA6, HA8 and HA10 oligomers, important compounds because of their biological 
activity and the potential to be used for understanding the mechanism of action of the enzymes involved 
in both the synthesis and breakdown of polymeric hyaluronan.  
In this study we have attempted to determine the parameters of the hyaluronidase reaction 
that stimulates total degradation of polymeric hyaluronan and intermediate-sized oligomers that are 
formed during the reaction to generate exclusively HA fragments lower than the HA decamer. A central 
composite experimental design was applied. The reaction parameters that were varied were the pH of 
the medium (x1), the enzyme to substrate ratio (x2) and the reaction time (x3). Table 2 shows the values 
of the independent variables (xi) used and the values of the response variables experimentally obtained. 
The reactions were carried out at 37°C and a concentration of polymeric hyaluronan of 5 mg/ml, which 
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were found to be optimal for this reaction in preliminary experiments (not shown). The resulting digests 
were analyzed by HPAEC-PAD and MALDI-TOF-MS. HA oligosaccharides covering the range from 
di- to dodecamer were identified as the products of the hyaluronan degradation under the conditions of 
the experiments listed in Table 2. The HA oligomers detected are listed in Table 3. Other peaks of low 
intensity were found in the HPAEC trace at retention times higher than 22 min, which were assigned to 
HA oligomers ranging from HA14 to HA20 by gel electrophoresis (not shown). These oligomers were 
however not identified in the MALDI-TOF-MS spectra, due to a too low signal-to-noise ratio.  
 
Table 2.   Central composite design and experimental data for response surface analysis.
Nr. pH E/SU/mg
Time 
(h)
Product yield (%)
HA2 HA4 HA6 HA8 HA10 >HA10
1 3.5 200.0 6.0 1.8 13.9 26.3 23.0 15.9 19.2
2 3.5 200.0 6.0 4.6 14.0 31.3 21.8 14.3 14.0
3 3.5 400.0 6.0 3.3 23.7 36.1 20.4 8.1 8.4
4 3.5 200.0 18.0 2.1 14.5 27.6 22.0 16.3 17.5
5 3.5 400.0 18.0 4.1 29.9 40.5 17.3 5.0 2.8
6 6.5 200.0 6.0 1.3 16.8 16.3 14.9 15.8 33.4
7 6.5 400.0 6.0 1.1 22.2 18.8 15.0 13.3 28.6
8 6.5 200.0 18.0 1.3 26.4 20.6 15.2 13.3 22.1
9 6.5 400.0 18.0 2.2 45.0 21.4 12.6 8.9 9.4
10 5.0 300.0 12.0 5.8 69.2 20.0 1.7 0.3 2.8
11 5.0 300.0 12.0 6.2 66.6 23.8 2.5 1.0 0.0
12 5.0 300.0 12.0 6.2 63.1 26.9 3.0 0.8 0.0
13 5.0 300.0 12.0 6.1 64.9 25.5 2.5 1.0 0.0
14 5.0 300.0 12.0 4.4 64.3 27.7 2.9 0.7 0.0
15 5.0 300.0 12.0 4.1 61.5 30.7 2.9 0.9 0.0
16 7.6 300.0 12.0 1.2 10.9 17.1 15.8 16.3 38.7
17 2.4 300.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0
18 5.0 300.0 22.4 5.6 66.3 25.2 1.4 0.7 0.8
19 5.0 300.0 1.6 1.9 37.5 39.1 14.2 5.1 0.9
20 5.0 473.2 12.0 3.8 69.1 25.0 1.7 0.5 0.0
21 5.0 126.8 12.0 3.7 39.5 42.0 10.1 3.2 0.0
22 5.0 300.0 3.0 2.2 44.8 40.2 9.1 2.7 0.0
23 5.0 300.0 3.0 2.5 46.8 36.4 9.5 3.0 0.8
24 5.0 300.0 3.0 2.5 43.8 40.6 9.2 2.8 0.0
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The results in Table 2 suggest that larger HA oligosaccharides are the preferred substrate for 
hyaluronidase and only when the concentration of oligomers larger than a decamer is below a critical 
level, short chain oligosaccharides are degraded. This is in agreement with recent data on the kinetics 
of hyaluronidase reaction, showing that the initial rate of chain degradation is strongly correlated with 
the length of the hyaluronan chain (Nakatani 2002; Deschrevel et al. 2008), reaching a maximum 
for medium chain length HA polymers (Mw ∈ 3.2⋅104 - 2⋅105 g/mol, HA160-HA1000) (Deschrevel et al. 
2008). 
The results in Table 2 clearly show that the composition of the product mixture can be tuned by 
the right selection of the reaction conditions, the pH (x1) and enzyme/substrate ratio (x2) being the 
most important. At low and high pH values, a broad range of oligosaccharides ranging from dimer to 
tetradecamers is obtained. No reaction was observed at pH below 3, due to enzyme inactivation. At pH 
5 and high enzyme-substrate ratio, the end product of the hyaluronan degradation with hyaluronidase 
consists of a mixture of low molecular weight hyaluronan, with Mw  < 2⋅103 Da, with HA4 and HA6 as 
major reaction products and HA2 and HA8 as minor products (entries # 10-15, 18, 20). This is the first 
time that quantitative data show the formation of significant amounts of the hyaluronan disaccharide 
HA2 during hyaluronan hydrolysis by testicular hyaluronidase. Volpi (Volpi 2007) reported in 2007 that 
using on-line HPLC/ESI-MS analysis, HA2 was identified among the products of hyaluronan digestion 
with hyaluronidase, but no yields or other quantitative data are given. 
Table 3.   MALDI-TOF analysis of peaks from anion exchange chromatography.
Rt 
a
(min)
Experimental masses 
(Da)
Theoretical 
masses (Da)b
Oligosaccharides present
 (Mw, Da); Formula
7.5 420.0, 442.2 420.1, 442.1 HA2: (397.1); [GlcA-GlcNAc]
10.4 799.1, 821.1 799.2, 821.2, 843.2 HA4: (776.2); [GlcA-GlcNAc]2
12.2 1178.1, 1200.3 1178.3, 1200.3, 1223.3, 1246.3 HA6: (1155.3); [GlcA-GlcNAc]3
14.0 1597.8, 1619.4, 1644, 1663.9
1577.4, 1599.4, 
1621.4, 1643.4, 
1665.4
HA8: (1534.4); [GlcA-GlcNAc]4
16.9 1936.4, 1958.4
1936.5, 1959.5, 
1982.5, 2005.5, 
2028.4
HA10: (1914.6); [GlcA-GlcNAc]5
21.6 2315.2 2315.6, 2338.5, 2361.6 HA12: (2293.4); [GlcA-GlcNAc]6
a the product  is eluted as a major peak  which is accompanied by a small peak at lower time, due to epimerization 
of the HA oligomers at the conditions of the analysis. Similar effect was observed for standard HA oligosaccharides 
and was reported in literature (Lee et al., 1990).
b based on average molecular mass.
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Formation of HA2 was also reported by Highsmith et al. (1975) but they have explained its 
generation by transglycosylation reactions catalyzed by the testicular hyaluronidase. Our results do not 
support this hypothesis because accumulation of HA4 at our observed high levels would be impossible, 
if  transglycosylation reactions would have occurred.  
It is generally accepted in the literature that the smallest oligosaccharide liberated by hyaluronidase 
is the HA tetramer, HA4 (Mahoney et al. 2001a; Gao et al. 2006a). However, our results clearly 
demonstrate that under reaction conditions that favor total hydrolysis of HA oligomers larger than 
decamer, significant amounts of HA2 are obtained (entries # 10-15 and entry #18 in Table 2). The 
finding that HA2 can be produced by hyaluronan digestion with hyaluronidase is important, since 
currently there are no methods for its synthesis other than chemical. Hydrolysis of hyaluronan with the 
bacterial hyaluronan lyase (EC 4.2.2.1) has been reported, but this enzyme cleaves hyaluronate chains 
at a β-D-GalNAc-(1-4)-β-D-GlcA bond, ultimately breaking the polysaccharide down to 3-(4-deoxy-β-
D-gluc-4-enuronosyl)-N-acetyl-D-glucosamine, an unsaturated HA disaccharide (Linhardt et al. 1986; 
Mishra et al. 2006).
The accumulation of HA4 as major reaction product of the hyaluronan digestion with hyaluronidase 
demonstrates once more that HA6 is the smallest  oligosaccharide that can be cleaved by hyaluronidase. 
The relative abundance of the low molecular weight HA oligosaccharides in the product mixtures (see 
entries # 10-15, 18, 20 in Table 2, where concentrations are ranked as HA4 > HA6 >> HA8 > HA2 
>> HA10 (traces)) suggest that the rate of degradation of the low molecular HA oligosaccharides 
decreases with the decrease of the chain length (HA10 > HA8 > HA6; see also Figure 1A). There 
are several possible pathways for the degradation of HA10 and HA8 into smaller oligomers (Figure 
1B), but our results suggest that pathways 1a, 1b, and 2a are preferred. The formation of HA2 can be 
explained by the other pathways shown in Figure 1B. The low amounts of HA2 found in our results 
Figure 1.   A) Conversion of hydrolysis products in time; B) Possible pathways for the degradation of short chain 
HA oligosaccharides (< HA10) by hyaluronidase. Glucuronic acid and N-acetylglucosamine are represented by 
symbols A and N, respectively. Glucuronic acid is the nonreducing end of the chain for all oligosaccharides in this 
figure.
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indicate that HA4 is the preferred endproduct.  Although we cannot exclude that condensation and 
transglycosylation reactions might occur at high concentration of the low molecular weight oligomers 
(Nakatani 2002; Gao et al. 2006a; Deschrevel et al. 2008), our results show that hydrolysis is still the 
preferred reaction catalyzed by hyaluronidase. 
Model fitting
The response variables were modelled to fit the quadratic equation (1) and the results of the regression 
analysis are given in Table 4. The analysis of variance indicated that the second order polynomial 
model is adequate to describe the relationship between the response (the percent yield of a target 
HA oligomer) and the significant independent variables, with a satisfactory coefficient of determination 
(R2). The results show that pH (x1) and enzyme-substrate ratio (x2) are the most important parameters 
that showed a statistically significant overall effect on the yield of all HA oligomers formed, except 
HA6, where only variable x1 (pH) is significant. The reaction time (x3) is statistically significant only 
with respect to the yield of HA2 and the larger oligomers (i.e. HA8, HA10 and larger). These results 
show that longer reaction time, high enzyme/substrate ratio and pH in the optimal range are required 
to produce higher amounts of HA2, while shorter reaction time, low enzyme activity and pH outside the 
optimal range results in high yields of large oligosaccharides. 
Figure 2 and Figure 3 show the response surface plot of yield of HA4 and HA10, respectively. They 
allow the visualization of the impact of two parameters, x1 and x2,  on the product yield, at three constant 
levels of parameters x3. 
Table 4.   Results of estimated parameters of the regression analysis of central composite design experiment.
Parameters Yield HA2
Yield 
HA4
Yield 
HA6
Yield 
HA8
Yield 
HA10
Yield 
>HA10
β0 -17.55 -306.20 20.81 153.54 122.34 125.08
β1 4.17 104.43 8.06 -37.76 -32.93 -54.08
β2 0.06 0.57 0.00 -0.24 -0.20 0.00
β3 0.62 0.00 0.00 -1.83 -0.85 2.09
β11 -0.47 -10.67 -1.07 3.53 3.00 6.00
β22 0.00 0.00 0.00 0.00 0.00 0.00
β33 -0.02 -0.14 0.00 0.06 0.03 0.00
β12 0.00 0.00 0.00 0.00 0.01 0.00
β13 0.00 0.50 -0.08 0.00 0.00 -0.30
β23 0.00 0.01 0.00 0.00 0.00 0.00
R2 0.87 0.96 0.46 0.92 0.83 0.87
se * 1.02 5.12 6.46 2.47 2.57 4.97
* se = standard error; se = √ (residual variance of the regression model)
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Figure 2.   Response surface plot of product yield of HA4 (%): enzyme/substrate ratio (U/mg) versus the pH of the 
reaction medium at three levels of the reaction time; 6 h, 12h and 18 h, respectively.  
Figure 3.   Response surface plot of product yield of HA10 (%): enzyme/substrate ratio (U/mg) versus the pH of the 
reaction medium at three levels of the reaction time; 6 h, 12h and 18 h, respectively.
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Experimental validation of hydrolysis model
For HA4, the optimal values for pH, enzyme/substrate ratio and reaction time are determined by a 
gradient-based method of the optimization toolbox within Matlab 7.6.0. The predicted maximal yield 
of HA4, within the boundaries of the experimental design, can be found at a pH of 5.3, enzyme 
concentration of 352.2 units/mg hyaluronan and time of 17.5 h. These conditions predict a HA4 
production yield of 70.3%. 
Digestion of polymeric hyaluronan with testicular hyaluronidase was carried out at optimal 
conditions predicted by the model, at 37°C and a hyaluronan concentration of 5 mg/ml. Figure 4 shows 
the chromatographic trace of the reaction mixture at 3 h. Time course analysis (Figure 4, insert) showed 
the increase of the yield of HA4 in time, up to 69.4 % at 17.5 h, close to the target value predicted by 
the model. The increase of the yield of HA2 and HA4 in time is accounted on the hydrolysis of HA6 
and HA8, respectively (Figure 1A and insert Figure 4). The reaction mixture at 17.5 h was separated 
into the constituent oligomers by flash chromatography, and HPAEC and MALDI-TOF-MS analysis 
demonstrated that HA4 and HA6 oligosaccharides of analytical purity were isolated (Figure 5). The 
purity of the HA4 oligomer was 98 %, and the only identified impurity was HA2 (Kooy et al. 2009a). The 
HA6 preparation contained traces of HA4 and HA8. 
One-step elongation of the isolated HA4 (98 % purity) with PmHAS with UDP-GlcNAc as donor 
resulted in the quantitative formation of the odd-number oligosaccaharides HA5 [GlcNAc-(GlcA-
GlcNAc)2], but no reaction was observed with UDP-GlcUA (Figure 6). This observation confirms once 
more the structure of the hyaluronan fragments obtained by hyaluronidase degradation of hyaluronan, 
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Figure 4.   HPAEC analysis of the hyaluronan digest at 3 h (black) and 17.5 h (gray). GlcNAc was added into the 
sample prior to analysis as internal standard. The insert shows the yield of HA oligomers at 3 and 17.5 h. The con-
ditions of the reaction described are: 20 mg HA (5 mg/ml), pH 5.3, enzyme-substrate ratio = 360 units/mg, 37°C.
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Figure 6.    Activity of PmHAS using purified HA tetramer for one-step elongations with UDP-GlcNAc (gray sphere) 
or UDP-GlcUA (white sphere) and for complete polymerization using both UDP-sugars (black square). One-step 
reactions contained either 1mM UDP-GlcNAc or 1mM UDP-GlcUA, whereas full polymerization reaction contained 
1mM of both UDP-sugars. All reactions contained 0.1mM HA4 and 0.6 μmol/ml PmHAS and were measured using 
a coupled enzyme assay described in Chapter 4.
Figure 5.   Characterization of purified HA4 product using MALDI-TOF-MS (main figure) and HPAEC (insert). 
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since PmHAS can only elongate at the nonreducing end of the oligosaccharide. Therefore, the purified 
oligosaccharides must contain a glucuronic acid residue at the nonreducing end of the  chain. In a 
reaction with both sugar nucleotide, complete polymerization of HA4 polymeric hyaluronan was 
achieved by PmHAS (Figure 6). Our activity studies with PmHAS has demonstrated that HA2 is not a 
preferred template for PmHAS (data not shown).    
Preparative synthesis, isolation and characterization of pure monodisperse HA oligomers
The optimal conditions for the simultaneous production of HA oligosaccharides from tetramer to decamer 
were determined from cross-sections based on the hydrolysis models given in Table 4, with the following 
boundary conditions: (1) yield of HA4 higher than 40 % and (2) yield of HA larger than HA10 lower than 
1 %. The following values for the independent variables xi conditions were selected:  pH 5; enzyme/
substrate ratio, 160 U/mg HA; reaction time, 16 h. These conditions were used for the hydrolysis of 
polymeric hyaluronan (200 mg, at a concentration of 5 mg/ml in the reaction mixture) at 37°C. Anion-
exchange chromatography of the reaction mixture at 16 h verified the formation of target HA oligomers 
(data not shown). No products larger than HA10 were observed. The reaction mixture obtained after 
16 h was fractionated by flash chromatography (data not shown) and fractions of identical composition 
as assessed by TLC and MALDI-TOF-MS  were pooled together and dried. Milligram quantities of  the 
even-numbered oligomers HA4, HA6, HA8 and HA8 were isolated and further characterized (Table 
5). MALDI-TOF-MS confirmed that the HA oligomers obtained were monodisperse and only traces of 
lower oligomers were observed as impurity (Table 5).
Table 5.   Products obtained by hyaluronan digestion with hyaluronidase at conditions determined from cross-
section analysis.
Fraction 
pooled
Experimental mass
(Da)
Oligosaccharide 
present
Isolated 
amount
mg (µmol)
Isolated 
yield*
(% weight)
46-52 442. 1, 799.2, 843.2 HA4, HA2 
(traces)
99.3 (0.13) 49.6
53-62 821.1, 843, 1200.1, 
1244.2
HA6, HA4 
(traces)
48.6 (0.042) 24.3
65-77 1645.1 HA8 30.0 (0.019) 15.0
81-92 2046 HA10 8.1 (0.0042) 4.1
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Conclusions
The statistical design and the multi-linear regression analysis used in this study have proven to be very 
useful for establishing predictive models for the yield of hyaluronidase digestion of hyaluronan towards 
either very low molecular weight oligomers from dimer to decamers or larger oligomers (> HA10). We 
achieved the production of monodisperse HA4, HA6, HA8 and HA10 templates with purity above 98 % 
and in good yield . The results of this study provide possible pathways of hyaluronidase action on low 
molecular weight HA oligosaccharides towards the formation of hyaluronan dimers. 
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Quantification and characterization of 
enzymatically produced hyaluronan 
with fluorophore-assisted carbohydrate 
electrophoresis (FACE) 
Floor K. Kooy, Muyuan Ma, Hendrik H. Beeftink, Gerrit Eggink, Johannes Tramper, and Carmen G. Boeriu. (2009) 
Analytical Biochemistry 384(2): 329 - 336
Hyaluronan (HA) is a polysaccharide with high-potential medical applications, depending on the chain length and the chain length distribution. Special interest goes to homogeneous HA oligosaccharides, which can be enzymatically produced using Pasteurella multocida 
hyaluronan synthase (PmHAS). We have developed a sensitive, simple and fast method, based on 
fluorophore-assisted carbohydrate electrophoresis (FACE), for characterization and quantification 
of polymerization products. A chromatographic pure fluorescent template was synthesized from 
HA tetrasaccharide (HA4) and 2-aminobenzoic acid. HA4-fluor and HA4 were used as template for 
PmHAS-mediated polymerization of nucleotide sugars. All products, fluorescent and non-fluorescent, 
were analyzed with gel electrophoresis and quantified using lane densitometry. Comparison of HA4 
and HA4-fluor derived polymers showed that the fluorophore did not negatively influence the PmHAS-
mediated polymerization. Only even-numbered oligosaccharide products were observed using HA4-
fluor or HA4 as template. The fluorophore intensity was linearly related to its concentration and the limit 
of detection was determined to be 7.4 pmol per product band. With this assay we can now differentiate 
oligosaccharides of size range DP2 to ~DP400, monitor the progress of polymerization reactions, and 
measure subtle differences in polymerization rate. Quantifying polymerization products enables us to 
study the influence of experimental conditions on HA synthesis.
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Introduction
Hyaluronan (or hyaluronic acid; HA) is a naturally occurring biopolymer of molecule sizes up to 107 
Da and has numerous biological functions depending on the molecular weight and the chain length 
distribution. HA is an unbranched copolysaccharide, composed of two alternating sugars glucuronic 
acid (GlcUA) and N-acetylglucosamine (GlcNAc), and is produced by the enzyme hyaluronan synthase 
(HAS) found in many organisms, including mammals, birds and several pathogenic bacteria (Weigel 
2002). 
In general, HA with molecular weight above 500 kDa has physicochemical applications (Asari 2004; 
Kogan et al. 2007), where elasticity and viscosity of the chain functions as a biological lubricant for 
smooth tissue movement or a flexible structural component in skin, eyes, and cartilage (Fraser et al. 
1997). HA with molecular weight below 500 kDa and especially below 10 kDa (~DP50) has interesting 
functions in signaling, adhesion and recognition (Fraser et al. 1997; Asari 2004). Research in the cell 
biological function of HA is still in an initial stage and the effect is not fully understood. This is underlined 
by results found in for instance cancer research, where HA oligosaccharides can both enhance or 
inhibit tumor progression depending on the tissue and state of tumor involved (Stern et al. 2006). 
To increase the understanding of the functions of HA oligosaccharides, it is essential to produce 
these oligosaccharides. One of the possible strategies is enzymatic synthesis of hyaluronan starting 
from sugar nucleotides UDP-GlcUA and UDP-GlcNAc using hyaluronan synthase (HAS). Up to now, two 
groups of HA synthases have been identified that differ in the mechanism of polymerization (DeAngelis 
1999b). First, the Class I enzymes produce the hyaluronan chain in a processive polymerization, through 
continuous addition of subsequent sugar nucleotides on the reducing end. The polymerization stops 
after the enzyme releases the polymer. Class II consists of a single member, Pasteurella multocida HAS 
(PmHAS), which synthesizes hyaluronan in a non-processive manner. PmHAS is originally the only 
enzyme that can release, rebind and extend the growing HA chain at the non-reducing end (DeAngelis 
1999b). Starting polymerization from mono-sugar nucleotides, defined as de novo synthesis, PmHAS 
synthesizes products with a broad chain length distribution. When a HA oligosaccharide with a length 
of 4 sugars (HA4), named template, is used in PmHAS-mediated polymerization as starting molecule, 
the chain length distribution of the product mixture narrows and the reaction rate increases (Jing et 
al. 2004). The template size is related to the polymerization rate and the minimal size of templates 
elongated with high efficiency by PmHAS contained a trisaccharide with two glucuronic acid residues 
(Williams et al. 2006).
To study the enzymatic production of HA oligosaccharides and the polydispersity of the 
polymerization products, we needed an assay that allows characterization and quantification of low 
molecular weight products in reaction volumes as low as few microliters. For this, a method derived 
from fluorophore-assisted carbohydrate electrophoresis (FACE) was developed as assay. FACE using 
polyacrylamide gels has several advantages in separating saccharides compared to other systems, 
such as high-pressure liquid chromatography (HPLC), size exclusion chromatography (SEC), and 
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capillary electrophoresis (CE). Using polyacrylamide gels for gel electrophoresis, low-molecular weight 
HA oligosaccharides up to DP100 can be separated based on size and charge as individual bands, 
while a low sample volume is required (Ikegami-Kawai et al. 2002). Separating several samples 
simultaneously on polyacrylamide gels makes screening for optimal experimental conditions more 
convenient. In addition, experimental time is reduced through directly applying the reaction mixture on 
the polyacrylamide gel without an additional separation step. Coupling a fluorophore to saccharides, 
which is the principle of FACE, results in a very sensitive assay measuring the amount of saccharides 
in the range of 5 to 500 pmol (Starr et al. 1996). The fluorescence intensity is linearly related to the 
amount of the fluorophore (Calabro et al. 2000a; Calabro et al. 2000b), facilitating the quantification of 
HA oligosaccharides coupled to that fluorophore.
In literature, FACE is generally used to analyze oligosaccharides produced by successively 
hydrolyzing hyaluronan, labeling hydrolysis products with a fluorophore, and analyzing them through 
gel electrophoresis (Calabro et al. 2000b; Seyfried et al. 2005). Only two groups have used FACE 
to label a hyaluronan template, demonstrating the possibility to elongate derivatized templates by 
PmHAS-mediated polymerization (Jing et al. 2004; Krupa et al. 2007). In this study, we further develop 
this latter technique into a quantitative assay by polymerizing the fluorescent template HA4-fluor (Figure 
1), separating the polymerization products with gel electrophoresis, and quantifying the products with 
densitometry. This developed quantitative assay is generally applicable for studying polysaccharide 
synthesis via chain elongation at the non-reducing end. We show the applicability of this method 
in monitoring the progress of the polymerization through the characterization and quantification of 
intermediary polymerization products. The limits and advantages of the developed technique are 
evaluated. The produced and purified fluorescent template did not affect the polymerization mechanism 
of PmHAS, resulting in a fast, simple and sensitive assay that enables us to study quantitatively the 
effect of experimental conditions on enzymatic HA synthesis. 
Figure 1.   Scheme representing the enzymatic elongation of a hyaluronan template (HA4) labeled with fluorophore 
2AA.
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Experimental procedures
All of the reagents were purchased from either Merck or Sigma-Aldrich unless otherwise noted. 
Hyaluronic acid from Streptococcus equi and UDP-glucuronic acid were purchased from Fluka 
Biochemika. Ovine testicular hyaluronidase type V, UDP-N-acetylglucosamine, 2-aminobenzoic acid, 
and Stains-all were acquired from Sigma-Aldrich. Sodium cyanoborohydride was from Acros Organics. 
The non-fluorescent hyaluronan markers nanoHA10-20 ladder and Select-HATM 50k were purchased from 
Hyalose. 20% TBE gels and Ultrapure 10xTBE buffer were from Invitrogen. For the polymerization 
reactions, two HAS enzymes were used, PmHAS Core and PmHAS HIS, both provided by Organon part 
of Shering-Plough. The PmHAS Core enzyme represents the soluble PmHAS1-703 enzyme as described 
by Jing & DeAngelis (Jing et al. 2000) cloned and expressed in a pET101/D-TOPO expression vector 
(Invitrogen) with a stop codon introduced after the PmHAS reading frame. Omitting of this stop codon in 
pET101/D-TOPO results in PmHAS HIS with an additional V5 epitope and polyhistidine (6xHis) region 
at the C-terminal end of the enzyme. The His-tag of the PmHAS HIS facilitates the enzyme purification 
on Ni-NTA columns (Qiagen).
Preparation of oligosaccharides from HA digests
The tetrasaccharide HA4, used in polymerization as template, was prepared through hydrolysis of 
hyaluronan (HA) with ovine testicular hyaluronidase type V basically as described by Gao et al. (Gao 
et al. 2006a). After heat inactivation of the enzyme and freeze drying the reaction mixture, the HA 
products were separated using flash column chromatography with Silica gel 60 as column material 
and n-butanol/water/acetic acid (3:1:1) as eluens (Boeriu et al. 2007). The tubes containing the same 
compound were pooled and dried with a rotavap. As final step, the purified HA oligosaccharides were 
identified using HPLC and MALDI-TOF. The prepared stock of HA4 still contained minor traces of 
HA2.
Synthesis of 2AA-labeled HA oligosaccharides
The purified HA4-oligosaccharides were labeled with the fluorophore 2-aminobenzoic acid (2AA; also 
known as anthranilic acid) by reductive amination at the reducing end sugar as described by Anumula 
(Anumula 1994), with the following adaptations. HA4 was dissolved in deionized, particle-free water 
at a concentration of 8 mg/ml (10.3 mM). The derivatization mixture consisted of three volumes of 
methanol-acetate-borate medium to one volume of HA solution and was incubated at 40ºC for 16 
hours. 
The derivatized HA-fluor products were purified in three separation steps on an ÄKTA explorer 
FPLC system monitoring the eluens at 215 and 340 nm: 1) desalting the derivatized oligosaccharides 
with a Sephadex G10 column and 50 mM ammonium acetate as eluens; 2) separating the fluorescent 
saccharides from the unreacted ones using a Source 30Q column with a NaCl gradient from 0- 0.5M 
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over 100 minutes at a flow rate of 2ml/min; and finally 3) removing the NaCl through desalting with a 
Sephadex G10 column and 50 mM ammonium acetate. Samples containing the same compound were 
pooled and were freeze dried after each separation step. After the last separation step, the products 
were identified with MALDI-TOF. 
Polymerization of HA oligosaccharides
 HA2-fluor, HA4 and HA4-fluor, purified after the derivatization step, were used as templates in 
polymerizations with either PmHAS Core or PmHAS HIS as enzyme. All reactions were carried out 
under similar conditions unless otherwise noted. Concentrations of enzyme, sugar nucleotides and 
template were constant at 80 μg/ml, 5.5 mM and 0.1 mM, respectively, in reaction volumes from 25-100 
μl. The reaction buffer contained 5 mM MnCl2, 50 mM Tris∙HCl (pH 7.1) and 1 M ethylene glycol (Jing et 
al. 2004). The reactions were incubated at 30ºC for 0.5 to 6 hours. All reactions were stopped through 
heating for 15 min at 95ºC and kept in the freezer (-20ºC) until analysis through gel electrophoresis.
Gel electrophoresis of polymerization products
The reaction samples were analyzed on 20% TBE polyacrylamide gels using Ultrapure TBE running 
buffer containing 0.1 M Tris, 0.09M boric acid and 1.0 mM EDTA. From each polymerization reaction 
mixture was 10 μl loaded on gel. Two commercial markers were used to characterize the polymerization 
products: the HA nanoladder with a DP range from 10 to 30 even oligosaccharides, named nano HA10-20 
ladder, and the high molecular weight HA polysaccharides with an Mn of 30.2 kDa and Mw of 30.3 kDa, 
named Select-HATM 50k. HA4-fluor was added to these markers to identify the location of fluorescent 
low molecular HA oligosaccharides. 
The electrophoresis conditions were adapted from Ikegami-Kawai and Takahashi (Ikegami-Kawai 
et al. 2002): gel electrophoresis was done in the cold room with a first electrophoresis step at 250V for 
20 minutes, followed with a second step for 10 minutes at 580V. To minimize the diffusion of bands, 
gels were imaged directly after electrophoresis one by one, while the other gels were kept in the cold 
room. 
Obtaining fluorescent and Stains-all images
Gels were illuminated with UV light (365 nm) and imaged with a FluorChem 8800 cooled-CCD detection 
system (Alpha Innotech Corporation) fitted with a 460 nm bandpass blue filter (Hoechst Blue, HB-500; 
Alpha Innotech Corporation) over the camera. For characterization of the fluorescent polymerization 
products, a second picture was taken oversaturating the pixel intensity of the products within the gels 
in order to make less abundant products visible. Pictures of the gels were corrected by subtracting 
background pictures without gels taken at identical exposure times using the ALPHA-EASETM software 
of FluorChem 8800. 
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After imaging the fluorescence of the gels, the gels were incubated in Stains-all solution for 30 
minutes at room temperature. Per gel, the Stains-all solution is prepared mixing 2.5 ml of 0.1 m/v % 
Stains-all in 100% formamide with 22.5 ml of solution 2, containing 45 mM Tris-HCl, 7.5 % formamide, 
25% isopropanol in MQ water (pH 9.2). After staining, the gels were washed repeatedly with MQ water 
over a period of several hours. Pictures of the Stains-all gels were obtained by the GS-800 calibrated 
Densitometer (Bio-Rad), a scanner with white light illumination. 
Data analysis: Determining molecular weight and polydispersity using lane densitometry
Both the fluorescent and the Stains-all pictures were analyzed using the software Quantity One from 
Bio-Rad. Additional noise in the data of the gel picture was decreased using a baseline determined with 
the “rolling disk” method at a disk size of 50. 
Through lane densitometry, the following parameters were determined from all polymerization 
products: relative front, trace quantity, and relative product quantity. The relative front, or relative 
mobility, is the location of a product band between the top of a defined lane to the bottom, divided by 
the total length of this lane. In this way, the top of the gel is defined as 0.00 and the bottom of the gel as 
1.00. A reference line was prepared plotting the logarithmic value of the HA markers molecular weight 
to the corresponding relative mobility.
Trace quantity is the amount of intensity of a product band measured by the area under its intensity 
profile curve; the units are intensity x mm. The relative product quantity of a product band is determined 
as followed and represents a percentage of total intensity: 
 
Since products above DP50 could not be separated individually, the amount of intensity in this 
part of the lane is measured in selected relative front steps of 0.01. Combining 1) the reference line 
of molecular weight plotted against the relative mobility with 2) the measured intensity of the selected 
relative front steps gives information on the size and quantity of high molecular weight products.
The polydispersity of a polymerization reaction can be calculated using the data of the relative 
product quantity and the molecular weight of the polymerization products. Polydispersity is defined as 
the width of a distribution curve of polymers, or to be specific: the ratio between the weight averaged 
molecular weight (Mw) and the number averaged molecular weight (Mn). When the polydispersity 
equals 1, the polymers are monodispers. Mn is defined as the total weight of all molecules (N x M) in a 
polymer mixture divided by the total number of mol polymer (N) present, also called a number averaged 
molecular weight:
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Mw gives a weight averaged molecular weight with the mass fraction (m) as weighing factor:
 
  
Both Mn as Mw can be calculated from the relative product quantity, depicted here as Ni, and the 
corresponding molecular weight of each product band or selected relative front step, depicted as Mi.
The reproducibility of FACE was assessed by determining the measurement error of the method 
for a random band from a random polymerization mixture. To determine the measurement error, the 
same polymerization mixture was analyzed on two polyacrylamide gels under the same separation 
and quantification conditions. Four samples of the same reaction mixture, twice put on each gel, were 
analyzed by gel electrophoresis. The products were quantified and the variance of the relative product 
quantity was determined between the lanes (σ2lane) and between separate gels (σ
2
gel) using variance 
components of SPSS 15. σ2lane and σ
2
gel was respectively 0.0682% and 0.01442%, expressed in the 
same percentage unit as the relative product quantity. The measurement error, represented as a 
standard deviation for one random observation, was calculated with: 
  
The background within each fluorescent picture contains a certain amount of intensity, considered 
noise. Products can only be detected and quantified if they can be distinguished from the noise. For 
this, the limit of detection and the limit of quantification were determined. The limit of detection is 
defined as the average noise of an empty lane added with 3 times the standard deviation. The limit 
of quantification used in our lab is defined as the average noise of an empty lane added with 6 times 
the standard deviation. The average noise was obtained from averaging the amount of intensity in ten 
empty lanes from Rf distance 0.4 to 0.6 in relative front steps of 0.01, corresponding to 200 points. 
Using Figure 2, the limit of detection and the limit of quantification were determined in pmol.
Results
Synthesis and characterization of 2AA-labeled HA oligosaccharides
Fluorescent labeled HA4 was synthesized from 2-aminobenzoic acid (2AA) and a HA4 stock, containing 
minor traces of HA2. The products of this reaction were purified in three sequential chromatography 
steps consisting of size exclusion-, anion exchange-chromatography and desalting, which resulted 
in chromatographically pure HA4-fluor. The isolated products were individually pooled and identified 
with MALDI-TOF MS. The MALDI-TOF mass spectrum (not shown) of HA4-fluor showed a large 
peak at m/z 920.08 corresponding to [HA4-fluor +Na]+. The percentage of HA4-fluor elongated during 
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polymerization was determined from reaction mixtures separated by gel electrophoresis. Based on the 
results of these experiments, a purity of 98% (mol/mol) of the HA4-fluor was calculated.
Sensitivity and reproducibility of FACE
The sensitivity of the assay was determined 
with HA4-fluor as model compound. Gels 
were run with different concentrations of 
fluorescent template and the intensity of the 
fluorescence emission after UV light excitation 
was measured. The fluorescence intensity of 
each HA4-fluor band was linearly related to 
the amount of HA4-fluor in the range of 6.25 
to 1000 pmol (Figure 2). The limit of detection 
and the limit of quantification were determined 
to be respectively 7.4 and 14.7 pmol. The 
maximal amount of fluorescent polymerization 
products was set at 1000 pmol to facilitate 
linear quantification, which corresponds to a HA4-fluor concentration of 0.1 mM that we use at the start 
of the reaction.
The sensitivity of the assay was verified by the quantification of fluorescent polymerization products. 
HA4-fluor, UDP-GlcUA and UDP-GlcNAc were polymerized with the enzyme PmHAS HIS, described in 
Materials and methods, for 0.5 hour and the reaction mixture was analyzed on a 20% polyacrylamide 
gel by gel electrophoresis, developing the gel both for fluorescence and Stains-all (Figure 3A). The 
amount of oligo- and polysaccharides of a defined molecular weight was quantified and expressed in 
molar percentage of the total amount of products detected, which was at the beginning of the reaction 
100% HA4-fluor. In this chapter, this amount is referred as relative product quantity. 
The development of the gel by the cationic dye Stains-all was used to reveal, if present, 
non-fluorescent polymerization products that are formed by de novo synthesis starting from sugar 
nucleotides. In this way, de novo synthesis products can be distinguished from fluorescent products that 
started from HA4-fluor. The analysis of the gels showed a difference in sensitivity between Stains-all 
and the fluorescent detection (Figure 3A). High molecular weight polysaccharides and oligosaccharides 
with DP above 10 were visualized using fluorescence and Stains all. However, HA oligosaccharides 
below DP10 are only observed when coupled to the fluorophore. Therefore, de novo synthesis can only 
be detected by Stains all when oligosaccharides are longer than DP10.
To evaluate the reproducibility of FACE, the measurement error of the method was determined as 
is described in Experimental Procedures. The measurement error of the method, represented by the 
standard deviation, was ±0.287%. 
Figure 2.   Standard curve of HA4-fluor. Upper left corner: 
structure of HA4-fluor.
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Relation between molecular weight and electrophoretic mobility
When using gel electrophoresis, the migration distance of the HA polymerization products in gels is 
related to their molecular weight and their charge. To determine the product size in a reaction mixture, 
a standard curve was made with three sets of markers (Figure 3B). The selected markers were 1) a 
commercial non-fluorescent HA ladder with a DP range from 10 to 30 even-numbered oligosaccharides; 
2) a commercial non-fluorescent high molecular weight HA polysaccharide with a molecular weight of 
around 30 kDa; and 3) polymerization products originated from HA4-fluor, UDP-GlcNAc and UDP-
GlcUA, where the products could be identified through band counting. 
The relative migration distance of the oligo- and polysaccharides in the gel was a linear function 
to the logarithm of their molecular weight (Figure 3B). With this method, a theoretical molecular weight 
range of 500 up to 78000 Da, corresponding to respectively DP2 to ~DP400, can be determined. An 
interesting result is that all polymerization products derived from HA4-fluor seem to be oligosaccharides 
with an even number of sugar residues. No odd-numbered oligosaccharides were observed.
Figure 3B shows that the migration rate of fluorescent HA and non-fluorescent HA was different. 
The fluorescent HA chains have one negative charge extra, which makes the HA chains somewhat 
faster than the non-fluorescent HA markers, but this difference in migration speed decreases as the HA 
chains become longer.
Monitoring PmHAS-mediated polymerization of templates
HA4-fluor, HA4 and HA2-fluor were used as templates for polymerization by two different HAS enzymes, 
PmHAS HIS and PmHAS Core. Both enzymes were used to see if the developed FACE assay is 
Figure 3.   A) Comparison of staining methods for analysis of PmHAS-mediated polymerization products. Reactions 
were incubated with HA4-fluor and PmHAS HIS for 0.5 h. Development of gels was done by UV light (upper picture 
and black line) and by Stains-all (lower picture and dotted line). The triangles show the HA oligosaccharides 
identified through band counting. Figure 3B was used to calculate the lines that predict Mw of the products. B) 
Relative mobility as a function of molecular weight for non-fluorescent hyaluronan (open square) and fluorescent 
hyaluronan (closed square). Degree of polymerization is given in the insert.
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able to measure differences in polymerization 
rates. Reaction mixtures were incubated for 
30 minutes under identical conditions and 
with similar enzyme-substrate ratio. Figure 
4 shows the products from HAS-catalyzed 
polymerization of the templates analyzed by 
gel electrophoresis. The reaction products 
in Figure 4 are the result of elongating the 
selected templates in a reaction where either 
PmHAS HIS (lane 1-3) or PmHAS Core (lane 
4-7) was used. Comparing the Stains-all and 
fluorescent picture of the gel illustrates that 
HA4-fluor (lane 1 and 5) and HA4 (lane 2 and 
6) were polymerized without observing de novo 
synthesized oligosaccharides. In contrast, HA2-
fluor was not elongated (see lane 3 and 7 in the 
fluorescent photo), while the Stains-all picture 
shows in these lanes a low concentration of de 
novo synthesized oligosaccharides. The characterized fluorescent oligosaccharides in lane 1 range 
from HA4 to HA72 and in lane 5 from HA4 to HA56 for the reactions incubated with PmHAS HIS and 
PmHAS Core, respectively.
To verify that the fluorophore residue coupled to the template HA4 has no effect on the polymerization, 
both HA4 and HA4-fluor where elongated under the same conditions (Figure 4 and 5). Figure 5 shows 
a quantitative analysis of the experiments in Figure 4. In Figure 5A is a polymerization with 0.5 hour 
incubation time depicted of HA4 and HA4-fluor using PmHAS HIS, corresponding to lanes 1 and 2 in 
Figure 4. Figure 5B demonstrates the polymerization results with identical conditions using PmHAS 
Core, corresponding to lanes 5 and 6 in Figure 4. The use of fluorescent labeled substrate allows 
visualization of all products, including short oligosaccharides with DP from 2 to 10, while Stains-all 
shows only longer oligo- and polysaccharides. From the Stains-all data of HA4 and HA4-fluor it is 
concluded that both templates generate almost identical products with similar polydispersity and that 
the fluorophore attached to HA4-fluor does not negatively influence the polymerization.
The developed FACE assay is able to measure subtle differences in the reaction rate. From Figure 
5 it is observed that PmHAS Core converted in 30 minutes 91% of the template HA4-fluor compared 
to 65% conversion by PmHAS HIS, suggesting that PmHAS Core has a higher activity. The difference 
between the two reactions is also illustrated by the polydispersity of the polymerization product, which 
is 2.11 for PmHAS HIS-mediated reaction and 1.22 for the reaction with PmHAS Core.
Figure 4.   Polymerization of templates analyzed on gel 
developed by UV light (left) and by Stains-all (right). 
Polymerization reactions were incubated for 0.5 hour 
with PmHAS HIS (1-3) or PmHAS Core (4-7) using 
templates: HA4-fluor (1, 5), HA4 (2, 6), and HA2-fluor (3, 
7). Lane 4 (M) contains a mixture of HA4-fluor and the 
reaction mixture of lane 5. 
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Figure 5.   Comparison between the polymerization of HA4-fluor (triangle or square) and HA4 (circle) for PmHAS 
HIS (A) and PmHAS Core (B) at 0.5 hour. The closed and open symbols represent the fluorescent and the Stains-
all data, respectively. The polydispersity of the products is given as values inserted in the photos. The symbols 
show the HA oligosaccharides identified through band counting. The lines that predict Mw of the products were 
calculated using a standard curve, see Figure 3B. 
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FACE analysis of polymerization progress
FACE was used to monitor the progress of the polymerization reaction in time. All reactions were carried 
out under identical conditions and with similar enzyme-substrate ratio. PmHAS HIS was selected to 
catalyze these polymerizations, because of practical advantages as straightforward purification and the 
possibility to immobilize this enzyme with the His-tag in a later stage. The products of different reaction 
times from 0.5 to 6 hours were analyzed on the same gel (Figure 6A) and quantified (Figure 6B). Figure 
6B demonstrates the conversion of HA4-fluor and the formation and decrease of elongated products 
in time. After a reaction of 0.5 hour, the number averaged molecular weight (Mn) is 1608 Da (~HA8) 
with products ranging from the starting material HA4 to HA22. After 4 hours, the Mn increased to 
4991Da (~HA26) with products ranging from HA4 to HA58. The formation and conversion of a number 
of selected products is shown in Figure 6C. For example, after 0.5 hour of polymerization, the relative 
product quantity of HA10 already has reached its maximum of 6.4%, while the amount of HA20 is still 
very low at 1.5 %. Further in time, both HA10 and HA20 are converted into longer oligosaccharides. 
After 2 hours, the relative product quantity of HA10 has decreased to a level of 2.3% and after 4 hours 
HA10 was not detected anymore. In comparison, the relative product quantity of HA20 has reached 
its maximum value of 8.8% after 2 hours, while the formation of longer oligosaccharides as HA30 and 
HA40 are beginning to show. Using these data, FACE allows monitoring the progress of the reaction 
and the polydispersity of its products.
Discussion
In our pursuit to produce HA oligosaccharides of DP6 to DP50 with a narrow chain size distribution, 
we lacked an appropriate assay to measure the molecular weight distributions of our products and to 
quantify the effect of experimental conditions on the product size and homogeneity. The required assay 
had to meet the following demands: 1) the ability to separate and visualize low molecular weight HA 
oligosaccharides, 2) low sample volume requirement, 3) fast quantitative analysis without additional 
separation steps, and 4) a high sensitivity. Fluorophore-assisted carbohydrate electrophoresis (FACE) 
has proven to meet these requirements characterizing and quantifying HA oligosaccharides after 
hydrolysis of high molecular weight hyaluronan (Calabro et al. 2000a; Calabro et al. 2000b; Seyfried 
et al. 2005). Therefore, we developed a quantitative FACE assay (FACE) to monitor synthesis of 
oligosaccharides through polymerization using a HA tetrasaccharide (HA4) derivatized with the 
fluorophore 2-aminobenzoic acid (2AA) to form HA4-fluor.
This FACE method characterizes and quantifies polymerization products starting from the purified 
fluorescent template HA4-fluor, instead of characterizing products derivatized to fluoresce after 
hydrolysis, as is done in the generally applied FACE assays. Elongation of fluorescent HA4 was carried 
out in only two other studies (Jing et al. 2004; Krupa et al. 2007). Jing and DeAngelis coupled HA4 to 
Oregon Green 488, a bulky fluorophore of 509.4 Da, to demonstrate that a modified template can be 
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Figure 6.   Monitoring polymerization products in time of reactions incubated with PmHAS HIS (360 μg/ml). A) 
Image of gel of fluorescent products formed after 0.5 to 6 hours incubation. Five selected products, identified 
through band counting, are indicated. B) For time points 0.5 to 4 hours, the relative quantity is shown of the 
polymerization products. C) The relative quantity of five selected products is followed in time.
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used to produce HA polysaccharides for special applications, such as biosensors. With HA4 coupled to 
ANDA (Mw 301.9 Da), Krupa et al. characterized HA polymerization products through band counting. 
In this study, we selected 2AA with a molecular weight of 137.14 Da for the coupling to HA4. The 
produced HA4-fluor was for 98% pure and contained no impurities that affected the polymerization 
reaction. HA4-fluor was polymerized by PmHAS, the reaction mixtures were simultaneously analyzed 
on polyacrylamide gels using gel electrophoresis, and the fluorescent products were characterized and 
quantified requiring reaction volumes below 10 microliters. This method makes it possible to monitor 
the progress of a polymerization reaction, to calculate the polydispersity of low molecular weight 
products and to quantify the effect of experimental conditions on the product size and homogeneity. The 
developed technique is also applicable in other fields involving the production of negatively charged 
polysaccharides.
Two main properties were important for the development of this FACE assay. First, HA4-fluor does 
not influence the polymerization mechanism (see Figure 5). If the fluorophore would have been too 
large, it might have changed the binding affinity of the template to the enzyme and consequently 
affect the polymerization mechanism. Second, all fluorescent products are separated according to their 
charge and size in a linear manner (see Figure 3B), which makes it possible to calculate their molecular 
weight from their migration distance in the gel. To quantify the effect of experimental conditions on the 
product size and homogeneity, it is important that the fluorophore does not influence the polymerization 
mechanism and that the migration distance can be used to predict the molecular weight of unknown 
oligo- and polysaccharides.
In selecting the appropriate fluorophore for our FACE assay, both the charge and the size of 
the fluorophore was taken into account. Since HA oligosaccharides are negatively charged, their 
separation during gel electrophoresis is based on molecular weight and charge. The derivatization of a 
fluorophore to oligosaccharides changes both these properties. A neutral fluorophore as AMAC slows 
down the smaller HA oligosaccharides during gel electrophoresis, through which the saccharides are 
not separated in the order of their molecular size (Calabro et al. 2000a; Oonuki et al. 2005). Other 
commonly used fluorophores ANDA (Starr et al. 1996) and ANTS (Jackson 1994; Oonuki et al. 2005) 
are both negatively charged, ensuring a linear separation, but are rather bulky. To avoid separating 
problems and possible negative influence on the polymerization mechanism caused by a bulky 
fluorophore, we have selected the small negatively charged fluorophore 2AA. This fluorophore did not 
show a negative influence on the polymerization and the products were separated according to their 
size and charge. As a result, FACE is a very sensitive, accurate, fast and simple method to quantify the 
effect of experimental conditions on the product size and homogeneity. 
In the FACE assay, fluorescent products are visualized using fluorescence. Besides developing 
the gels for fluorescence, Stains-all was used to distinguish fluorescent products from HA products 
formed through de novo synthesis. Comparison of both techniques demonstrated that Stains-all does 
not stain the shorter oligosaccharides below 10 saccharides (Figure 3A), which is in agreement with 
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the study of Turner and Cowman (Turner et al. 1985). Detection and quantification of oligosaccharides 
below DP10 can only be done when labeled to a fluorescent tag. Despite the limitations, Stains-all does 
give information on the broadness of the formed polymerization products and was successfully used to 
compare the polymerization products of both HA4-fluor and HA4 (Figure 5). 
Several tests were carried out to evaluate the sensitivity and reproducibility of FACE. The intensity 
of the fluorophore was linearly related to the amount of HA4-fluor in the range from 6.25 to 1000 pmol 
(Figure 2), and the limit of detection was determined as 7.4 pmol of fluorescent HA. This sensitivity is 
in the same order of magnitude as other FACE methods (Anumula 1994; Starr et al. 1996; Calabro et 
al. 2000a) and is comparable or slightly less sensitive than radiometric assays (Sugahara et al. 1979; 
Armstrong et al. 2002). The reproducibility of the developed FACE method was tested by analyzing 
the same polymerization reaction mixture two times on 2 different gels, resulting in a measure of the 
reproducibility (measurement error), represented as standard deviation, of ±0.287%. Not only can the 
developed method differentiate HA oligosaccharides in the range of DP2 to ~DP400 (Figure 3B), it 
also analyzes several reaction samples simultaneously on one gel without additional separation steps, 
which decreases the analysis time substantially. Furthermore, no expensive equipment is needed and 
no hazardous materials as radioactive substrates are involved, resulting in an easy-to-use assay for 
many laboratories.
During the development of this FACE assay, it appeared that only oligosaccharides with an 
even amount of sugars were present in the gel after polymerization of HA4-fluor or HA4. Figure 3B 
demonstrates that the distances of each band from the HA nanoladder, containing even-numbered 
bands from HA10 up to HA30, are comparable to the distances between the bands in the reaction with 
HA4-fluor. In addition, only even-numbered oligosaccharides were observed in MALDI-TOF analysis 
of the polymerization products (data not shown). However, it could be that the concentration of odd 
numbered oligosaccharides was below detection. A possible explanation for observing only even 
numbered oligosaccharides is that the conversion rate to synthesize an odd numbered oligosaccharide 
is lower than to produce an even numbered one. During polymerization, the HA chain is elongated by 
two transferase reactions within PmHAS: one to add the glucuronic acid (GlcUA) residue and one to 
add the N-acetylglucosamine (GlcNAc) residue. In the polymerization reactions using HA4 or HA4-fluor, 
the even and odd numbered oligosaccharides have respectively a GlcUA residue or a GlcNAc residue 
at the non-reducing end, where the chain is elongated. Williams et al. demonstrated that GlcUA 
transferase activity is ~20-fold faster than the GlcNAc transferase activity (Williams et al. 2006). 
Apparent Km values described in literature (DeAngelis 1996; Krupa et al. 2007) are for UDP-GlcNAc 
(75 - 660 μM) higher than for UDP-GlcUA (14 – 20 μM). This demonstrates that the binding affinity 
for UDP-GlcNAc is lower than for UDP-GlcUA, which possibly causes a lower GlcNAc transferase 
activity. This difference in conversion rate could explain why there are no oligosaccharides ending with 
a GlcNAc, or odd-numbered oligosaccharides, observed. In the near future, we will investigate the 
polymerization mechanism in more detail.
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To show the application possibilities of FACE, three templates have been used to explore the effect 
on PmHAS-mediated polymerization: HA2-fluor, HA4-fluor and HA4. PmHAS is from origin the single 
hyaluronan synthase that can polymerize both starting from UDP-monosaccharides and extending a 
HA template. HA4 and HA4-fluor with a concentration of 0.1 mM could easily be polymerized, while 
HA2-fluor with the same concentration was not elongated. This is in agreement with other studies, 
where it was demonstrated that the minimal template size for elongation by PmHAS with high efficiency 
contains a trisaccharide with two glucuronic acid residues (Williams et al. 2006). 
Using this quantitative FACE assay, we were able to measure subtle differences in polymerization 
rate (Figure 5). Furthermore, Figure 6 demonstrates that the developed method is convenient to 
monitor the progress of a polymerization in time and can be used to obtain information on kinetic 
parameters. The high reproducibility and low detection limit makes this FACE method a useful tool to 
characterize and quantify polymerization products of PmHAS. The use of HA4-fluor showed no effect 
on the polymerization mechanism or on the migration distance in the gel used for the determination of 
molecular size of unknown polymerization products. In summary, we have developed a fast, sensitive, 
accurate and simple method for investigating and quantifying the influence of experimental conditions 
on the product size and homogeneity. The method can be extended to other fields involving chemical 
or enzymatic synthesis of polysaccharides such as heparosan.
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2AA, 2-aminobenzoic acid; AMAC, 2-aminoacridone; ANDA, 7-amino-1,3-naphtalene disulfonate; ANTS, 
8-amino-naphthalene-1,3,6-trisulfonate; CCD, charge-coupled device; CE, capillary electrophoresis; 
DP, degree of polymerization; FACE, fluorophore-assisted carbohydrate electrophoresis; GlcNAc, 
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Appendix I 
HPAEC separation of 2AA-derivatized HA oligosaccharides on a Source 30Q column using 0 – 0.5M NaCl gradi-
ent. The three largest peaks have been identified with MALDI-TOF.
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Reproducibility of the developed FACE method in quantifying fluorescent polymerization products. The plot rep-
resents the average relative product quantity of four lanes. The error bar shows the measurement error of the 
method, represented as the standard deviation.
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CHAPTER 4
Pasteurella multocida hyaluronan synthase (PmHAS) is a bi-functional glycosyltransferase, containing a β1,3-glucuronyltransferase and β1,4-N-acetylglucosaminetransferase domain. PmHAS catalyzes the elongation of hyaluronan (HA) through sequential addition of single 
monosaccharides to the nonreducing end of the hyaluronan chain. In this paper, we focus on the 
influence of the oligosaccharide on the elongation reaction, investigating initial velocity kinetics of 
single step elongations using HA oligosaccharides of different lengths, from HA4 up to HA9. The kcat 
increases with the oligosaccharide length to a maximum of 11 and 14 s-1 at the NAc- and UA-transferase 
domains, respectively. Interestingly, the specificity constant kcat/Km increases from HA5 to HA7 to a 
value of 44 mM-1 s-1, indicating an oligosaccharide binding site with increasing specificity towards a 
heptasaccharide at the UA domain, while kcat/Km was moderately constant around 8 mM-1 s-1 for HA4, 
HA6, and HA8, indicating a binding site with significant lower binding specificity at the NAc domain 
than at the UA domain. These findings are confirmed by a structural homology model of PmHAS, 
revealing two separate oligosaccharide binding sites of different sizes, one in each transferase domain. 
Structural alignment studies between PmHAS and glycosyltransferases of the GT-A fold showed great 
similarity in the binding of the UDP-sugars and the orientation of the acceptor substrate, which were 
used to localize the two HA oligosaccharide binding sites. Due to the large distance between these 
oligosaccharide binding sites, each HA oligosaccharide has to be bound and released for every 
elongation, causing an inevitable increase in product polydispersity in time.
Biosynthesis of hyaluronan: Structural/
functional evidence for two separate 
oligosaccharide binding sites in Pasteurella 
multocida hyaluronan synthase
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Introduction
Enzymatic production of glycosaminoglycans has become of great interest in the last two decades 
as these polysaccharides have many pharmaceutical and cosmetic applications. For organ integrity 
and function, glycosaminoglycans are essential, since they activate signaling pathways that control 
cell proliferation, differentiation, adhesion, and migration (Gandhi et al. 2008; Schaefer et al. 2010). 
The controlled production of oligosaccharides with defined chain length and sulphate groups would 
be an immense breakthrough in medical sciences with potential applications in, for instance, anti-
cancer therapeutics (Stern 2008) and disrupting viral invasion and pathogenesis (Gandhi et al. 2008). 
In nature, glycosaminoglycans are produced by glycosyltransferases, catalyzing the transfer of an 
activated donor sugar to an acceptor substrate, such as an oligosaccharide.
One of these glycosaminoglycans is hyaluronan (HA), a polysaccharide consisting of β3-N-
acetylglycosamine (GlcNAc)-β4-glucuronic acid (GlcUA) building blocks. After the first HA isolation 
from animal tissues (Meyer et al. 1934; Chain et al. 1940; Meyer et al. 1941; Boas 1949), it was 
discovered that HA was also produced by a small number of microbial pathogens (Kendall et al. 1937; 
Carter et al. 1953; MacLennan 1956) to disguise themselves from the mammalian immune system 
using HA as a cloak. Numerous cultivation procedures have been developed to produce HA using 
either these pathogenic microorganisms (Kendall et al. 1937; Thonard et al. 1964; Armstrong et al. 
1997) or safe recombinant hosts (DeAngelis et al. 1993a; Widner et al. 2005; Chien et al. 2007; Mao et 
al. 2007; Yu et al. 2008; Mao et al. 2009), containing the hyaluronan synthases (HAS) that synthesize 
HA. The quality of the product is crucial, since applications of HA differ depending on the length of 
the oligo- or polysaccharide, and, therefore, the production of HA with defined lengths is needed. 
Innovative production techniques aim for high molecular weight HA with a small product distribution, 
or polydispersity, by inflicting stress through culture conditions (Johns et al. 1994; Kim et al. 1996; 
Armstrong et al. 1997; Huang et al. 2006) or by avoiding HA degradation through hyaluronidase (Kim 
et al. 1996; Widner et al. 2005; Mao et al. 2009).
Recently, it was shown for Streptococcus zooepidemicus that overexpression of genes involved 
in UDP-GlcNAc biosynthesis increased the molecular weight of the HA products (Chen et al. 2009), 
indicating that the chain length is controlled by the availability of the substrates. This is underlined by 
kinetic data from HAS enzymes of different sources, demonstrating a significantly higher KmNAc value 
than KmUA value (Pummill et al. 1998; Itano et al. 1999; Tlapak-Simmons et al. 1999c; Krupa et al. 2007). 
Furthermore, the hyaluronan synthase in Pasteurella multocida (PmHAS) has the ability to elongate 
HA oligosaccharides (DeAngelis 1999b), which offers another opportunity to control the product length 
and polydispersity through substrate availability. The addition of HA oligosaccharides to the reaction 
in the presence of both UDP-sugars increases the polymerization rate of PmHAS and decreases the 
polydispersity of the HA products  compared to reactions starting with only the UDP-sugars (Jing et al. 
2004). Although these findings have resulted in high molecular weight products with narrow product 
ranges, the kinetic elongation mechanism of HAS enzymes behind these results are still unknown.
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In this chapter, we describe the influence of HA oligosaccharide chain length on the polymerization 
through one step sugar elongation using HA4 up to HA9. Several one-substrate models were evaluated 
and kinetic parameters kcat and Km were determined for each oligosaccharide individually using the 
Michaelis Menten model that gave the best fit with the data. The observed binding affinities kcat/Km 
for the HA oligosaccharides elongated at the UA-transferase site were considerably higher than at 
the NAc-transferase site, indicating two separate oligosaccharide binding sites. These results were 
supported by a structural homology model built for PmHAS that was based on the crystal structure 
of chondroitin polymerase K4CP (Osawa et al. 2009). This chondroitin polymerase has a significantly 
high sequence identity and sequence homology with PmHAS of 62% and 79%, respectively, resulting 
in a reliable structural model for PmHAS. Through structural alignment studies, similarities in the active 
sites of PmHAS and other glycosyltransferases have been found such as the location of acceptor 
binding sites and several conserved amino acids involved in binding the substrates. Conserved regions 
have been reported before for UDP-sugar binding sites, whereas in this work we have also found 
structural similarities for the acceptor binding site. To summarize, this study presents further evidence 
for two separate oligosaccharides binding sites within PmHAS, which affects the polydispersity of the 
HA products.
Experimental procedures
Characterization of PmHAS
All of the reagents were purchased from either Fisher or Sigma–Aldrich unless noted otherwise. PmHAS 
(purified) was provided by Schering-Plough (formerly Organon N.V.). PmHAS represents the soluble 
PmHAS1–703 enzyme, as described by Jing and DeAngelis (Jing et al. 2000), cloned and expressed in 
a pET101/D-TOPO expression vector (Invitrogen) with an additional V5 epitope and polyhistidine (6x 
His) region at the C-terminal end of the enzyme. PmHAS was purified from the crude extract by affinity 
chromatography on Ni-NTA columns (Qiagen).
A coupled-enzyme assay, similar to assays created for other glycosyltransferases (Fitzgerald 
et al. 1970; Gosselin et al. 1994; Krupa et al. 2007), was developed to measure PmHAS activity. 
The coupled-enzyme assay directly links the formed UDP byproduct of the PmHAS elongation to the 
decrease of NADH, which was spectrophotometrically measured at 340 nm. PmHAS activity was 
measured varying one of the reaction conditions, while keeping others constant. The standard reaction 
buffer contained 5 mM MgCl2, 112.5 mM KCl, 1 M ethylene glycol, and 50 mM Tris*HCl (pH 8.0) and 
the assay components 60 U PK/ml, 75 U LDH/ml, 2 mM PEP, and 0.4 mM NADH. Bis-Tris*HCl was 
used for the experiments below pH 7, and Tris*HCl for the experiments above or equal to pH 7. The 
following reaction conditions were varied and measured with the coupled-enzyme assay: pH range 
from 5.6 to 9; temperature range from 20 to 40 °C; 5 mM of MgCl2, MnCl2, CoCl2, NiCl2, or CaCl2; 
MgCl2 concentrations ranging from 5 to 50 mM; and the presence of viscous buffer component 1 M 
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trehalose, 1 M sucrose, or 0.1 – 2 M ethylene glycol. Within the coupled-enzyme assay experiments, 
concentrations of PmHAS, UDP-GlcNAc, UDP-GlcUA, and HA4 were kept constant at 50 μg/ml, 5.5 
mM, 5.5 mM and 0.1 mM, respectively. In the experiment with varying MgCl2 concentrations were 
substrate concentrations 1mM for both UDP-sugars and 0.1mM for HA4.
The reactions were measured at 35 °C for 20 minutes in reaction volumes of 150 μl using UV 
star microplates of 96 wells (Greiner Bio-One, Germany) and a temperature controlled Safire 
spectrophotometer (Tecan, Switserland). After measuring the decrease in absorbance, the reactions 
were stopped through heating for 15 min at 95 °C and kept in the freezer (-20 °C) until analysis 
through gel electrophoresis. PmHAS activity was also examined for 1 and 5 hours of reaction at 
varied concentrations of KCl ranging from 0 to 200mM, but because KCl is needed for PK activity, this 
experiment was only analyzed through gel electrophoresis.
HA product analysis by gel electrophoresis
Reaction mixtures were analyzed on 20% TBE polyacrylamide gels (Invitrogen) by gel electrophoresis 
and stained by Stains-All using the procedure as described in (Kooy et al. 2009). On the gels, Generuler 
DNA ladder Ultra low range (Invitrogen) was used as a marker.
PmHAS activity in single-step elongations
Initial rates were measured at 35 °C for each one-step elongation from HA4 up to HA9 using the 
coupled-enzyme assay with 60 u PK/ml, 75 u LDH/ml, 2 mM phosphoenolpyruvate, 0.4 mM NADH, 
15 mM MgCl2, 112.5 mM KCl, 1 M ethylene glycol, 50 mM Tris*HCl at pH 8.0. These purified HA 
oligosaccharides were all purchased from Hyalose, L.L.C (USA). All reactions with even-numbered 
oligosaccharides were performed under saturating UDP-GlcNAc concentrations of 40 mM. The reactions 
with odd-numbered oligosaccharides were performed under saturating UDP-GlcUA concentrations of 1 
mM. After an incubation time of 5 minutes, the reactions were started by the addition of 5 μg/ml PmHAS 
and the varied oligosaccharide concentration of 0.1, 0.5, 1, 2, 4, or 6 mM. The reactions were stopped 
by heating for 15 min at 95 °C and enzymes were removed from the reaction mixtures with a Microcon 
YM-30 centrifugal filter unit (Millipore). These samples were desalted using Dowex AG 50W-X8 (Bio-
rad Laboratories) before measuring product formation in the reaction mixtures by Matrix Assisted Laser 
Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS).
For MALDI-TOF MS analysis, an Ultraflex workstation (Bruker Daltonics, Germany) equipped with 
a 337 nm laser was used. The mass spectrometer was operated in the positive mode and calibrated 
with a mixture of maltodextrins (mass range 250-2500 Da). The laser irradiance was set between 29 
to 32% of the full laser power and, after a delayed extraction time of 200 ns, the ions were accelerated 
by a 25 KV voltage. The ions were detected using the reflector mode and for data collection 200 shots 
were used. The matrix was prepared by solving 10 mg of 2,5-dihydroxybenzoic acid (DHB) in water. 
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The samples were 10 times diluted in the matrix solution and for analysis 2 ml of the mixture was 
transferred to a MALDI sample plate and dried under a stream of warm air.
Analysis of kinetic data
The kinetic data were fitted to three one-substrate equations to find the best fit. The equations of 
Michaelis Menten, Hill, and substrate inhibition (Cornish-Bowden 1995; Cook et al. 2007) were fitted in 
Excel using unweighted nonlinear regression:
Michaelis Menten:         with   
Hill:             
substrate inhibition:     
The uncertainties of the fits, standard deviations of the parameters and the correlation matrices were 
determined using the Excel SolverAid macro (de Levie 2004). Goodness of fit for the three models were 
evaluated using graphical plots, such as residual and normal probability plots, and through analysis of 
the following goodness-of-fit estimators: stability of the model; the corrected Akaike criterion; Sy.x; the 
correlation between the estimated parameters kcat, Km, n or Ki; and the standard deviation of these 
estimated parameters (Motulsky et al. 2003; Van Boekel 2009). More explanation about goodness of fit 
parameters can be found in Appendix I.
Competition studies
Competition at the oligosaccharide site was assessed, as described by Williams et al. (Williams et al. 
2006), by measuring the activity of, for example, the elongation of UDP-GlcNAc to an even-numbered 
oligosaccharide in the presence of an odd-numbered HA that cannot be extended by this donor sugar. 
Activity was measured by the coupled-enzyme assay using the same reaction conditions as the kinetic 
studies and containing 10 mM UDP-GlcUA or 20mM UDP-GlcNAc. The reactions of HA4, HA5 and 
HA6 were individually monitored in the presence of a competing oligosaccharide with a molar ratio 
between the reacting and competing oligosaccharide of 1:1 or 1:10. Reactions of 0.3mM reacting 
oligosaccharide without the competing oligosaccharide were taken as a reference.
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Structure homology modeling
Model building and energy minimization of PmHAS was performed with Modeler using the Accelrys 
Discovery Studio 2.1 software package with K4CP as template structure. The protein model was 
validated with Profiles-3D (Accelrys Discovery Studio 2.1), the stereochemical quality of the homology 
model was verified by PROCHECK (Laskowski et al. 1993), and the protein folding was assessed 
with PROSAII (Sippl 1993). Docking studies of HA oligosaccharides were performed with the program 
Autodock Vina (Trott et al. 2009). Structural alignment was performed using DaliLite (Holm et al. 
1996). Structural alignment of enzymes is evaluated by their root mean square deviation (RSMD) and 
Z-scores. Low RSMD values (below 4.0 Å) and high Z-scores (above 2) are a sign of a good structural 
superimposition and may indicate a conserved fold structure. All structural images were generated with 
PyMOL version 0.99 (Delano Scientific LLC, San Carlos, California, USA).
Polymerization reactions with HA4-fluor
Purified HA4 oligosaccharides were labeled with the fluorophore anthranilic acid at the reducing end 
of the chain. Labeling and purification of HA4-fluor was done as described in earlier work (Kooy et al. 
2009). All reactions contained 2 mM UDP-GlcUA, 40 mM UDP-GlcNAc, 15 mM MgCl2, 1 M ethylene 
glycol, and 50 mM Tris*HCl with pH at 8.0. The HA4-fluor concentration was kept at saturating conditions 
(2.5 mM) or at unsaturating conditions (0.1 mM). The reactions were started by adding either 15 or 30 
μg/ml PmHAS. Reactions were performed in PCR eppendorf tubes, containing each 7.5 μl of reaction 
volume. The reaction was followed for 130 minutes at 30 °C by stopping the reaction of 1 sample tube 
every 5 or 10 minutes by freezing in liquid nitrogen and keeping it at -20 °C. After the experiments, 
all samples were heated for 15 minutes at 95 °C. Reaction mixtures were analyzed on 20% TBE 
polyacrylamide gels and images of the gel were processed as described in (Kooy et al. 2009).
Results and discussion
A combination of kinetic characterization and structural modeling was used to study the polymerization 
of hyaluronan by Pasteurella multocida hyaluronan synthase (PmHAS), focusing on the influence of 
the oligosaccharide length on the turnover number (kcat) and the specificity constant (kcat/Km). First, 
the results of the kinetic studies are presented, including the characterization of the optimal conditions 
for PmHAS activity, the investigation of single-step elongation kinetics, and the influence of competing 
oligosaccharides on the reaction rate. Subsequently, a structural homology model of PmHAS is 
discussed and structural relations to other glycosyltransferases are presented. Using the determined 
kinetic parameters, we show that product polydispersity is increased at unsaturated HA concentration 
levels due to two oligosaccharide binding sites.
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Figure 1.   Specific activity of PmHAS under different reaction conditions. From top to bottom: A) PmHAS activity 
at different pH values, with reaction products in duplicate of pH 5.6, 7, 8 and 9 analyzed on gel showing most 
abundant and longest products for highest activity at pH8. The letter M in the gel stands for Generuler DNA ladder 
and the bars indicate the corresponding duplicates; B) PmHAS activity at several temperatures, with reactions 
products of 20, 25, 35 and 40 °C analyzed on gel. Product size and amount concur with activity measurements; 
C) PmHAS activity using different divalent ions. Best results were obtained with Mg2+. Mg2+ concentration of 15mM 
resulted in highest activity; D) PmHAS activity using viscous buffer components: sucrose (S), trehalose (T) and 
ethylene glycol (E) compared to buffer without any viscogen, the negative control (N.C.). The reaction products 
analyzed on gel show that ethylene glycol stimulates narrow polydispersity.
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Characterization of PmHAS
The polymerization activity of PmHAS was measured to study optimal elongation conditions using HA4 
as template and both UDP sugars. The following reaction conditions were varied: pH, temperature, 
different divalent ions and stabilizing buffer components. PmHAS activity has a pH optimum between 
7.5 and 9 (Figure 1A), with highest activity found at pH 8. Activity increased with increasing temperature 
(Figure 1B) to 35 °C, after which activity decreases probably by progressive enzyme inactivation. At 
optimal conditions of pH and temperature, high molecular weight products were obtained with a narrow 
product range, as can be seen in the gels of Figure 1A and B. Divalent metal ions greatly affected the 
activity; most efficient was the use of Mg2+, whereas the activity was decreased to 70% using Mn2+ or 
Co2+, to 28% for Ni2+ and to 22% for Ca2+ (Figure 1C). The influence of MgCl2 concentrations on PmHAS 
activity was further investigated resulting in an optimal concentration of 15 mM. Viscous components in 
the buffer, such as ethylene glycol and trehalose, not only influenced the PmHAS activity, but also had 
an effect on the polydispersity of the products (see gel Figure 1D). Significant lower polydispersity and 
highest activity were found for 1 M ethylene glycol. Varying the ethylene glycol concentration from 0.1 
up to 2 M resulted in minor changes in PmHAS activity and highest activity was found at 1 M ethylene 
glycol (not shown). In summary, the following optimal conditions were selected for kinetic experiments: 
pH 8.0, 35 °C, 15 mM Mg2+ and 1 M ethylene glycol.
The activity of PmHAS in cell membrane preparations has been described in literature with highest 
activity between pH 6.8 and 7.6 and a 2-3 fold higher activity in the presence of Mn2+ than Mg2+ (DeAngelis 
1996). The observed differences in optimal conditions could be caused by the use of isolated PmHAS 
in our studies. Similar pH and temperature optima were reported for hyaluronan synthases isolated 
from Streptococcus equisimilis (SeHAS) and Xenopus laevis (XlHAS) (Pummill et al. 1998; Tlapak-
Figure 2.   Effect of the HA oligosaccharide concentration and length on the specific activity of PmHAS. The 
elongation rates for three even-numbered HA4 (●), HA6 (●), and HA8 (●) oligosaccharides and three odd-
numbered HA5 (▲), HA7 (▲), and HA9 (▲) oligosaccharides were measured at varying oligosaccharide 
concentrations from 0.1 to 6mM and the corresponding UDP-sugar in excess. The lines, solid ones for HA4, HA8, 
HA5 and HA9 and dashed ones for HA6 and HA7, show the results of the model, the Michaelis Menten equation.
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Simmons et al. 2004). The metal ion preference of PmHAS is also comparable with that observed for 
XlHAS. The most effective divalent metal ion for XlHAS was Mg2+ with a 4 to 10 fold reduction of activity 
for Mn2+, Ni2+ and Co2+ (Pummill et al. 1998). Although the metal ion preference was not reported for 
other HAS enzymes, the corresponding activity assays included 15-20 mM of MgCl2 (Kumari et al. 
1997; Itano et al. 1999; Tlapak-Simmons et al. 1999c; Yoshida et al. 2000), suggesting that Mg2+ is the 
preferred ion for HAS enzymes. In addition, viscous compounds increased SeHAS activity as well as 
PmHAS activity when using ethylene glycol and sucrose below 0.5 M, but at increasing concentrations 
of these viscogens SeHAS activity showed inhibition (Tlapak-Simmons et al. 2004).
The influence of oligosaccharide length on kcat and Km
HA oligosaccharides, varying from HA4 up to HA9, were individually elongated in single-step reactions 
with the corresponding sugar nucleotide in excess, namely UDP-GlcNAc for the even-numbered 
and UDP-GlcUA for the odd-numbered oligosaccharides, respectively. The non-reducing end, where 
elongation takes place, contains a GlcUA sugar for the even-numbered oligosaccharides used, and vice 
versa a GlcNAc sugar for the odd-numbered oligosaccharides. The reactions were followed using the 
coupled enzyme assay described in Materials and methods. MALDITOF-MS confirmed the formation of 
the expected products HA(n+1) in all reactions (data not shown). Since the corresponding UDP-sugar is in 
excess, the elongation can be considered as a one-substrate reaction (Cornish-Bowden 1995). Three 
models for one-substrate kinetics were used for fitting the data through nonlinear regression: Michaelis 
Menten, substrate inhibition and the Hill equation (see Materials and methods). These models were 
selected to see if PmHAS elongates HA through classical Michaelis kinetics or if the elongation was 
regulated by other mechanisms, such as cooperativity or substrate inhibition.
Goodness-of-fit was determined by statistical means, including examining the residual and 
normal probability plots, evaluating the standard deviations of the estimated parameters kcat and 
Km and executing several statistical tests, such as the corrected Akaike criterion. These statistical 
tests demonstrated that all three models fitted well (see Appendix I). However, no cooperativity was 
observed with an estimated Hill number (n) value of around 1 for every reaction, which reduced the 
Hill equation into the Michaelis Menten equation. In addition, the substrate inhibition model could not 
estimate the parameters kcat and Km very accurately, resulting in very large standard deviation, and 
a very strong correlation between kcat and Km varying from 0.90 to 0.99, which was not observed 
for the other models. In summary, the Michaelis Menten equation fitted the data best for the chosen 
oligosaccharide concentration, but substrate inhibition may be relevant when the concentrations are 
increased beyond our measurements.
The data fitted with the Michaelis Menten model is illustrated in Figure 2 and the corresponding 
kinetic parameters kcat and Km estimated with this model are shown in Table 1. To our best knowledge, 
it is the first time that these kinetic parameters are reported for individual oligosaccharides for any of 
the HAS enzymes. We observe that kcat increases with oligosaccharide length and seems to be higher 
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for the odd-numbered HA than for the even-numbered HA oligosaccharides, with values of 14.0 and 
10.8 s-1 for HA7 and HA8, respectively. Since no kcat values are available to relate our results with 
other studies, we use specific activity values for comparison. The UA-transferase specific activity of 
approximately 450 μmol/mg*hr observed for 1 mM HA7 or HA9 at 1 mM UDP-GlcUA (Figure 2) are 
almost equal to the reported value of 484 μmol/mg*hr for HA21 (Williams et al. 2006). This indicates 
that the maximal rate at the UA-transferase domain is reached using a heptasaccharide or longer. 
The NAc-transferase specific activities with values of 175 μmol/mg*hr observed in our study for 1 
mM HA8 at 1 mM UDP-GlcNAc is seven times higher than reported (Williams et al. 2006). Maximal 
NAc-transferase rates were only reached in our studies at elevated UDP-GlcNAc concentration of 40 
mM; this in comparison to the 1 mM UDP-GlcNAc used in literature (Williams et al. 2006).
Interestingly, there is a significant difference between Km’s of the even-numbered and odd-numbered 
oligosaccharides. The Km’s of the odd-numbered oligosaccharides are decreasing with the increase of 
the chain length, while those for the even-numbered increase. These trends become understandable 
by assessing the differences in the specificity constant kcat/Km of even-numbered and odd-numbered 
oligosaccharides. The specificity constant gives information about the affinity of the enzyme towards 
different substrates (Cornish-Bowden 1995; Eisenthal et al. 2007); e.g. a higher ratio indicates a higher 
affinity for this substrate. In Table 1 is shown that the specificity constant increases from 10.8 to 44.4 
mM-1 s-1 for HA5 and HA7, respectively, and shows some decrease for HA9 to 34.1 mM-1 s-1. This implies 
that the two sugar residues at the reducing end of HA7 (GlcUA2-GlcNAc1), compared to HA5, enhance 
the binding to the oligosaccharide site by forming more interactions. The specificity constant of HA9 
is not further increased, indicating that HA9 does not form additional interactions with the binding site. 
Williams et al. (2006) demonstrated by investigating the initial velocity rates of HA acceptor analogs of 
lengths up to hexasaccharides that the minimal oligosaccharide length elongated with high efficiency 
contained at least a trisaccharide with two glucuronic acid residues. This means that the oligosaccharide 
Table 1.   Parameter estimates and uncertainties for the kinetic constants of the Michaelis Menten model.
Reaction kcat 95% CI* kcat Km
95% CI*
Km kcat/Km
95% CI* 
kcat/Km
s-1 s-1 mM mM mM-1s-1 mM-1s-1
HA4 4.6 ± 0.2 4.1 – 5.1 0.5 ± 0.1 0.3 – 0.8 8.7± 0.15 8.3 – 9.0
HA6 9.9 ± 0.7 8.5 – 11.4 0.9 ± 0.2 0.5 – 1.4 10.7± 0.16 10.3 – 11.1
HA8 10.8 ± 0.8 9.0 – 12.6 1.6 ± 0.3 0.8 – 2.3 6.9± 0.17 6.6 – 7.2
HA5 8.7 ± 0.5 7.5 – 9.9 0.8 ± 0.17 0.4 – 1.2 10.8± 0.18 10.5 – 11.2
HA7 14.0 ± 0.6 12.7 – 15.3 0.3 ± 0.07 0.2 – 0.5 44.4± 0.14 44.0 – 44.8
HA9 13.8 ± 0.7 12.2 – 15.4 0.4 ± 0.08 0.2 – 0.6 34.1± 0.17 33.7 – 34.5
*95% CI is the upper and lower boundary of the 95% Confidence Interval for the corresponding parameter 
estimate.
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binding site at the UA-transferase site has the capacity to bind minimal three saccharide residues, as is 
suggested by Williams, and maximal seven saccharide residues, as is proposed by us, now.
In contrast, the kcat/Km for even-numbered oligosaccharides is moderately constant ranging 
from 6.9 to 10.7 mM-1 s-1. The difference in binding specificity of PmHAS for odd and even-numbered 
oligosaccharides is difficult to understand if there would be only one oligosaccharide binding site in 
PmHAS at which both elongations (NAc and UA) would take place. These differences can only be 
explained by two separate oligosaccharide binding sites for odd and even-numbered oligosaccharides. 
A relatively long oligosaccharide binding site at the UA-transferase site could explain the increased 
specificity constant for HA7, whereas the moderately constant specificity constant of HA4, HA6 and 
HA8 can be explained by a short oligosaccharide binding site interacting with the first four sugar 
residues of HA4, HA6 and HA8 at the NAc-transferase site.
Competition studies
To examine the difference in binding specificity for odd-numbered and even-numbered oligosaccharides 
further, we did competition studies to investigate 1) the influence of HA5 as competing oligosaccharide on 
the elongation reaction of HA4 with UDP-GlcNAc, 2) the influence of HA4 as competing oligosaccharide 
on the elongation reaction of HA5 with UDP-GlcUA, and 3) the competition between HA4 and HA6 
within NAc-transferase activity. For each single step reaction, a reference reaction was measured 
to determine the enzyme activity in absence of the competing oligosaccharide. Two reactions were 
carried out with a molar ratio between the reacting and competing oligosaccharide of 1:1 or 1:10 (see 
Figure 3). Theoretically, if there is only one oligosaccharide binding site, the reacting and competing 
oligosaccharide should bind at the same site, and are therefore competing for this site. If there are 
two oligosaccharide binding sites, the competing oligosaccharides HA4 or HA5 could still be able to 
bind in a nonproductive manner at the oligosaccharide binding site where the elongation takes place, 
since these competing oligosaccharides only differ with the reacting oligosaccharide at the last sugar 
on the non-reducing end. In both cases, if the competing oligosaccharide binds at the reacting site, the 
measured activity must decrease compared to the reference reaction.
The results in Figure 3A show that HA5 does not influence the reaction between HA4 with 
UDP-GlcNAc, nor does HA4 change the rates of the reaction between HA5 with UDP-GlcUA. The 
absence of competition confirms that there are two separate oligosaccharide binding sites within 
PmHAS, one for each transferase activity, and that these binding sites are very specific for their 
substrates. This is in agreement with the report of Williams et al., who also observed the absence of 
competition between HA14 and HA15 (Williams et al. 2006).
Both HA4 and HA6 oligosaccharides can react with UDP-GlcNAc at the same site, and this is 
confirmed by the experimental results. The reaction rate measured in experiments with both substrates 
offered simultaneously to PmHAS is a summing-up of the individual rate for elongation of HA4 and HA6 
(see Figure 3B). The specificity constants of HA4 and HA6 are roughly the same, which is the result of 
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approximately twice as high Km and kcat values for HA6 compared to the Km and kcat values of 
HA4 (see Table 1). In the reactions with 3 mM HA4 present, the equivalent of 6*Km of HA4, the kcat 
is almost reached for the HA4 reactions, corresponding to a specific activity of 177 μmol/mg*hr (see 
Figure 2 and the last two white bars in Figure 3B). The specific activity (see second to last white bar in 
Figure 3B) is slightly increased to 213 μmol/mg*hr by the addition of 0.3 mM HA6. On the contrary, the 
kcat of HA6 is not reached, since 3 mM HA6, the equivalent of ~3*Km of HA6, is not enough to achieve 
saturating concentrations (see the last two grey bars in Figure 3B). The results from the competition 
studies between HA4 and HA6 show that elongation of these two oligosaccharides depends on their 
concentration levels and that with the chosen conditions the measured rate is the sum of both reaction 
rates.
Structure homology modeling
A three-dimensional model of the PmHAS structure was built based on the recently obtained crystal 
structure of K4CP chondroitin polymerase (Osawa et al. 2009), which has a sequence identity of 62% 
and sequence homology of 79% compared to PmHAS (Figure 4A). The Ramachandran plot obtained 
from PROCHECK showed that the stereochemical quality of the model was very good.  Only two 
residues, Ala310 and Asn411, have slightly deviating Phi and Psi angles with no consequence on the 
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Figure 3.   Influence of the competing oligosaccharide on the PmHAS elongation reaction. A) The light grey bars 
show the results of HA5 as competitor to the elongation reaction of HA4 with UDP-GlcNAc, whereas the dark grey 
depicts the HA5 elongation reaction with UDP-GlcUA and competing oligosaccharide HA4. B) The results of HA6 
as “competing” oligosaccharide are shown in grey, and for HA4 in white.
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Figure 4.   Structural homology model of PmHAS: A) Sequence alignment of PmHAS and the K4CP chondroitin 
polymerase. Structurally equivalent residues are in uppercase, structurally non-equivalent residues are in 
lowercase. Amino acid identities are marked by vertical bars. B) Superimposition of the crystal structure of K4CP 
chondroitin polymerase (green) and the PmHAS homology model (blue) with RMSD value and Z-score of 0.5Å 
and 53.4, respectively. Substrates UDP (orange) and UDP-GalNAc (yellow), shown in sticks, and Mn2+,as red 
dots, were originally present in the crystal structure. Secondary structural elements are indicated by ribbons for 
α-helices, and arrows for β-strands. C) Overall structure of PmHAS with UDP-GlcUA (green) and UDP-GlcNAc 
(yellow) in sticks and Mn2+ as red dots. The structure is divided in three domains: the N-terminal region (residues 
72-134) in green, the UA-transferase (427-688) in orange and the NAc-transferase (135-426) in blue.
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overall structure, since both residues are localized in flexible loops. The structure of PmHAS residues 
72 to 688 is almost identical to the K4CP structure, as can be seen in the overlay of the two structures 
in Figure 4B; only the last 15 residues (689 - 703) could not be modeled. This structural model enables 
us to locate the two separate oligosaccharide binding sites that the kinetic studies indicate.
PmHAS consists of three domains (see Figure 4C): the N-terminal domain (residues 72 to 134); the 
NAc-transferase-domain (residues 135 to 426); and the UA-transferase domain (residues 427-688). 
The N-terminal domain consists of a random coil and two α-helices, the first 71 residues are missing as 
no alignment could be found for this N-terminal region. The NAc-transferase domain of PmHAS contains 
13 α-helices and 12 β-strands, whereas the UA-transferase domain consists of 10 α-helices and 12 
β-strands like the structure of K4CP. Both the NAc- and the UA-transferase domain of PmHAS adopt 
the GT-A fold, which consists of an α/β/α sandwich and is one of the fold types in glycosyltransferases 
(Breton et al. 2006). As can be seen in Figure 4, the orientation of the two active sites and the great 
distance of over 60 Å make a single oligosaccharide binding site within PmHAS unlikely.
The PmHAS model was further analyzed by structural alignment with GT-A folded 
glycosyltransferases to identify conserved regions in structure and sequence. Conserved regions 
are often important for enzyme functionality, such as amino acid residues involved in binding 
substrates. Similarities in substrate binding and substrate orientation are here used to locate the 
binding sites of HA oligosaccharides in PmHAS, as will be discussed below. The following GT-A 
folded glycosyltransferases were structurally aligned with PmHAS, showing their abbreviation in 
parentheses: UDP-GalNAc:polypeptide α-N-acetylgalactosaminyl-transferase T2 (hT2) (Fritz et al. 
2006), β1,3-glucuronosyltransferase (GlcAT1) (Pedersen et al. 2000), β1,3-glucuronosyltransferase 
(GlcAT-P) (Kakuda et al. 2004), β1,4-galactosyltransferase (β4Gal-T1) (Ramasamy et al. 2005), α1,4-
N-acetylhexosaminlytransferase (EXTL2) (Pedersen et al. 2003), α1,3-galactosyltransferase (α3GT) 
(Zhang et al. 2003), blood Group A α1,3-N-galactosaminyltransferase (hGTA) (Patenaude et al. 2002), 
α1,4-galactosyltransferase (LgtC) (Persson et al. 2001). The corresponding sequence alignment for 
the NAc- and UA-transferase domains, Z-scores and RMSD of the aligned structures can be found in 
the Appendix IIA and IIB, respectively.
Structural similarities in the UDP-sugar binding site
Although the structurally aligned enzymes represent a broad spectrum of glycosyltransferase reactions, 
the regions binding the UDP-sugars are conserved, resulting in UDP-sugar binding sites with great 
similarities such as the characteristic orientation of the UDP-sugar in the site with the sugar residue 
bent under the diphosphate group (Figure 5). The DXD motif (Breton et al. 1998; Tarbouriech et al. 
2001) is highly conserved within GT-A folded glycosyltransferases and forms a complex with divalent 
ions, such as Mn2+ and Mg2+, crucial for UDP-sugar binding. The DXD motif is in PmHAS defined as 
Asp247, Cys248 and Asp249 within the NAc-transferase site and Asp527, Ser528, and Asp529 within the UA-
transferase site. Mutation studies within PmHAS have shown that changing any of these Asp residues 
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deactivates the transferase site containing that DXD motif (Jing et al. 2003). In addition, the DGS motif 
in PmHAS contains an Asp residue that is conserved in some of the aligned glycosyltransferases as 
well (see Appendix IIA and B). This Asp residue interacts with the N3 of the uracil group within the UDP 
moiety. Mutation of Asp196 or Asp477 in PmHAS resulted in loss of NAc- or UA-transferase activity (Jing 
et al. 2000), respectively, which emphasizes the importance of these residues.
Structural similarities in the acceptor binding site
Since PmHAS contains β1,3-glucuronyltransferase and β1,4-N-acetylglucosaminyltransferase domains, 
the aligned glycosyltransferases were selected on the ability to elongate the donor sugar to the 3OH 
or 4OH group of the acceptor. The results of structural alignment show that the acceptor has different 
orientations towards the UDP-sugar, depending on the type of linkage formed after the sugar moiety 
transfer (Figure 5). The α-configuration of the C1 in the sugar moiety attached to UDP is preserved 
in the product after transfer by retaining glycosyltransferases, whereas inverting glycosyltransferases 
convert this into a β-linked product. As a result, the attacking OH group in the acceptor in retaining 
enzymes is placed next to the C1 of the sugar moiety, ready to form the α-linkage (Figure 5B and D). 
Similarly, the attacking OH group in inverting glycosyltransferases lies opposite to the α-linked UDP 
(Figure 5A and C). This is emphasized by the hydrogen bonds found in retaining glycosyltransferases 
between the attacking OH group in the acceptor and an oxygen atom of the β-phosphate group in UDP 
(Persson et al. 2001; Patenaude et al. 2002; Negishi et al. 2003; Zhang et al. 2003). These hydrogen 
bonds were not possible in inverting enzymes, where the distance between UDP and the acceptor are 
too large.
In addition to the similarities in acceptor orientation, there are aromatic hydrophobic residues Phe, 
Trp, and Tyr found near every catalytic centre. Their roles in the acceptor binding site seem to depend on 
their location and orientation within the active site. Mutation studies in the aligned glycosyltransferases 
illustrate that aromatic hydrophobic residues show specific affinity towards the acceptor (Zhang et al. 
2004; Fondeur-Gelinotte et al. 2007), act as stabilizer of the transition state (Zhang et al. 2004), or help 
to orient the acceptor into the right position (Ramasamy et al. 2005). Replacement of these aromatic 
hydrophobic residues critically decreases either the binding affinity for the acceptors or the reaction 
rate, indicating that these residues are essential for the acceptor binding site.
Modeling HA oligosaccharides in the active sites
Structural similarities between PmHAS and other glycosyltransferases showed that the HA 
oligosaccharide should be located underneath the C1 of the sugar moiety to form β-linkages, since 
PmHAS has two inverting transferase domains. Autodock Vina (Trott et al. 2009) was used to model 
HA6 and HA7 into the NAc- and UA-transferase sites (Figure 6), respectively. The orientations of HA6 
and HA7 (see Figure 6A and B) concur with the results from Figure 5. In addition, the amino acids likely 
to interact with the substrates are shown in sticks (Figure 6).
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Figure 5.  Substrate orientation in active sites of structurally aligned glycosyltransferases of the GT-A fold. Crystal 
structures of enzymes with both donor and acceptor substrates were superimposed to investigate the orientation 
of the attacking OH group of the acceptor toward the UDP-sugar. Grey arrows point out the direction of the reacting 
OH group to the C1 of the sugar moiety. The DXD motif, the proposed catalytic residue and other conserved 
residues are shown. A) inverting β1,3-transferases GlcAT-1 in dark blue (1fgg (Pedersen et al. 2000) and 1kws 
(Pedersen et al. 2002), Galβ1-3Gal and UDP-GlcUA in green) and GlcAT-P in blue (1v84 (Kakuda et al. 2004), 
N-acetyllactosamine and UDP in orange); B) retaining α1,3-transferases α3GT in dark blue (1o7q (Zhang et 
al. 2003) and 1g93 (Gastinel et al. 2001), N-acetyllactosamine and UDP-Gal in purple) and hGTA in blue (1lzi 
(Patenaude et al. 2002), H-antigen and UDP in pink); C) inverting β1,4-transferase β4Gal-T1 in dark blue (1tvy 
(Ramakrishnan et al. 2004), UDP-Gal in green)  with three acceptors (chitotriose in orange, 2ah9 (Ramasamy et 
al. 2005); trisaccharide GlcNAcβ1,2-Manα1,6-Manβ-OR (1,2-1,6-arm) in green, 2aec (Ramasamy et al. 2005); 
trisaccharide GlcNAcβ1,4-Manα1,3-Manβ-OR (1,4-1,3-arm) in orange, 2agd); D) retaining α1,4-transferases 
EXTL2 in dark blue (1on8 and 1on6 (Pedersen et al. 2003), GlcUAβ1-3Galβ1-O-naphthalenemethanol and 
UDP-GalNAc in purple), and LgtC in blue (1ga8 (Persson et al. 2001), 4’-deoxylactose and UDP-2-deoxy-2fluoro-
galactose in pink).
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Figure 6.  Docking of HA oligosaccharides in the PmHAS active sites. On top are the results shown for the UA-
transferase site with a heptasaccharide (HA7) modeled into the active site and, vice versa, the results for the 
NAc-transferase with a hexasaccharide (HA6) below. The orientation of the acceptors towards the UDP-sugars 
is shown in A and B, and an overview of the PmHAS structure with the two acceptor binding sites is given in 
C. The surface of PmHAS is made transparent to show the substrate orientation and the amino acid residues 
that are most likely involved in substrate binding (shown in sticks). The residues are color coded based on their 
characteristics: hydrophobic residues Ala, Gly, Ile, Leu, Met, Pro, and Val are green; residues with an aromatic or 
imidazole side chain His, Phe, Trp and Tyr are dark green; polar but uncharged residues Asn, Gln, Ser, and Thr 
are purple, polar residues with a positive charge Arg and Lys are red; polar residues with a negative charge Asp 
and Glu are blue.
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Kinetic results indicated that there is a difference in binding specificity between the NAc- and 
UA-transferase sites and that in the UA-transferase site the specificity constant is strongly increased 
using HA7 instead of HA5 in the elongation. Both results can be explained by the structural model. 
First, the channel-shaped oligosaccharide binding site in the UA-transferase site is longer than in the 
NAc-transferase site (see Figure 6C). At the NAc-transferase site, only the first four sugar residues 
at the non-reducing end of HA6 are in direct contact with amino acid residues in the oligosaccharide 
site, while the other sugar residues have considerably more degrees of freedom without amino acid 
interactions. Second, all the sugar residues of HA7 are surrounded by the oligosaccharide binding site 
at the UA-transferase site, which explains the higher specificity constant for HA7 than for HA5.
Influence of HA concentration on polydispersity
We have shown that PmHAS has two transferase domains containing each one oligosaccharide and 
one UDP-sugar binding site. As a result, substrate availability will have its effect on molecular weight 
and polydispersity of the HA products. The obtained kinetic parameters were used to monitor the 
effect of HA4 concentration on the polydispersity of the HA products in time. Two situations were 
chosen, namely a polymerization reaction with the concentration of the oligosaccharide acceptor at 
(a) unsaturated levels (1/5 of Km value) and (b) saturated levels (5*Km value). For both reactions, 
Figure 7.  Influence of HA4-fluor concentration of HA product polydispersity in time. Reactions were followed 
for 130 minutes and analyzed on 20% TBE polyacrylamide gel. A) Reactions containing 0.1 mM HA4-fluor, 2 
mM UDP-GlcUA, 40 mM UDP-GlcNAc and 15 μg/ml PmHAS. B) Reactions containing 2.5 mM HA4-fluor, 2 mM 
UDP-GlcUA, 40 mM UDP-GlcNAc and 30 μg/ml PmHAS. M and M2 are other reactions with HA4-fluor used as 
markers.
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the UDP-sugars were at saturated concentration of 2 mM UDP-GlcUA and 40 mM UDP-GlcNAc, 
respectively. To visualize all the formed products, HA4 labeled with anthranilic acid (HA4-fluor) was 
used for polymerization. Since in a previous study we have established that HA4-fluor and HA4 have 
similar behavior when elongated by PmHAS (Kooy et al. 2009), we assumed that HA4-fluor and HA4 
have comparable Km values.
As can be seen in Figure 7, the polydispersity increases in time for both reactions with significantly 
more HA products found for the reaction with unsaturated HA4-fluor concentrations. The observed 
increase in polydispersity in time is the effect of elongation at two separate active sites. Oligosaccharide 
elongation in PmHAS can only occur by the sequential binding, elongation and release of the growing 
HA chain. Since the two oligosaccharide binding sites in PmHAS are far apart, the HA oligosaccharide 
extended at one transferase site is not immediately extended by the other. At unsaturated HA4-fluor 
concentrations, this effect is enlarged because complex formation between PmHAS and HA4-fluor is 
slow, resulting in an increased polydispersity. In a previous study we have observed the formation of 
only even numbered oligosaccharides with high polydispersity (Kooy et al. 2009) caused by unsaturated 
levels of HA4-fluor and UDP-GlcNAc. Polydispersity of HA products can be decreased by offering 
saturated levels of HA oligosaccharide and UDP-sugars.
Concluding remarks
In this study, we present evidence for two separate oligosaccharide binding sites within PmHAS, one 
in each transferase domain. Based on kinetic and structural analysis, we show that the two transferase 
domains act as two separate enzymes, where GlcNAc is transferred at the NAc-transferase domain 
and GlcUA at the UA-transferase domain. The transferase domains in PmHAS show structural 
similarity with glycosyltransferases of the GT-A fold. Using structural alignment of these enzymes, we 
have found general characteristics of acceptor binding sites in these enzymes that are useful to locate 
oligosaccharide binding sites in other GT-A folded glycosyltransferases. In our study, we propose two 
locations for these oligosaccharide binding sites, which are far apart from each other. As a result of this 
big distance, the number of products will increase in time in a polymerization reaction unless single-
step reactions are imposed. The molecular weight and polydispersity of the product can be controlled 
by the availability of the substrates. The discovery of two separate oligosaccharide binding sites in 
PmHAS, the kinetic results demonstrating their difference in cavity size and the effect of these two 
separate oligosaccharide binding sites on hyaluronan polymerization are important new insights in the 
biosynthesis of hyaluronan.
Two separate oligosaccharide binding sites in PmHAS
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Appendix I
Materials and Methods - Model discrimination. 
All models were evaluated on their goodness of fit using graphical plots, such as residual and normal 
probability plots, and through analysis of the following goodness-of-fit estimators: stability of the model; 
the corrected Akaike criterion (AICc); Sy.x; the correlation between the estimated parameters (kcat, Km, 
n and Ki); and the standard deviation of these estimated parameters (Motulsky et al. 2003; Van Boekel 
2009). Discrimination between the models was achieved through combining these goodness-of-fit esti-
mators. For instance, residual plots, in which the data show a clear trend instead of a random distribu-
tion, indicate that the corresponding model is not performing well and should be rejected. Similarly, a 
model is instable and should be rejected, when several different sets of estimated parameters lead to 
a minimal SSr. The goodness-of-fit estimator AICc indicates quantitatively how much a model is more 
likely over another one. The best performing model has the lowest AICc value and the AICc differences 
(ΔAICc) indicate how models perform relative to each other. A rule of thumb is that models with ΔAICc 
values below 3 are worthwhile to consider, values ΔAICc between 4 and 7 indicate that models are less 
supported, and values higher than 10 indicate that models may be discarded (Van Boekel 2009). The 
parameter Sy.x shows the average distance, expressed in the same unit as the y-axis, between the 
model and the data and should be low to obtain a good fit. 
Results and discussion - Model discrimination
Three models for one substrate kinetics were used for fitting the data through nonlinear regression: 
Michaelis Menten, substrate inhibition and the Hill equation (see Experimental Procedures). The good-
ness of fit parameters for each model are given in Table I and the estimated parameters with standard 
deviation and 95% confidence interval in Table II.
As can be seen in Table I, the ΔAICc values indicate that all reactions, except for the HA5 elongation, fit 
best with Michaelis Menten. However, the other models show ΔAICc values below 10 and are therefore 
less supported, but could still be valid. Correlation values of above 0.95, which is often the case for the 
substrate inhibition model, indicate that the model has difficulty to estimate the parameters, resulting 
in large standard deviations (Table II) and should consequently be rejected. For the Hill model, large 
standard deviations are found for the estimated Hill number (n) with values of around 1, showing that 
the model is unable to fit n correctly. At a value of 1 for n, the Hill model simplifies into the Michaelis 
Menten model. As a result, the Michaelis Menten model fits our data best. 
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Reaction Model SSr AICc ΔAICc
Correlation 
between 
parameters
Sy.x
HA4
Michaelis Menten 1607.1 67.8 0.0 0.81 12.7
Hill 1469.2 71.4 3.6 0.41– 0.77 12.8
Substrate inhibition 1185.9 68.8 1.0 0.91 – 0.97 11.5
HA6
Michaelis Menten 9228.0 88.7 0.0 0.86 30.4
Hill 8713.0 92.8 4.1 0.66 – 0.88 31.1
Substrate inhibition 8369.0 92.3 3.6 0.94 – 0.98 30.5
HA8
Michaelis Menten 7510.9 85.7 0.0 0.91 26.7
Hill 6590.2 89.4 3.7 0.94 – 0.99 27.1
Substrate inhibition 7150.9 90.4 4.7 0.92 – 0.97 28.2
HA5
Michaelis Menten 6955.7 85.3 6.3 0.85 26.4
Hill 4428.8 84.6 5.6 0.34 – 0.74 22.2
Substrate inhibition 2777.3 79.0 0.0 0.97 – 0.99 17.6
HA7
Michaelis Menten 18731.6 97.2 0.0 0.76 43.3
Hill 18609.0 101.9 4.7 0.39 – 0.77 45.5
Substrate inhibition 18731.6 102.0 4.8 0.79 – 0.93 45.6
HA9
Michaelis Menten 12288.9 81.1 0.0 0.82 39.2
Hill 9385.8 84.4 3.3 0.29 – 0.70 36.6
Substrate inhibition 10651.9 85.7 4.6 0.86 – 0.95 39.0
Table I.   Goodness of fit for three models describing the elongation of HA oligosaccharides by PmHAS.
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Legenda for Appendix IIA
Alignment of Pasteurella multocida hyaluronan synthase (PmHAS) residues 132-431 and structurally related 
glycosyltransferase enzymes. The residues are color coded based on their characteristics: hydrophobic residues 
Ala, Gly, Ile, Leu, Met, Pro, and Val are green; residues with an aromatic or imidazole side chain His, Phe, Trp and 
Tyr are dark green; polar but uncharged residues Asn, Gln, Ser, and Thr are purple, polar residues with a positive 
charge Arg and Lys are red; polar residues with a negative charge Asp and Glu are blue; residue with an active 
thiol group Cys is orange. 
Sequences from the following glycosyltransferases were used (their abbreviation, RSCB pdb file, and 
corresponding Z-score and RMSD in parentheses): Chondroitin polymerase (K4CP (Osawa et al. 2009), 2z87, 
53.4, 0.5), UDP-GalNAc:polypeptide α-N-acetylgalactosaminyltranserase T2 (hT2 (Fritz et al. 2006), 1ffu, 18.1, 
3.1), β1,3-glucuronosyltransferase (GlcAT1 (Pedersen et al. 2000), 1fgg, 13.8, 3.5), β1,3-glucuronosyltransferase 
(GlcAT-P (Kakuda et al. 2004), 1v84, 13.4, 3.8), β1-4-galactosyltransferase (β4GAlT1 (Ramasamy et al. 2005), 
2aec, 13.2, 2.8), α1,4-N-acetylhexosaminlytransferase (EXTL2 (Pedersen et al. 2003), 1on8, 14.1, 3.1), α1,3-
Galactosyltransferase (α3GT (Zhang et al. 2003), 1o7q, 10.1, 3.4), blood Group A α1,3-N-galactosaminyltransferase 
(hGTA (Patenaude et al. 2002), 1lzi, 8.8, 3.2), α1,4-galactosyltransferase (LgtC (Persson et al. 2001), 1ga8, 9.8, 
3.5).
Legenda for Appendix IIB
Alignment of Pasteurella multocida hyaluronan synthase (PmHAS) residues 432-688 and structurally related 
glycosyltransferase enzymes. The residues are color coded based on their characteristics: hydrophobic residues 
Ala, Gly, Ile, Leu, Met, Pro, and Val are green; residues with an aromatic or imidazole side chain His, Phe, Trp and 
Tyr are dark green; polar but uncharged residues Asn, Gln, Ser, and Thr are purple, polar residues with a positive 
charge Arg and Lys are red; polar residues with a negative charge Asp and Glu are blue; residue with an active 
thiol group Cys is orange. 
Sequences from the following glycosyltransferases were used (their abbreviation, RSCB pdb file, and 
corresponding Z-score and RMSD in parentheses): Chondroitin polymerase (K4CP (Osawa et al. 2009), 2z87, 
50.0, 1.0), UDP-GalNAc:polypeptide α-N-acetylgalactosaminyltranserase T2 (hT2 (Fritz et al. 2006), 1ffu, 17.6, 
3.4), β1,3-glucuronosyltransferase (GlcAT1 (Pedersen et al. 2000), 1fgg, 14.5, 2.8), β1,3-glucuronosyltransferase 
(GlcAT-P (Kakuda et al. 2004), 1v84, 14.1, 2.8), β1-4-galactosyltransferase (β4GAlT1 (Ramasamy et al. 2005), 
2aec, 11.1, 3.7), α1,4-N-acetylhexosaminlytransferase (EXTL2 (Pedersen et al. 2003), 1on8, 13.1, 3.0), α1,3-
Galactosyltransferase (α3GT (Zhang et al. 2003), 1o7q, 9.1, 3.8), blood Group A α1,3-N-galactosaminyltransferase 
(hGTA (Patenaude et al. 2002), 1lzi, 7.2, 4.0), α1,4-galactosyltransferase (LgtC (Persson et al. 2001), 1ga8, 9.8, 
3.3).
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Kinetic analysis of β1,3-glucuronyl 
transferase and β1,4-N-acetylglucosamine 
transferase activities in Pasteurella 
multocida hyaluronan synthase
Pasteurella multocida hyaluronan synthase (PmHAS) consists of two transferase domains, elongating either GlcNAc or GlcUA residues from UDP-sugars to a growing hyaluronan (HA) oligosaccharide chain. Initial velocity studies of single-step elongations were carried out 
for both transferase domains by varying the concentrations of HA oligosaccharide and UDP-sugar 
independently. Two-substrate models were distinguished using goodness-of-fit parameters and dead-
end inhibition studies. A mechanistic shift from steady state ordered bi-bi to rapid equilibrium ordered 
bi-bi mechanism was observed at the NAc-site between the HA6 and HA8 elongation, caused by a 
minor decrease in kcat. Both NAc- and UA-transferase domains follow a sequential kinetic mechanism, 
most likely an ordered one in which the UDP-sugar donor binds first, followed by binding of HA 
oligosaccharide. After transferring the sugar moiety, products are released in the order of the elongated 
HA oligosaccharide followed by UDP. This mechanism was visualized using a structural model of 
PmHAS, presenting two flexible loops, one in each transferase domain forming a bridge above the 
active site. Based on structural similarities between PmHAS, α1,3-galactosyltransferase (α3GT) and 
β1,4-galactosyltransferase (β4Gal-T1), these flexible loops are most likely involved in a conformational 
change upon binding the UDP-sugar, inducing the ordered mechanism. Kinetic analyses have shown 
large differences in dissociation constant KdUA and KmNAc of 124 ± 31 μM and 28 ± 8.8 mM, respectively, 
suggesting that the difference in binding affinity of the two UDP-sugars control the molecular weight of 
hyaluronan.
Floor K. Kooy, Michel H.M. Eppink, Johannes Tramper, Gerrit Eggink, and Carmen G. Boeriu.
(To be submitted for publication).
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Introduction
Hyaluronan (HA) is an unbranched polysaccharide composed of two alternating sugars, 
N-acetylglucosamine (GlcNAc) and glucuronic acid (GlcUA). HA with molecular weight of above 500 
kDa is abundant in mammalian tissues, such as skin, eyes, cartilage and extracellular matrix, where 
elasticity and viscosity of the chain serves as a biological lubricant or as a flexible structural component. 
HA with molecular weight below 500 kDa is involved in a number of cell biological phenomena, including 
cell motility, cell proliferation, cell differentiation and cell-cell interactions (Asari 2004). HA plays an 
ambiguous role in cancer treatment, where long HA chains promote cell proliferation and short HA 
oligosaccharides inhibit cancer growth (Stern 2008). Thus, the HA chain length determines its function, 
and for pharmaceutical applications it is essential to produce homogeneous chains.
Production of monodisperse HA oligosaccharides has been achieved using a stepwise addition or 
removal of sugar units through either enzymatic (Kobayashi et al. 2001; DeAngelis et al. 2003; Blundell 
et al. 2006; Boeriu et al. 2007) or chemical approaches (Dinkelaar et al. 2009), but is still limited 
in the number of additions or eliminations that can be accomplished and often requires extensive 
separation procedures. The most promising technique is controlling the enzymatic synthesis of HA 
using Pasteurella multocida hyaluronan synthase (PmHAS), which needs a better understanding of the 
biological characteristics of this enzyme. 
PmHAS contains two transferase domains that alternatively transfer the sugar moiety of 
UDP-GlcNAc or UDP-GlcUA to a growing HA chain. This study is the first to investigate the kinetic 
mechanism of a hyaluronan synthase (HAS) using two-substrate kinetics. PmHAS is, unlike Class I 
HAS enzymes, able to bind, extend and release the HA oligosaccharide (DeAngelis 1999b), which 
makes it possible to complete steady state kinetics using two-substrate models. Our results indicate that 
both transferase domains elongate through a sequential type mechanism and that the large difference 
in binding affinity between UDP-GlcNAc and UDP-GlcUA may control the hyaluronan molecular weight. 
At the NAc-transferase domain, a shift in mechanism was observed at increasing length of the HA 
oligosaccharide. These mechanistic results are further explored using a structural model of PmHAS, 
which was built based on a crystal structure of a related glycosyltransferase enzyme (Chapter 4).
Experimental procedures
Enzyme expression and activity measurements
PmHAS (purified) was provided by Schering-Plough (formerly Organon N.V.). PmHAS represents 
the soluble PmHAS1–703 enzyme, as described by Jing and DeAngelis (Jing et al. 2000), cloned and 
expressed in a pET101/D-TOPO expression vector (Invitrogen) with an additional V5 epitope and 
polyhistidine (6x His) region at the C-terminal end of the enzyme. PmHAS was purified from the crude 
extract by affinity chromatography on Ni-NTA columns (Qiagen). 
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Steady state kinetic studies of the two PmHAS transferase domains were performed using a 
coupled-enzyme assay as described in Chapter 4. Coupled-enzyme assay components included 60 
u PK/ml, 75 u LDH/ml, 2 mM phosphoenolpyruvate, 0.4 mM NADH, 15 mM MgCl2, 112.5 mM KCl, 1 
M ethylene glycol, 50 mM Tris*HCl at pH 8.0. Purified HA oligosaccharides HA4, HA5, HA6 and HA8 
were all purchased from Hyalose, L.L.C (USA). The even numbered templates (HA4, HA6 and HA8) 
are elongated with UDP-GlcNAc, the odd numbered template HA5 is elongated with UDP-GlcUA. Initial 
rates were measured in duplicate at 35 °C for each one-step elongation at varying HA oligosaccharide 
concentrations of 0.1, 0.5, 1, 2, 4, or 6 mM, and fixed UDP-sugar concentration ranging from 1-40 mM 
or 0.025-10 mM for UDP-GlcNAc and UDP-GlcUA, respectively. For the dead-end inhibition study 
with UMP, the concentration of the fixed substrate UDP-GlcNAc was set as close to the saturation 
level as possible (40 mM) while the HA4 concentration were varied at 0.1, 0.5, 1, 2, 4 or 6 mM. The 
inhibition of PmHAS was measured at three fixed UMP concentrations of 0, 100 and 150mM UMP. 
After an incubation time of 5 minutes, reactions were initiated by the addition of 5 μg/ml PmHAS 
and the HA oligosaccharide. Reactions were monitored for 20 minutes in reaction volumes of 150 μl 
using UV star microplates of 96 wells (Greiner Bio-One, Germany) and a temperature controlled Safire 
spectrophotometer (Tecan, Switserland).
Kinetic analysis
Initial velocity data were fitted to kinetic models (Leskovac 2003; Cook et al. 2007) for sequential 
mechanisms random bi-bi (1) and ordered bi-bi (2+3), and the substrate-substituted mechanism Ping-
Pong bi-bi (4):
                  (1)
            
                                 (2+3)
          
     (4)
 with 
where Vmax is the maximum velocity, Kma and Kmb are the Michaelis Menten constants for the 
substrates, Kda is the dissociation constant for substrate A, and [A] and [B] are the concentrations 
of substrates A and B. The mechanisms are further explained in Scheme 1, where the order of the 
substrate binding and product release are shown. For the random and Ping-Pong models, substrate A 
can be both an UDP-sugar or a HA oligosaccharide. For the ordered bi-bi mechanism, the sequential 
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binding of the substrates is relevant to the 
model, and was thus used twice: Model 2) with 
the UDP-sugar (substrate A) binding before the 
HA oligosaccharide (substrate B), and Model 3) 
with HA oligosaccharide (substrate A) binding 
before the UDP-sugar (substrate B). 
For the models above, the assumptions 
are made that the enzyme-substrates complex 
(EAB) is in rapid equilibrium with the free 
substrates and free enzyme and that product 
formation is the rate-limiting step (Cook et 
al. 2007). Other models use the steady state 
assumption, where the concentration of EAB 
is considered constant and the disintegration 
of the EAB complex and the formation of the 
product have comparable rates. This shift in 
rate-limiting steps in the mechanism gives 
different equations for the steady state models. 
Details about how to obtain these equations can be found in literature (Leskovac 2003; Cook et al. 
2007), but the result is that Model 1, used to express the rapid equilibrium random bi-bi mechanism, 
also expresses the steady state ordered bi-bi and the Theorell-Chance mechanisms. Theorell-Chance 
is an ordered mechanism, where, at saturating substrate concentrations, the only slow step within the 
overall reaction is the release of the second product (Scheme 1). All the models mentioned above were 
used to identify the kinetic mechanism of the two transferase domains of PmHAS, except for the steady 
state random mechanism, which is rarely observed and difficult to distinguish from rapid equilibrium 
random mechanism.
In dead-end inhibition studies, the inhibition is measured at several inhibitor concentrations, 
whereas the concentration of one substrate is varied and the other substrate kept constant, resulting 
in Michaelis Menten kinetics as described below. The results of the dead-end inhibition experiment 
were fitted to Models 5-7 corresponding to competitive, noncompetitive and uncompetitive inhibition, 
respectively (Leskovac 2003; Cook et al. 2007): 
   
       (5)
          
     (6)
Scheme 1.   Cleland notation of sequential mechanisms 
random, ordered and Theorell-Chance and substrate-
substituted mechanism Ping-Pong. A and B represent 
substrates A and B, and Q and P are the products formed 
out of substrate A and B, respectively. The enzyme is de-
picted by E, and the enzyme intermediate by E’.
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       (7)
where [I] is the concentration of inhibitor I. Kis and Kii are the dissociation constants of the enzyme-
inhibitor complex and the enzyme-substrate-inhibitor complex, respectively.
The analysis was done within Excel fitting all data of a one-step elongation in one regression 
dataset, also known as global fitting, using unweighted nonlinear regression by minimizing the residual 
sum of squares (SSr). The uncertainties of the fits, standard deviations of the parameters and the 
correlation matrices were determined using the Excel SolverAid macro (de Levie 2004).
Model discrimination 
All models above were evaluated on their goodness of fit using graphical plots, such as residual and 
normal probability plots, and through analysis of the following goodness-of-fit estimators: stability of the 
model; the corrected Akaike criterion (AICc); Sy.x; the correlation between the estimated parameters 
(kcat, KmHA, KmNAc, KdUA, KdNAc, Kis or Kii); and the standard deviation of these estimated parameters 
(Motulsky et al. 2003; Van Boekel 2009). The combination of these goodness-of-fit estimators enables 
us to discriminate between the models. For instance, when data in residual plots are not randomly 
distributed, but show a clear trend, it indicates that the corresponding model is not performing well and 
should be rejected. Similarly, when several different sets of estimated parameters lead to a minimal 
SSr, the model is instable and should be rejected. A visual example of data fitting badly with one of the 
models is given in Appendix I. The goodness-of-fit estimator AICc indicates quantitatively how much 
a model is more likely over another one. The best performing model has the lowest AICc value and 
the AICc differences (ΔAICc) indicate how models perform relative to each other. A rule of thumb is that 
models with ΔAICc values below 3 are worthwhile to consider, values ΔAICc between 4 and 7 indicate that 
models are less supported, and values higher than 10 indicate that models may be discarded (Van 
Boekel 2009). The parameter Sy.x shows the average distance, expressed in the same unit as the 
y-axis, between the model and the data and should be low to obtain a good fit. 
Structure homology modeling
A structural model of PmHAS that was developed for Chapter 4, based on the crystal structure of K4CP 
chondroitin polymerase (Osawa et al. 2009), was used for structural alignment studies by DaliLite 
(Holm et al. 1996). Structural alignment of enzymes is evaluated by their root mean square deviation 
(RSMD) and Z-scores. Low RSMD values (below 4.0 Å) and high Z-scores (above 2) are a sign of a 
good structural superimposition and may indicate a conserved fold structure. All structural images were 
generated with PyMOL version 0.99 (Delano Scientific LLC, San Carlos, California, USA).
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Results and discussion
Since PmHAS consists of two transferase domains, the kinetic mechanism was individually investigated 
for both domains using initial velocity kinetics. Single-step elongations of HA4, HA6 and HA8 were 
monitored for the NAc-transferase domain, and HA5 for the UA-transferase domain. The elongation 
of HA7 at the UA-transferase domain was measured as well, but resulted in large variation between 
duplicates because of problems with the kinetic assay caused by high PmHAS activity at low UDP-
GlcUA concentrations. Decreasing the enzyme concentration in the assay was not possible due 
to enzyme instability. Therefore, the data of the HA7 elongation was excluded from this study and 
HA9 could not be studied because of the same problem. To identify the kinetic mechanism for each 
individual elongation, models were distinguished evaluating the goodness-of-fit parameters (Table 1) 
and examining the inhibition pattern of dead-end inhibitor UMP (Figure 1). 
Model discrimination by goodness of fit
Based on the ΔAICc values in Table 1, the rapid equilibrium ordered bi-bi mechanism with HA 
oligosaccharide binding before the UDP-sugar (Model 3) can be excluded for all investigated reactions 
at both the NAc- and UA-transferase domains. Results in Table 1 further indicate that the elongation 
reactions of HA4 and HA6 are best described by the Ping-Pong mechanism (Model 4) and the three 
Reaction Model SSr AICc ΔAICc
Correlation 
between 
parameters
Sy.x
HA4+UDP-
GlcNAc
1 12441.0 278.1 0.9 0.63 – 0.96 16.8
2 32435.8 321.6 44.4 0.35 – 0.99 26.8
3 14685.0 286.3 6.4 0.39 – 0.89 18.1
4 12862.5 277.3 0.0 0.67 – 0.96 16.9
HA6+UDP-
GlcNAc
1 45199.5 340.0 0.0 0.65 – 0.92 32.0
2 79262.2 364.5 24.6 0.40 – 0.99 42.0
3 63312.5 353.8 13.8 0.39 – 0.92 37.5
4 47793.5 340.3 0.3 0.60 - 0.90 32.6
HA8+UDP-
GlcNAc
1 45847.1 349.0 2.4 0.56 – 0.99 30.5
2 42858.0 346.5 0.0 0.30 – 0.85 30.2
3 75035.5 374.5 28.0 0.26 – 1 40.0
4 71327.3 372.0 25.5 0.51 – 0.88 39.0
HA5+UDP-
GlcUA
1 45072.1 408.4 0.0 0.38 – 0.95 28.4
2 46980.0 408.5 0.1 0.32 – 0.79 28.7
3 211891.3 498.9 90.5 0.23 – 0.99 61.0
4 47806.3 409.5 1.2 0.04 – 0.79 29.0
Table 1.   Goodness of fit for four models describing the elongation of HA oligosaccharides with one sugar moiety
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mechanisms expressed by Model 1, namely rapid equilibrium random bi-bi, steady state ordered bi-bi 
and Theorell-Chance. In contrast, data from the elongation reaction of HA8 only fits well with the rapid 
equilibrium ordered bi-bi with UDP-GlcNAc binding before the HA oligosaccharide (Model 2) because 
Model 1 is unstable, resulting in several different sets of estimated parameters (not shown) and strong 
correlations between the estimated parameters (Table 1), and Models 3 and 4 fit badly with ΔAICc values 
above 10 (Table 1). 
For the HA5 elongation reaction, Model 2 and 4 fit well with the data. The fit with Model 1 had higher 
standard deviations of the estimated parameters and strong correlations compared to the other models 
(Table 1), indicating that Model 1 has problems to fit the data and can thus be excluded. 
Model discrimination by dead-end inhibition studies
The mechanisms of the two PmHAS transferase domains were further distinguished by inhibition 
studies. Inhibition studies with UDP were not possible because the kinetic assay was based on 
monitoring UDP-formation. Therefore, UMP was selected as dead-end inhibitor to measure the activity 
of the HA4 elongation reaction at varying HA4 concentrations and a fixed UDP-GlcNAc concentration 
at 40 mM. No suitable dead-end analog of HA4 was found, but the exclusion of several mechanisms 
can already be realized by UMP as dead-end analog of UDP-GlcNAc, as can be seen in the inhibition 
patterns of Table 2. Table 2 shows what kind of inhibition can be expected of UMP with respect to HA4 
at saturating or unsaturating levels of UDP-GlcNAc, which differs for each mechanism. The numbers in 
Table 2 correspond to the Models given in Materials and Methods.
The AICc values for the noncompetitive, uncompetitive and competitive model fitted to the inhibition 
data were 185.7, 196.1 and 232.9, respectively. With these large differences in AICc, UMP acts as a 
noncompetitive inhibitor for HA4. This is also shown in the double reciprocal plot of the inhibition data 
by the intersection point behind the ordinate (Figure 1). The estimated dissociation constants Kii and Kis 
of UMP were almost equal at values of 134 ± 17 and 128 ± 48 mM, respectively.
Inhibitor Substrate
UDP-GlcNAc binds first
Rapid eq. 
random
Ping 
Pong 
Steady state 
ordered
Theorell-
Chance
Rapid eq. 
ordered
UMP (Q) HA4 (B); unsaturating fixed [UDP-GlcNAc] NC NC C NC UC
UMP (Q) HA4 (B); saturating fixed [UDP-GlcNAc] NC _ _ _ _
Model  (see p.79) 1 1 2 1 4
Table 2.   Expected patterns of dead-end inhibition for sequential and substrate-substituted mechanismsa (Lesko-
vac 2003; Cook et al. 2007).
 aCompetitive (C), noncompetitive (NC), and uncompetitive inhibition (UC). No inhibition observed (-).
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Figure 1.   Double reciprocal plot showing the inhibition the NAc-transferase activity of PmHAS by the dead-end 
inhibitor UMP at varying concentrations of HA4 and a fixed concentration (40 mM) of UDP-GlcNAc. The concentra-
tions of the inhibitor UMP were as follows: 0 (●), 100 (●) or 150 mM (●). The insert shows the inhibition data at 
low HA concentrations.
Assuming that the concentration of 40 mM UDP-GlcNAc is saturating, the only possible mechanism 
that leads to a noncompetitive inhibition by UMP is steady state ordered bi-bi (Table 2). On the other 
hand, since the Km values for UDP-GlcNAc are very high, as will be discussed below, chances are 
that the UDP-GlcNAc concentration is not saturated, resulting in other inhibition patterns for each 
mechanism (Table 2). If the UDP-GlcNAc concentration was at unsaturated levels, the Ping-Pong bi-bi 
mechanism (Model 4) can be excluded as a possible mechanism for the HA4 elongation, but the 
mechanisms expressed by Model 1 are still valid: rapid equilibrium random bi-bi, steady state ordered 
bi-bi and Theorell-Chance. Since HA4 and HA8 are both elongated by sequential mechanisms and 
HA6 is elongated at the same NAc-transferase domain, it is likely that HA6 is elongated by a sequential 
mechanism as well.
Kinetic mechanisms of both transferase domains in PmHAS
As discussed above, both the HA4 and HA6 elongation reaction are best described by Model 1, which 
is the model expression for three sequential mechanisms, namely rapid equilibrium random bi-bi, 
steady state ordered bi-bi and Theorell-Chance. Since the HA8 elongation reaction follows the rapid 
equilibrium ordered bi-bi mechanism, a shift in mechanism is observed at the NAc-transferase domain 
from the elongation of HA6 to HA8. This shift in mechanism is probably caused by a change in rates for 
the formation of the enzyme-substrate complex and the transfer reaction, while a shift in the order of 
binding the substrates is less likely. For example, the rapid equilibrium ordered bi-bi mechanism for the 
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HA8 elongation indicates that the kcat rate is 
significantly lower than the binding and release 
rates, whereas for a steady state ordered bi-bi 
mechanism these rates are comparable. In fact, 
the kcat value of the HA8 elongation is to some 
extent lower than the kcat value of HA6 (Table 3). 
Based on this mechanistic shift, we believe that 
the mechanism of all elongations at the NAc-
transferase domain is most likely an ordered 
one, where UDP-GlcNAc binds first and the HA 
oligosaccharide second before transferring a 
sugar residue to the growing oligosaccharide 
chain. The original kinetic data of the HA4, 
HA6 and HA8 elongations are shown in Figure 
2, fitted with the best performing mechanisms 
steady state ordered bi-bi and rapid equilibrium 
ordered bi-bi, respectively. 
For the HA5 elongation at the UA-transferase 
domain, two mechanisms, namely rapid 
equilibrium ordered bi-bi (Model 2) and Ping-
Pong (Model 4), fit the kinetic data well and the 
mechanisms cannot be distinguished further. 
Based on structural similarities shown in Chapter 
4 between the UA- and NAc-transferase domain 
and other glycosyltransferases, it is likely that 
the UA-transferase domain elongates HA 
oligosaccharides via a sequential mechanism 
as well, as will be further discussed below. The 
original kinetic data of the HA5 elongation is 
shown in Figure 3, fitted with the best performing 
mechanism rapid equilibrium ordered bi-bi.
Estimated kinetic parameters 
The kinetic parameters kcat, KmHA, KdUA, 
KdNAc, and KmNAc were determined using the 
best performing mechanism for each individual 
elongation reaction (Table 3). In Chapter 4, 
Figure 2.   Effect of UDP-GlcNAc concentration on the 
NAc-transferase activity of PmHAS. The elongation rates 
for oligosaccharides HA4, HA6, and HA8 were measured 
at varying oligosaccharide concentrations from 0.1 to 6 
mM with constant UDP-GlcNAc concentrations of 1 (○), 
6 (●), 15 (●) or 40 mM (●). The lines show the global fit-
ting results of the best fitting model, Steady state ordered 
bi-bi (Model 1) for HA4 and HA6 and Rapid equilibrium 
ordered bi-bi (Model 2) for HA8.
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we focused on the influence of the HA oligosaccharide on the elongation reaction through single-
substrate kinetics and the reported kcat and KmHA values are similar to those determined now through 
two-substrate kinetics (Table 3). In this study, the values of Michaelis Menten constant KmNAc and 
dissociation constant Kd for both UDP-sugars are obtained as well. In Scheme 1, each arrow represents 
a rate constant for binding or releasing one of the substrates or products. Km consists of several rate 
constants, including the dissociation constant Kd of the enzyme-substrate complex. Large differences 
between Km and Kd of the same substrate often indicate either an increase or decrease of affinity of 
enzyme for one substrate by binding a second substrate.
As can be seen in Table 3 by the large standard deviations and 95% confidence intervals, the 
model had problems estimating KdNAc for HA4 and HA6, which demonstrates that this model fits not 
completely to satisfaction. Better results are obtained for the estimated KdNAc for HA8. Table 3 shows 
that the differences between the estimated KdNAc values and KmNAc are not large, therefore no allosteric 
regulation was observed.
The estimated KmNAc in Table 3 is significantly higher than the reported apparent Km values for 
PmHAS (DeAngelis 1996; Jing et al. 2000; Krupa et al. 2007) and other HAS enzymes (Pummill et 
al. 1998; Itano et al. 1999; Tlapak-Simmons et al. 1999c), ranging from 0.06 to 1.0 mM. However, 
these reported values are apparent Km values that are determined by measuring the activity of both 
transferase activities at the same time using a fixed UDP-GlcUA concentration and neglecting the 
Figure 3.   Effect of UDP-GlcUA concentration on the UA-transferase activity of PmHAS. The elongation rates for 
oligosaccharide HA5 was measured:1) at varying UDP-GlcUA concentrations from 0.025 to 1 mM with constant 
HA5 concentrations of 0.1 (●), 0.5 (●) or 1.5 mM (●) (see main figure); and 2) at varying HA concentrations from 
0.1 to 6 mM with constant UDP-GlcUA concentrations of 1 (●) or 10 mM (●) (see insert). The lines show the global 
fitting results of the best fitting model, Rapid equilibrium ordered bi-bi (Model 2).
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HA oligosaccharide as a substrate. Therefore, apparent Km values are not absolute constants and 
they tend to increase at increasing concentrations of the fixed substrate, as was observed in (Itano 
et al. 1999; Tlapak-Simmons et al. 1999c). In our kinetic analyses, we studied the two transferase 
activities separately and data was measured by varying both the UDP-sugar and HA oligosaccharide 
independently. Thus, the observed variation between our results and literature could be explained by 
the different approach. Table 3 shows that there is no KmNAc estimated for the HA8 elongation because 
the rapid equilibrium ordered bi-bi mechanism (Model 2) does not include this parameter.
In contrast to the high KmNAc values, the estimated KdUA of 124 ± 31 μM is well in range with the 
(apparent) KmUA values for PmHAS (DeAngelis 1996; Jing et al. 2000; Krupa et al. 2007) and other HAS 
enzymes (Pummill et al. 1998; Itano et al. 1999; Tlapak-Simmons et al. 1999c), varying from 14 to 140 
μM. For most HAS enzymes is the KmNAc value significantly higher than the KmUA value (Pummill et al. 
1998; Itano et al. 1999; Tlapak-Simmons et al. 1999c; Krupa et al. 2007), as was observed here for the 
KdNAc and KdUA, suggesting that this difference in Km values is important for regulating HA formation. 
This result is in agreement with the work of Chen et al. (2009), where the metabolite concentrations 
in the HA pathway were manipulated by overexpression of genes involved in HA synthesis operon 
in Streptococcus equi subsp. zooepidemicus. Chen et al. showed that overexpression of genes 
involved in UDP-GlcNAc biosynthesis increased molecular weight of HA, whereas overexpression of 
genes involved in UDP-GlcUA biosynthesis decreased molecular weight. Our results indicate that the 
concentration levels of UDP-GlcNAc controls the HA molecular weight due to low binding affinity and 
that the polydispersity of the products will decrease when the concentrations of both UDP-sugars are 
appropriately balanced. 
Kinetic pa-
rameters
HA4+UDP-
GlcNAc
HA6+UDP-
GlcNAc
HA8+UDP-
GlcNAc
HA5+UDP-
GlcUA
Best fitting 
model 1 1 2 2
kcat (s-1) 7.9 ± 1.3 13.5 ± 1.6 8.8 ± 0.4 7.9 ± 0.3
95% CI 5.2 – 10.6 10.2 – 16.8 8.0 – 9.6 7.2 – 8.5
KmHA (mM) 0.7 ± 0.4 1.0 ± 0.4 0.7 ± 0.2 0.6 ± 0.1
95% CI 0.0 – 1.4 0.3 – 1.7 0.4 – 1.0 0.4 – 0.8
KmNAc (mM) 27.9 ± 8.8 12.6 ± 3.7 - -
95% CI 10.3 – 45.6 5.0 – 20.1 - -
KdNAc (mM) 8.6 ± 11.3 6.6 ± 6.4 16.4 ± 4.6 -
95% CI -14.3 – 31.4 -6.3 – 19.5 7.1 – 25.7 -
KdUA (µM) - - - 123.9 ± 31.0
95% CI - - - 61.7 – 186.0
Table 3.   Estimated kinetic parameters of PmHAS with standard deviations and 95% confidence intervals (CI).
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Ordered mechanism generated by conformational change in the enzyme 
The ordered mechanism discussed above can be visualized using a structural homology model 
of PmHAS that we built based on the crystal structure of a related glycosyltransferase (Chapter 
4). Through structural analysis we demonstrated that the two transferase domains in PmHAS are 
structurally related to glycosyltransferases of the GT-A fold. The GT-A fold is one of the major fold 
types found in glycosyltransferases (Breton et al. 2006), consisting of an α/β/α sandwich structure and 
containing a DXD motif that is involved in binding the UDP-sugar and a divalent metal ion, such as Mn2+ 
or Mg2+. Kinetic analysis demonstrated that these enzymes transfer the sugar moiety to the acceptor 
through an sequential mechanism, such as steady state ordered bi-bi (Morrison et al. 1971; Khatra et 
al. 1974; Ly et al. 2002), Theorell-Chance (Kamath et al. 1999), partially ordered bi-bi (Nishikawa et al. 
1988), rapid equilibrium random bi-bi (Wragg et al. 1995) or an undetermined sequential mechanism 
following Model 1 (Seto et al. 1997; Zhang et al. 2001). This sequential mechanism is generated by a 
flexible loop in the structure of these enzymes that changes conformation upon binding the donor sugar 
(Qasba et al. 2005). Crystal structures have shown that this flexible loop structure acts as a lid covering 
the bound donor substrate and offers together with the UDP-sugar interactions for binding the acceptor 
(Ünligil et al. 2000; Ramasamy et al. 2005; Fritz et al. 2006; Alfaro et al. 2008). The conformational 
change creates for several of these glycosyltransferases an acceptor-binding site that was not available 
before binding the UDP-sugar (Boix et al. 2002; Fritz et al. 2006; Ramakrishnan et al. 2006). 
Examples of the conformational change are shown in Figure 4A and B, where the binding of 
the UDP-sugar and acceptor are illustrated for UDP-GalNAc:polypeptide α-N-acetylgalactosaminyl-
transferase T2 (hT2) (Fritz et al. 2006) and β1,4-galactosyltransferase (β4Gal-T1) (Ramasamy et al. 
2005; Ramakrishnan et al. 2006). In these figures, both the open and closed formation are shown, 
where the surface of this loop is transparent to show the UDP-sugar below. The flexible loop in open 
conformation (in orange) obstructs the acceptor site, while the acceptor (in forest green) binds when 
the flexible loop is in the closed conformation (in yellow). In this closed conformation is the UDP-sugar 
covered by the loop and the sugar moiety of the donor sugar is directed towards the acceptor. 
Figure 4 (see right).   Conformational change in glycosyltransferases generates an ordered mechanism of transfer-
ring the sugar moiety from the donor sugar to the acceptor. In two examples (A and B) is shown that a flexible loop 
in an open conformation (shown in orange) makes the UDP-sugar binding site accessible for binding (left picture). 
After binding the UDP-sugar, the flexible loop changes to a closed conformation (shown in yellow) to cover the 
UDP-sugar as a lid, while in the same time revealing the acceptor binding site to the surface (right picture).  A) 
Structures of UDP-GalNAc:polypeptide α-N-acetylgalactosaminyl-transferase T2 are shown in green with open 
(2ffv) and closed (2ffu (Fritz et al. 2006)) conformation, UDP in red and the acceptor EA2 peptide in forest green; 
B) Structures of β1,4-galactosyltransferase are shown in red with open (2fyb (Ramakrishnan et al. 2006)) and 
closed (2aec (Ramasamy et al. 2005)) conformation, with UDP in blue and the trisaccharide GlcNAcβ1,2-Manα1,6-
Manβ-OR in forest green; C) PmHAS structural model shown as a blue ribbon structure with proposed flexible 
loops shown in red. Mn2+ ions are shown as red dots, and substrates as sticks with UDP-GlcNAc in yellow and 
UDP-GlcUA in green. The flexible loops of α1,3-galactosyltransferase and β1,4-galactosyltransferase in closed 
conformation are superimposed on both transferase domains and are shown in orange and green, respectively.
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Structural alignment of the two PmHAS transferase domains with α1,3-galactosyltransferase 
(α3GT) (Boix et al. 2002) and β4Gal-T1 (Ramasamy et al. 2005) resulted into good structural 
superimposition with Z-scores of 10.1 and 13.2 and RSMD values of 3.4 Å and 2.8 Å for α3GT and 
β4Gal-T1, respectively. Superimposition of these enzymes demonstrated that the flexible loops of 
α3GT and β4Gal-T1, shown in closed conformation, are on the same location as the loops in PmHAS 
that form a bridge over the active sites of the NAc- and UA-transferase domains (Figure 4C). Based 
on these results, we hypothesize that the residues Pro397 to Thr413, part of the NAc-transferase domain, 
and His639 to Val658, part of the UA-transferase domain, form two flexible loops in PmHAS that possibly 
play a role in substrate binding. Kinetic analysis of α3GT (Zhang et al. 2001), β4Gal-T1 (Morrison 
et al. 1971; Khatra et al. 1974), and PmHAS (this study) all showed sequential mechanisms that is 
supported by structural evidence for a conformational change in α3GT (Boix et al. 2002) and β4Gal-T1 
(Ramasamy et al. 2005). Therefore, it is likely that PmHAS shows a similar conformational change 
upon binding the UDP-sugar, after which the HA oligosaccharide can bind.
Concluding remarks
Based on the presented results, we hypothesize that the NAc- and the UA-transferase domains in 
PmHAS elongate by means of an ordered mechanism. In this ordered mechanism, the UDP-sugar 
is the first substrate to bind PmHAS and the HA oligosaccharide the second, after which the transfer 
reaction takes place and the elongated HA oligosaccharide and UDP are released. Structural similarities 
between a homology model of PmHAS and crystal structures of α3GT and β4Gal-T1 suggest that the 
ordered mechanism is induced by a conformational change in the active site. Furthermore, kinetic 
analysis indicated that the low affinity for UDP-GlcNAc regulates the hyaluronan molecular weight 
and will have a significant effect on the polydispersity of the products. These results point to several 
possible strategies to decrease the polydispersity of the products, including metabolic engineering to 
increase the UDP-GlcNAc concentration in HA producing microorganisms or single mutation studies to 
increase the binding affinity of UDP-GlcNAc within HAS enzymes.
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Appendix I 
Example of kinetic data that doesn’t fit well with the model. Data shown is the elongation reaction of HA4 with UDP-
GlcNAc at constant concentrations of 1 (○), 6 (●), 15 (●) or 40 mM (●). The lines show the global fitting results of 
the rapid equilibrium ordered bi-bi mechanism with UDP-GlcNAc binding before HA4 (Model 2).
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General discussion
Hyaluronan, a polysaccharide found in mammals and certain bacteria, is a versatile molecule that has many pharmaceutical applications depending on its chain length. To obtain hyaluronan with improved quality, new hyaluronan production methods, such as bacterial fermentation and 
enzymatic in vitro synthesis, are in development. In both methods, hyaluronan synthases (HAS) are 
used, enzymes that elongate precursors UDP-N-acetylglucosamine (UDP-GlcNAc) and UDP-glucuronic 
acid (UDP-GlcUA) into hyaluronan chains of different lengths. There are two classes of HAS enzymes, 
each with their own characteristics. Generally, Class I HAS enzymes are used in bacterial fermentation, 
whereas Class II is preferred in in vitro synthesis. In the first part of this chapter, differences and 
resemblances between these two classes are further examined and results obtained for Class II HAS 
in the earlier chapters are used to create new insights for Class I HAS.
One of the main issues in hyaluronan production is acquiring the desired chain length. This is for 
pharmaceutical applications either hyaluronan of high molecular weight with narrow polydispersity or 
small monodisperse hyaluronan oligosaccharides. These two product types need different production 
processes. Depending on the production process, hyaluronan molecular weight is controlled by many 
aspects, such as intrinsic properties of the HAS enzyme, bacterial metabolism and fermentation reac-
tion conditions, which will be discussed in the second part of this chapter. In the third part, I will describe 
how these aims can be achieved by discussing latest results in research on hyaluronan production. 
Both bacterial fermentation and enzymatic in vitro synthesis will be addressed.
Parts of this chapter are included in a book chapter:
Carmen G. Boeriu, Jan Springer, Floor K. Kooy, Lambertus A.M. van den Broek, and Gerrit Eggink. “Hyaluronan 
oligo- and polysaccharides: Production, properties, and applications.” In Polymeric Biomaterials III Ed, vol. I. 
Volume I Polymers as Biomaterials, Taylor and Francis – (Manuscript submitted). 
Another part of this chapter will be submitted as a trend manuscript – (Manuscript in preparation)
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Introduction
Hyaluronan is a polysaccharide composed of repeating units of β4-glucuronic acid (GlcUA)-β3-
N-acetylglucosamine (GlcNAc) disaccharides. Its viscoelastic and water-absorbing properties are 
essential for creating flexible and protective layers in tissues of the mammalian body. In addition to these 
structural roles, hyaluronan is involved in many signaling pathways during embryonic development, 
wound healing, inflammation and cancer (Stern et al. 2006). 
Due to these diverse biological roles, there are numerous applications for hyaluronan in the 
pharmaceutical and cosmetic industry (see Chapter 1) and the number of possible products is still 
growing. Applications depend on the chain length of the product, since that determines the function 
of hyaluronan in the body. In general, hyaluronan products can be divided into two groups, namely 
high molecular weight hyaluronan with narrow polydispersity and small hyaluronan oligosaccharides of 
defined length, also called monodisperse.
To obtain these two types of hyaluronan products, two different production strategies are required. 
High molecular weight products are originally obtained from extracting hyaluronan from animal tissues. 
Nowadays, these processes are more and more replaced by bacterial fermentation processes because 
product quality can be further improved. Production of small monodisperse hyaluronan oligosaccharides 
is only possible in vitro by stepwise addition of sugar moieties to the hyaluronan oligosaccharide chain 
or by controlled cleavage with isolated enzymes as catalyst, as was shown in Chapter 2. The most 
promising technique for large scale production of monodisperse hyaluronan oligosaccharides is through 
controlled stepwise addition in enzymatic in vitro processes.
In both strategies, hyaluronan is produced by hyaluronan synthases (HAS), which is for bacterial 
fermentation often Class I HASs and for in vitro processes Class II HAS. To understand how these 
enzymes can be used to control hyaluronan molecular weight, the first part of this chapter is focused 
on the differences and resemblances between the characteristics of Class I and Class II HASs. In this 
thesis, I have studied the polymerization mechanism of PmHAS, the single member of Class II HAS, 
using kinetic and structural methods. The results obtained for PmHAS will be reviewed here and used 
to clarify some of the properties of Class I HAS enzymes. 
Depending on the desired hyaluronan product, hyaluronan biosynthesis is controlled by several 
conditions. The effect of intrinsic properties of HAS enzymes, such as substrate affinity, on hyaluronan 
molecular weight is relevant for bacterial fermentation processes and enzymatic in vitro synthesis. 
Moreover, hyaluronan molecular weight is controlled during fermentation processes by the metabolism 
of the bacterial cell and by specific reaction conditions. The influence on hyaluronan molecular weight 
by these different aspects on enzyme level, cell level and reactor level will be reviewed in the second 
part of this chapter.
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After evaluating the different aspects that affect hyaluronan molecular weight, the status quo of 
hyaluronan production using HAS enzymes will be reviewed in the third part of this chapter. A short 
outlook on future bacterial fermentation processes and integrated enzymatic in vitro systems to produce 
high molecular weight products and small monodisperse oligosaccharides will be given. At last, several 
suggestions will be made to improve PmHAS performance for future hyaluronan production processes. 
In Figure 1, all of the topics that will be discussed in this chapter are presented in an outline.
Figure 1.   Outline of this chapter. Different aspects that are involved in controlling hyaluronan molecular weight 
are shown. 
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PART 1 - Family resemblances: how different are Class I and Class II HAS enzymes?
All HAS enzymes are glycosyltransferases, transferring GlcNAc and GlcUA sugar moieties from sugar 
nucleotide precursor to the growing hyaluronan chain. How this transfer is achieved differs between the 
two Classes of HAS enzymes. Class I HASs are processive enzymes, which start elongation with UDP-
GlcUA and UDP-GlcNAc and are unable to polymerize a hyaluronan chain after its removal from the 
binding site. In contrast, PmHAS can only polymerize hyaluronan by constant relocating and rebinding 
the growing chain on two separate transferase domains (see Chapter 4). 
The direction of elongation by PmHAS occurs at the nonreducing end of the hyaluronan chain 
(DeAngelis 1999b). For Class I HASs, polymerization at the nonreducing or reducing end have both 
been observed, resulting in the proposal of subdividing Class I into two subclasses (Weigel et al. 
2007). Other major differences are found in sequence similarity, topology and predicted structure. 
Nevertheless, some resemblances are to be expected for both HAS Classes in terms of binding the 
substrates or transferring the sugar moiety, as will be discussed below.
Sequence similarities of HAS enzymes
High sequence similarity (Appendix I and II) is observed within all Class I HAS enzymes, containing 
members from streptococci, mammals and an algal virus. Streptococcal HASs are ~70% identical to 
each other and ~25% identical to mammalian and algal HASs. The animal HAS family, with ~55-70% 
sequence identity, is subdivided into three isozymes, which are >90% identical within an isozyme family. 
In contrast, PmHAS has less than 10% sequence identity with members of Class I HASs, indicating that 
these two Classes have different ancestors.
Based on sequence similarities, Class I HAS enzymes are evolutionary related to processive 
glycosyltransferase 2 (GT2) family, such as cellulose synthases, chitin synthases, and chito-
oligosaccharide synthesizing NodC proteins (Merzendorfer 2006). All of these glycosyltransferases 
produce important polysaccharides in plants, fungi, bacteria, and animals by elongating UDP-sugars 
on a growing chain in a processive manner (Saxena et al. 1995). Similarities in conserved sequence 
regions between these processive GT2 enzymes and Class I HASs have indicated domains that are 
essential for catalysis, and will be further discussed below. 
Topology of HAS enzymes
Class I HASs are transmembrane proteins, with four membrane-spanning domains and two membrane-
associated regions (Heldermon et al. 2001a), see Figure 1A. The sequences of mammalian HASs are 
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~40% longer than streptococcal HASs with two additional membrane domains predicted at the COOH 
terminus (Weigel et al. 1997). The major portion of the HASs are localized intracellularly with an UDP-
sugar binding site at or near the cell membrane (Kumari et al. 2005). On the contrary, PmHAS is a 
soluble, intracellular enzyme with a putative membrane domain at the C-terminus (Jing et al. 2000). 
Streptococcal HASs are, unlike other glycosyltransferases, phospholipid dependent and contain 
around 16 cardiolipins in their structure (Tlapak-Simmons et al. 1999b). Based on high sequence 
similarity, mammalian HASs might also require phospholipids for enzyme activity, but so far no 
increased activity has been observed in the presence of phospholipids (Yoshida et al. 2000). The 
multiple transmembrane domains and phospholipid dependency has led to the hypothesis that HAS 
forms a pore, stabilized by phospholipids, in the cell membrane and transports the growing hyaluronan 
chain out of the cell (Weigel et al. 1997). This hypothesis was supported by the fact that HAS is the only 
enzyme needed for hyaluronan biosynthesis in either streptococci or in recombinant hosts (DeAngelis et 
al. 1993b). Similar hypotheses of polysaccharide transport have been proposed for cellulose synthases 
(Delmer 1999) and chitin synthases (Merzendorfer et al. 2003), which contain 8 or 16 transmembrane 
domains, respectively. 
If HAS enzymes are indeed involved in the transportation of hyaluronan, the pore characteristics 
could affect molecular weight, as will be discussed in the second part of this chapter. Since there are 
no crystal structures available for Class I HASs, the hypothesis of HAS’s ability to transport hyaluronan 
has not been confirmed yet.
Predicted structure of HAS enzymes
With the absence of crystal structures, other techniques have been used to obtain predictions on Class 
I HAS structures. Hydrophobic cluster analysis, a method to illustrate structural similarities between 
enzymes with low sequence identity, has revealed structural relations between Class I HASs and 
processive GT2 enzymes (Saxena et al. 1995). Saxena et al. showed that these enzymes consist 
of two conserved domains, called domain A and B. For Class I HASs, domains A and B are located 
between membrane domain 2 – 3 and 3 – 4, respectively (Figure 2A). These domains form the majority 
of the intracellular part of a HAS enzyme, where the active site is located (Heldermon et al. 2001a), and 
are likely to contain substrate binding sites. 
Based on hydrophobic cluster analysis, PmHAS consists of two equivalent domains A1 and A2 
(Jing et al. 2003), which are located in the NAc- and UA-transferase domain, respectively. In Chapter 
4, structural similarities between these transferase domains in PmHAS and glycosyltransferases of the 
GT-A fold have been shown. The GT-A fold is one of the major fold types for glycosyltransferases and 
consists of an α/β/α sandwich structure (Breton et al. 2006). Comparison of the Domains A’s in PmHAS 
and Class I HASs through sequence alignment reveals several conserved regions (Figure 2B and  II). 
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These conserved regions are involved in binding the UDP-sugars in glycosyltransferases of the 
GT-A fold, as was shown in Chapter 4. The uracil ring within the UDP moiety forms aromatic stacking 
interactions with the tyrosine residue in the IXXY motif and the N3 of the uracil ring interacts with the 
aspartate residue in the DGS motif (Chapter 4). The DXD motif is one of the trademark characteristics of 
the GT-A fold glycosyltransferases (Breton et al. 1998). The aspartate residues in the DXD motif forms 
a complex with the divalent ion Mg2+, required for binding the diphosphate-group of UDP (Chapter 4).
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Figure 2.   Topology and conserved regions within Class I HASs. A) Topology of SeHAS, as model for the other 
Class I HASs, contains four membrane-spanning domains ( corresponding to 1, 2, 4 and 5) and two membrane-
associated regions (corresponding to 3 and 6). The position number of amino acids in SeHAS predicted to be 
at membrane junctions are shown. Conserved regions located in Domain A and B are indicated. Adapted from 
(Heldermon et al. 2001a). B) Binding site for UDP-sugars. Sequence alignment of Domain A in PmHAS and Class 
I HASs revealed three conserved regions: IXXY, DGS, and DSD. The sequences are color coded to show family 
resemblances, using SeHAS as a model (grey shade). Other color codes are based on the mammalian isozymes: 
HAS1 (orange), HAS2 (green) and HAS3 (blue). Asterisks indicate conserved amino acids in Class I HASs.  Other 
sequence similarities within Class I HASs and with PmHAS are shown in Appendix II.
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The UDP-sugar binding sites in the NAc- and UA-transferase domains of PmHAS that were used 
for sequence alignment with Class I HASs are illustrated in Figure 3. The conserved sequence regions 
found in both Class I as Class II HASs are also indicated (Figure 3). The structure of these binding 
sites is highly conserved within glycosyltransferases of the GT-A fold (Liu et al. 2003). Thus, domain A 
in Class I HASs forms an UDP-sugar binding site for either UDP-GlcNAc or UDP-GlcUA. 
Interestingly, mutation studies in a recombinant MmHAS1 indicate that the SGPL motif on Domain 
B (Figure 2A) is direct or indirectly involved in binding UDP-GlcUA. Changing leucine in the SGPL motif 
into valine or isoleucine destroyed the ability of UA-transferase activity, whereas UDP-GlcNAc could 
still be polymerized into chito-oligosaccharides (Yoshida et al. 2000). The SGPL motif is also conserved 
in vertebrate UDP-glucuronosyltransferases (UDP-GT’s), although the direction of the amino acid 
Figure 3.   Conserved GT-A fold within Domains A1 and A2 of PmHAS. Structural alignment of residues 158-282 
of the NAc-transferase domain and residues 441-562 of the UA-transferase domain shown in white and gray, 
respectively. Important areas for UDP binding are indicated: DGS (green), IPAY (red), and DXD motif (blue). UDP-
GlcNAc is in light orange, UDP-GlcUA in orange and Mn2+ is shown as a red dot.
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sequence order is reversed. In a recently obtained crystal structure of UDP-GT2 B7, the SGPL motif 
forms interactions with the diphosphate group in UDP and the GlcUA moiety without the presence of 
a divalent ion or a DXD motif (Miley et al. 2007). It could be speculated, based on these results, that 
there is a second binding site, specifically for UDP-GlcUA, on Domain B. On the other hand, the SGPL 
motif may alter substrate specificity in the UDP-sugar binding site in Domain A. Elongation from one or 
two UDP-sugar binding sites require different polymerization mechanisms, as will be further discussed 
below.
In processive GT2 enzymes, 4 conserved regions, namely DGS, DXD, GDDR and QXXRW, are 
identified (Saxena et al. 1995), which are indicated in Figure 2A. Mutation studies have shown that 
these conserved regions are essential for catalysis in cellulose synthases (Saxena et al. 2001), chitin 
synthases (Nagahashi et al. 1995) and even hyaluronan synthases (Yoshida et al. 2000). As was 
discussed above, the DGS and DXD motif are part of an UDP-sugar binding site. Mutation of the highly 
conserved second aspartate residue in GDDR destroyed all transferase activity (Nagahashi et al. 1995; 
Yoshida et al. 2000; Saxena et al. 2001). Since the other aspartate residues are involved in UDP-sugar 
binding and a base is needed to catalyze the transfer reaction (Charnock et al. 2001), this aspartate 
residue is assumed to be the catalytic residue within processive GT2 enzymes (Charnock et al. 2001; 
Saxena et al. 2001). 
In addition, mutations in the QXXRW motif considerably decrease activity, but activity could still be 
observed (Nagahashi et al. 1995; Yoshida et al. 2000; Saxena et al. 2001). Since the QXXRW motif is 
present in all processive GT2 enzymes, this sequence is proposed to be involved in the processivity 
function of the enzyme and possibly forms the binding site for the growing polysaccharide chain in 
the active site (Saxena et al. 2001). This hypothesis was supported by activity measurements of a 
recombinant human HAS2 (rhHAS2) that was truncated to contain Domain A, membrane domain 3 
and Domain B, while the flanking transmembrane domains were omitted (Hoshi et al. 2004). In this 
study, rhHAS2 was surprisingly able to use a hyaluronan tetrasaccharide as an acceptor, but lacked the 
capacity to synthesize oligosaccharides above 14 sugar residues (HA14). Since hyaluronan templates 
were accepted for elongation, Domain B must contain an oligosaccharide binding site, possibly the 
QXXRW motif, that is otherwise blocked by the transmembrane domains. In addition, the results 
indicate that the flanking transmembrane domains are essential for producing high molecular weight 
hyaluronan (Hoshi et al. 2004), which supports the pore hypothesis.
Polymerization mechanism
To summarize the discussion above and in Chapters 4 and 5, five schematic models are illustrated for 
Class I and Class II HASs (Figure 4). These models demonstrate how polymerization is achieved and 
why Class I and Class II elongate through a processive or nonprocessive mechanism. 
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Polymerization mechanism in Class I HASs 
Class I HAS are transmembrane proteins with an intracellular active site. The growing hyaluronan chain 
may interact with the QXXRW motif in Domain B, as was proposed by Saxena et al. (2001). Based on 
the high sequence similarities within Class I HAS members, a general polymerization mechanism is to 
be expected, but the results on the direction of chain elongation are inconclusive. As discussed above, 
Domain A contains an UDP-binding site for either UDP-GlcNAc or UDP-GlcUA, but it is uncertain if 
the SGPL motif forms the UDP-GlcUA binding site in Domain B or if this motif is involved in changing 
substrate affinity in Domain A. In Figure 4, different models are shown for elongation at the nonreducing 
and reducing end of the chain and for single and double addition mechanisms. In the models, the 
substrates are placed in the required orientations for elongation.
To be able to elongate through a processive manner, the oligosaccharide chain has to be in the 
right position to form β-linkages for each elongation. Since cellulose consists of β1,4-linkages, the 
adjacent sugar residues have opposed orientations. Therefore, a double addition mechanism was 
proposed with two UDP-sugar binding sites (Figure 5A) to ensure that the orientation of the growing 
chain remains unchanged (Saxena et al. 1995). In comparison, hyaluronan consists of β4-GlcUA-β3-
GlcNAc linkages. For Class I HASs, the double addition mechanisms are shown in Figure 4C and D, 
with the substrates placed at their predicted binding sites and in the right orientation for bond formation. 
However, the orientation of the UDP-sugar in the model of Saxena et al. are not in agreement with the 
Figure 4.   Schematic models of Class I and Class II HASs. GlcNAc and GlcUA (white and gray spheres, respec-
tively) are transferred to hyaluronan chains at the nonreducing (A,C) or reducing end (B,C) for Class I and at the 
nonreducing end for Class II. Distinction is made for single (A,B) and double (C,D) addition mechanisms in Class 
I HASs. In case of the single addition mechanism,  UDP-sugar affinity has to change after each elongation. Sticks 
represent UDP. 
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UDP-sugars found in the crystal structures of GT-A folded glycosyltransferases, which demonstrate 
a characteristic orientation with the sugar moiety bent under the diphosphate group (Chapter 4 and 
Figure 5B). This latter orientation is ingeniously constructed because the attacking OH group for the 
next elongation step at the nonreducing end is already in the right direction due to the backwards-folded 
orientation of the sugar moiety (Figure 5B). Therefore, there is no need of changing the orientation of 
the oligosaccharide chain, since the newly added sugar is ready for the next elongation. 
In addition, if a second UDP-sugar binding exist, it should be located in Domain B together with 
the oligosaccharide binding site. Since the UDP-sugar binding site in Domain A is build out of 160 
amino acid residues, it is unlikely that the 
remaining 100 residues in transmembrane 
domain 3 and Domain B (see Figure 2A) is able 
to create the second UDP-sugar binding site 
and an oligosaccharide binding site. Based on 
these conclusions, I propose that Class I HASs 
elongates through a single addition mechanism 
(Figure 4A or B).
Numerous crystal structures of 
glycosyltransferases all indicate that the 
corresponding active sites contain one 
binding site for a sugar moiety, activated by a 
phosphate, a lipid phosphate, or a nucleotide, 
and one binding site for the oligosaccharide 
or sugar residue that is elongated (Charnock 
et al. 2001). For Class I HASs, this means 
that hyaluronan synthesis through a single 
addition mechanism is only possible when 
the specificity of the UDP-sugar binding site 
changes after each elongation (Figure 4A 
and B). Small changes in the active site are 
known to change specificity, as was observed 
by point mutations in blood Group A α1,3-N-
galactosaminyltransferase (Seto et al. 1999) 
and β1,3-glucuronosyltransferase (Ouzzine et al. 2002). As is discussed above, the SGPL motif is 
involved in the transfer reaction of UDP-GlcUA, but is not required for UDP-GlcNAc binding (Yoshida et 
al. 2000), and is therefore a likely motif that determines substrate specificity. 
The orientation of the growing hyaluronan chain in the active site has as well important implications 
for the catalytic mechanism of Class I HASs. The direction of hyaluronan elongation has been frequently 
Figure 5.   Double addition versus single addition 
mechanism. A) Double addition mechanism at reducing 
end in as proposed by (Saxena et al. 1995). After 
the transfer reaction, the grey sugar residue will be 
translocated to the UDP-binding on the right and the 
elongation cycle can start again. B) Single addition 
mechanism as modeled in UA-transferase domain in 
PmHAS. Conserved UDP-sugar fold with sugar moiety 
folded back, exposing C1 for catalysis with Asp613 as 
putative catalytic residue and OH group of C3 in HA 
oligosaccharide ready for nucleophilic attack.
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studied with puzzling results. Hyaluronan synthesis by streptococcal HAS occurs at the reducing end 
(Prehm 1983; Bodevin-Authelet et al. 2005; Tlapak-Simmons et al. 2005), whereas eukaryotic HASs 
have been observed to elongate at the nonreducing (Hoshi et al. 2004; Bodevin-Authelet et al. 2005) 
and the reducing end (Asplund et al. 1998; Prehm 2006). 
Similar confusing results have been obtained for processive GT2 enzymes as well, although the 
majority of data indicates that elongation occurs at the nonreducing end (Koyama et al. 1997; Delmer 
1999; Kamst et al. 1999; Cartee et al. 2000; Charnock et al. 2001; Imai et al. 2003). In addition, 
processive glycosyltransferases that elongate at the reducing end of a polysaccharide chain tend to 
use oligosaccharides activated by phospholipids instead of UDP-sugars (Delmer 1999; Lovering et 
al. 2007; Yuan et al. 2007). Therefore, it is most likely that all HASs elongate at the nonreducing end, 
but confirmation will have to wait until the crystal structure of a processive GT2 enzyme is obtained 
(Charnock et al. 2001). Based on these results, I propose a single addition at the nonreducing end of 
the hyaluronan chain as the most probable polymerization mechanism for Class I HASs (Figure 4A). 
This makes Class I HASs not so different from PmHAS, after all.
Polymerization mechanism in Class II HAS
In contrast to one active center in Class I HASs that changes UDP-sugar affinity, PmHAS elongates 
UDP-GlcNAc and UDP-GlcUA in two separate transferase sites. Both transferase sites contain an 
oligosaccharide binding site (Figure 4, Class II), as was discussed in Chapter 4. The DXD motifs, in 
complex with Mg2+, bind the UDP-sugars. Loss of any of the aspartate residues in the DXD motif through 
point mutation destroys the capacity of UDP-sugar binding and thus inactivates the corresponding 
transferase activity (Jing et al. 2003). 
Based on structural similarities between PmHAS and glycosyltransferases of the GT-A fold (Chapter 
4), two locations were proposed for the two oligosaccharide binding sites, which are illustrated in Figure 
4. The results discussed in Chapter 4 indicate that the oligosaccharide binding site is longer at the 
UA-transferase than at the NAc-transferase site. Steady state kinetics using single-step elongations 
of hyaluronan oligosaccharides HA4, HA5, HA6 and HA8 demonstrated that the elongations at 
both the NAc- and UA-transferase site occur through a sequential mechanism (Chapter 5). This 
sequential mechanism is most likely an ordered one, in which the UDP-sugar binds first, followed by 
binding of the hyaluronan oligosaccharide. Structural similarities between PmHAS and GT-A folded 
glycosyltransferases indicate that a flexible loop, one across each active site (see Figure 4), will change 
its conformation upon binding a UDP-sugar in that site (Chapter 5). 
Polydispersity of hyaluronan products
Since the distances between the transferase domains in PmHAS are large, the growing hyaluronan 
chain has to relocate from one active site to another, causing a nonprocessive elongation. These two 
active sites in PmHAS offer the opportunity to influence the polydispersity of hyaluronan products by 
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the addition of hyaluronan templates. Adding small hyaluronan oligosaccharides, like HA4, avoids the 
first slow reaction steps of forming these small oligosaccharides, which reduces the polydispersity 
remarkably (Jing et al. 2004). In Chapter 4, an increase of the reaction rate was observed at increasing 
chain length, until the binding specificity kcat/Km was constant. Although an increase in polydispersity 
due to elongation at two sites in PmHAS is inevitable, polydispersity can be decreased by the addition 
of saturated hyaluronan oligosaccharide concentrations (Chapter 4). 
In Class I HASs, polydispersity is determined by the moment that the chain is released from the 
enzyme. Since this is depending on the properties of hyaluronan chain binding, it will be for each 
polymerization reaction at saturating UDP-sugar levels approximately the same and cannot be further 
influenced without changing binding properties. In the second part of this chapter, different aspects will 
be addressed of how hyaluronan synthesis is controlled in hyaluronan synthases, in cells, and during 
fermentation. 
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PART 2 - Size matters: how to control molecular weight in hyaluronan production?
Control of molecular weight in hyaluronan synthesis is a goal many have tried to achieve. Controlled 
hyaluronan synthesis would not only contribute to specialized hyaluronan products, but would also 
offer the opportunity to study the complex signaling roles induced by hyaluronan in the human body. 
However, hyaluronan synthesis is regulated by several intrinsic properties of hyaluronan synthases and 
by cell metabolism. In addition, reaction conditions during bacterial fermentation to produce hyaluronan 
have divergent outcomes on molecular weight. Molecular weight is less complicated to control in in 
vitro synthesis using hyaluronan synthases, requiring regulation of ‘just’ the enzyme, but is limited 
by the mandatory regeneration of UDP-sugars. In bacterial fermentation, UDP-sugar regeneration 
is accomplished by bacterial metabolism, but controlling all bacterial pathways to produce more 
hyaluronan of desired length is complicated. 
In this part of the chapter, various degrees in regulation are reviewed, starting from enzyme level to 
cell level and, last, the level of reaction conditions. Not all regulation pathways are completely clarified 
at this moment and in these cases the status quo of research will be described. The main focus is 
on regulation that is important for hyaluronan production, concentrating on streptococcal HASs and 
PmHAS. Some examples from mammalian HASs will be discussed, there where it is useful to do so. 
Regulation through intrinsic properties of HAS enzymes 
Even though Class I HASs are alike in sequence, topology and predicted structure, their minor differences 
in sequence causes major differences in stability, kinetics and, more important, molecular weight 
of hyaluronan products. For example, MmHAS3, isozyme of MmHAS1 and MmHAS2, polymerizes 
hyaluronan to a molecular mass of 1*105 ~ 1*106 Da, while MmHAS1 and MmHAS2 synthesize in 
the same time hyaluronan of 2*105 ~ 2*106 Da (Itano et al. 1999). MmHAS1 is stable for an hour after 
which the activity is considerably decreased, compared to at least 4 hours of stability for MmHAS2 and 
MmHAS3 after which activity reduces gradually. Furthermore, Km values of UDP-sugars vary for all 
three isozymes with largest KmNAc and KmUA values of 1 mM and 73 μM, respectively, for MmHAS1. As 
a result, cells containing only MmHAS1 had a significantly smaller amount of hyaluronan surrounding 
the cells than those containing MmHAS2 or MmHAS3 (Itano et al. 1999). 
This example indicates that differences in intrinsic properties of HAS enzymes result in different 
hyaluronan products. In this section, intrinsic properties, such as enzyme stability, conversion rate, 
chain transportation and substrate affinity, and their effect on molecular weight will be described. 
Extrinsic properties, such as UDP-sugar availability and substrate/enzyme ratio, will be discussed in 
the next section about regulation within the cell. 
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Stability 
Enzyme stability, as discussed above, is one possible approach to regulate molecular weight within 
animal tissues (Itano et al. 1999). For in vitro synthesis, it is important to know that prolonged storage 
time can cause alterations in kinetic parameters, resulting in smaller hyaluronan products. This was 
demonstrated for purified SeHAS and SpHAS enzymes kept at -80 °C, resulting in a considerable 
increase in Km values for UDP-sugars and decrease in Vmax (Tlapak-Simmons et al. 1999a). In my 
studies, no change in kinetic parameters were observed for PmHAS during storage at -80 °C over a 
period of 6 months and, during activity measurements, activity was stable during 4 hours of incubation 
(data not shown). 
Conversion rate 
The effect of conversion rates is under saturating substrate conditions the same for Class I and Class 
II enzymes in in vitro synthesis. Since Class I are processive enzymes, the conversion rate will not 
influence molecular weight or polydispersity. When these enzymes are stable and incubation time is 
prolonged, slow HAS enzymes with equal substrate binding properties as fast enzymes can synthesize 
hyaluronan of high molecular weight (Pummill et al. 2003). Similarly, a slow mutant of PmHAS can still 
achieve high molecular weight because hyaluronan chains can be rebound for further elongation. The 
effect of slow conversion rates in in vivo synthesis will depend on how and when hyaluronan chains are 
transported out of the cell.
Chain transportation
As already discussed in Part I of this chapter, Class I HASs consist of multiple transmembrane domains 
and streptococcal HASs activity is phospholipid dependent. These findings has led to the hypothesis 
that HAS forms an internal pore in the cell membrane, transporting the growing hyaluronan chain 
out of the cell as it is elongated (Weigel et al. 1997). In support of this theory, the activity studies 
using a truncated human HAS2 mutant indicated that the transmembrane domains were essential 
for accelerating synthesis and without these domains only small oligosaccharides could be produced 
(Hoshi et al. 2004). Other mutation studies involving point mutations within transmembrane domains 
also influence molecular weight. For instance, it was demonstrated that positively charged Lys48 and 
negatively charged Glu327, located in membrane domains 2 and 4 of SeHAS (Figure 2A), form a 
bond (Kumari et al. 2006). Disrupting this bond by mutation caused a 6 fold reduction of hyaluronan 
molecular weight, suggesting that pore formation was affected or that the protein was inadequately 
folded (Kumari et al. 2006). 
In addition, changing Ser77 residue, located in transmembrane domain 2 in XlHAS1, into Phe or Ile 
resulted in 40% longer hyaluronan chains, whereas molecular weight was reduced by 25% when Ser77 
was changed into Tyr (Pummill et al. 2003). KmNAc and KmUA values decreased 2 ~ 4 fold by the change 
into Phe or Ile, where Tyr mutation resulted in slightly increased Km values. Since Ser77 is located in 
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the transmembrane domain, it is unlikely to form a part of an UDP-sugar binding site. An alternative 
explanation for the results is that mutations Phe and Ile increased the affinity of the hyaluronan chain, 
which extended chain elongation (Pummill et al. 2003). Both explanations support the hypothesis of 
hyaluronan transport by HASs.
In contrast to the pore hypothesis, recent studies have demonstrated that an ATP-binding cassette 
(ABC) transporter, a generic substrate transport system in the cell membrane, is involved in hyaluronan 
transport in both bacterial and human cells (Ouskova et al. 2004; Prehm et al. 2004). Hyaluronan 
production in Streptococcus pyogenes mutants with a defect ABC transport system decreased 
by approximately 70% and the hyaluronan capsule was reduced by 40% (Ouskova et al. 2004). 
Since introduction of a HAS gene from Class I or Class II alone is enough to produce hyaluronan in 
recombinant hosts, a generic transport system, such as the ABC transporter, is proposed (Chong et al. 
2005). Additional research will be necessary to exclude or confirm the pore hypothesis.
UDP-sugar affinity
Kinetic studies on Class I HASs have been challenging because purification of these enzymes from 
the cell membrane frequently resulted in instable enzymes with, in some cases, changed kinetic 
behavior. Class I HASs are unable to use hyaluronan templates, complicating kinetic studies by the 
inability to study activity at varying oligosaccharide concentrations. Since the elongation mechanism 
and sequence regions involved in catalysis are unknown, the NAc- and UA-transferase activities in 
Class I HASs cannot be separated or disabled. Class I HASs kinetic studies are, therefore, restricted 
in measuring apparent Km and kcat values, since only the UDP-sugar concentrations can be varied. 
However, apparent Km values are not absolute constants; these parameters often increase at increasing 
concentrations of the second substrates. 
In my studies, NAc- and UA-transferase activities were measured separately, and are therefore 
difficult to compare with the apparent Km values from literature. In Chapter 5, KdUA and KmNAc values 
were determined to be at 124 μM and 28 mM, respectively, using two-substrate kinetics. This difference 
in binding affinity for the two UDP-sugars is unusually high, but large differences between Km values 
are common for Class I HASs as well (see Chapter 5 for discussion). These results indicate that the 
difference in binding affinity of the two UDP-sugars controls the molecular weight of hyaluronan.
For some of the HAS enzymes, additional regulation has been observed. For instance, SpHAS 
showed sigmoidal behavior as the UDP-GlcNAc concentration was increased, with a Hill number of ~2, 
indicating considerable positive cooperativity (Tlapak-Simmons et al. 1999a; Heldermon et al. 2001b). 
Positive cooperativity makes SpHAS more sensitive to UDP-GlcNAc and activity is increased within a 
narrow range of UDP-GlcNAc concentration (0-0.18 mM). These results indicate that there could be an 
alternative binding site for UDP-GlcNAc that is involved in regulation rather than catalysis. In contrast, 
no cooperativity was observed for SeHAS, with a Hill number of ~1 (Tlapak-Simmons et al. 1999a). 
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In my results, no cooperativity was observed for the individual transferase domains within PmHAS 
between the hyaluronan oligosaccharides and UDP-sugars (Chapter 4). However, mutation studies on 
PmHAS suggest that ‘cross-talk’ between the two domains does occur. Mutation of the Asp477 into Gln 
within the DGS motif of the UA-transferase domain resulted into a twofold increase of UDP-GlcNAc 
transferase activity and a twofold decrease in KmNAc compared to wild-type PmHAS (Jing et al. 2000). 
In addition, mutations of D527N, D529N, and D529K in the DXD motif reduces UA-transferase activity 
to <0.1%, but surprisingly increases NAc-transferase activity to 280%, 230% and 360% (Jing et 
al. 2003), respectively. Considering that both of these conserved regions are located far from the 
NAc-transferase active site, I hypothesize that the observed increase in activity indicates, therefore, 
some kind of allosteric behavior. In support of this theory, the mutants with one transferase activity 
disabled were significantly less efficient, when joined together in a reaction to form hyaluronan from 
UDP-sugars, in hyaluronan synthesis than wild type PmHAS, suggesting that for chain initiation two 
active sites are required (Jing et al. 2000).
Another interesting finding is shown in binding studies of UDP-sugars on the active sites of 
Escherichia coli (E. coli) K4 chondroitin polymerase (K4CP), the enzyme that was used to build the 
structural model of PmHAS (Chapter 4). Sobhany et al. (2008) demonstrated in binding studies using 
UDP-GlcUA, UDP-GalNAc and UDP that one donor molecule was bound to one molecule of K4CP 
at a time, and that UDP-GalNAc was able to bind both active sites. Surprisingly, mutation of the 
second aspartate into lysine in the DXD motif of the UA-transferase domain disabled the bindings of 
UDP-GalNAc and UDP in the NAc-transferase domain (Sobhany et al. 2008). The equivalent mutation 
(D529K) in PmHAS showed a considerable increase in NAc-transferase activity, as discussed above. 
Based on the results of Sobhany et al. (2008) and Jing et al. (2000), it seems that the DXD motif 
and perhaps even the DGS motif in the UA-transferase domain regulate UDP-sugar binding in the 
NAc-transferase domain. These interesting results have to be further explored to confirm allosteric 
regulation.
Since UDP-GlcNAc is an important compound for bacterial cell wall synthesis, cell growth 
competes with hyaluronan synthesis for this precursor (Chong et al. 2005). It is therefore plausible that 
UDP-GlcNAc usage for hyaluronan synthesis is regulated by high KmNAc values or allosteric regulation, 
as was discussed above.
Hyaluronan oligosaccharide affinity
The focus of Chapter 4 was on the influence of oligosaccharide chain length on the polymerization 
reaction. Although the single-step reactions followed Michaelis-Menten kinetics, a significant increase 
in kcat was observed with increasing oligosaccharide length. For the UA-transferase site, this could be 
explained by the decreasing Km for the oligosaccharides HA5, HA7 and HA9. At the NAc-transferase 
site, Km values for oligosaccharides HA4, HA6 and HA8 were moderately constant (Chapter 4). 
However, the two-substrate kinetic studies demonstrated that KmNAc values decreased at increasing 
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oligosaccharide length, which results in higher 
kcat values (Chapter 5). There is no simple 
explanation for the observed decrease in KmNAc 
values, but one could speculate that longer HA 
oligosaccharides induce this improved binding 
affinity of UDP-GlcNAc at the NAc-transferase 
site.
For Class I HASs, the affinity for hyaluronan 
oligosaccharides cannot be measured due 
to the inability of binding and elongating 
an oligosaccharide. It is, however, of great 
importance because strong binding between 
the hyaluronan chain and HASs ensures the 
continuation of processive elongation. Chain 
length is likely to increase when affinity for 
the hyaluronan chain increases. Possible 
interactions between the enzyme and 
hyaluronan chain include: i) a covalent intermediate formed during catalysis, ii) hydrogen bonding of 
enzyme with hydroxyls or amides of hyaluronan, iii) hydrophobic interaction of the enzyme with the 
apolar faces of the hyaluronan pyranose rings, iv) ionic bond formation between  positive synthase 
residues and the negative groups of hyaluronan, and v) interaction with the UDP moiety of the chain if 
elongation occurs at the reducing end of the chain (Pummill et al. 2003). 
Increasing the NaCl concentration in the reaction buffer to 1 M caused XlHAS1 to produce longer 
hyaluronan products. Hydrophobic interactions are increased at high salt concentrations, suggesting 
that hyaluronan oligosaccharides form hydrophobic interactions either through hydrophobic stacking 
of the pyranose rings of the oligosaccharide or the uracil ring of the UDP moiety (Pummill et al. 2003). 
In my studies, increasing KCl concentrations resulted in decreased polydispersity of hyaluronan 
products in PmHAS polymerization reactions, and, during longer incubations, more hyaluronan 
product with high molecular weight was produced (Figure 6). This suggests that increased hyaluronan 
oligosaccharide affinity in PmHAS by increased hydrophobic interactions could lead to products with 
narrow polydispersity. 
In Chapter 4, it was shown that the proposed oligosaccharide binding site in the UA-transferase 
site contains four to five aromatic hydrophobic residues, while in the NAc-transferase site there are only 
two aromatic hydrophobic residues in close contact with the hyaluronan oligosaccharide. The higher 
amount of hydrophobic residues in the UA-transferase site together with the longer oligosaccharide 
binding site could explain the difference observed in Km values for HA oligosaccharides between the 
UA- and NAc-transferase sites. 
Figure 6.   Effect of KCl concentration on polydispersity. 
Polymerization reactions containing 5.5 mM of both UDP-
sugars, 0.1 mM HA4 and 80 μg/ml PmHAS incubated 
for 1 or 5 hours at 30°C. The numbers indicate the KCl 
concentration in mM. M1 shows a 30kDa hyaluronan 
product above. M2 is the ultra low range Gene Ruler DNA 
ladder from Fermentas that is used for reference.
General discussion    Part 2 - Regulation of hyaluronan molecular weight
116
As discussed in Chapter 4, glycosyltransferases contain often aromatic hydrophobic residues 
tryptophane, phenylalanine or tyrosine in the oligosaccharide binding sites, showing specific affinity 
towards an oligosaccharide (Zhang et al. 2004; Fondeur-Gelinotte et al. 2007), acting as stabilizer 
of the transition state (Zhang et al. 2004), or positioning the acceptor for catalysis (Ramasamy et al. 
2005). Therefore, these interactions are currently used in structural studies to predict carbohydrate-
binding sites on three-dimensional protein structures (Taroni et al. 2000; Shionyu-Mitsuyama et al. 
2003; Malik et al. 2007). With the structural model of PmHAS available, it is now possible to pinpoint the 
involved hydrophobic residues and investigate their role in polymerization through mutation studies.
Regulation of molecular weight within the cell
The regulation of hyaluronan synthesis is extensively more complex in vertebrates than in bacteria 
because hyaluronan fulfils various functions in the mammalian body depending on the tissue involved 
and the hyaluronan chain length (Chapter 1). Different expression patterns are observed for the three 
mammalian HAS isozymes between adult and embryonic tissues (Nardini et al. 2004; Tien et al. 
2005). Several regulatory factors are known to be involved in controlling HAS transcription, such as 
morphogenes, cytokines, growth factors and antisense mRNA (Suzuki et al. 1995; Chao et al. 2005). 
Furthermore, hyaluronan synthesis seems to be controlled through translation regulation, since a latent 
pool of HAS exits within the cell interior, in the endoplasmic reticulum-Golgi compartments, that upon 
insertion in the cell membrane becomes activated (Rilla et al. 2005). HAS activity can be modulated by 
post-translational modification, such as phosphorylation and N-glycosylation (Vigetti et al. 2009). And to 
finish, intermediate and small oligosaccharides are probably provided through hyaluronan cleavage by 
hyaluronidases, since mammalian HAS isozymes synthesize hyaluronan of above 105 Da (Stern 2003). 
With all these different cellular compounds involved in hyaluronan synthesis regulation, a cohesive 
view of how these compounds are interrelated is unavailable at the moment.
On the other hand, hyaluronan synthesis seems to be far less regulated within bacteria. Only a small 
number of microbial pathogens are able to synthesize hyaluronan, namely the Group A and C streptococci 
and Pasteurella multocida (Kendall et al. 1937; Carter et al. 1953; MacLennan 1956). Streptococcus 
pyogenes belongs to Group A streptococci and Group C streptococci include Streptococcus equisimilis 
and Streptococcus equisimilis subspecies zooepidemicus. From these bacteria, S. zooepidemicus is 
most frequently used for hyaluronan synthesis, since they are less pathogenic to humans and they 
have superior hyaluronan productivity. The answer for this high productivity lies in the genes of S. 
zooepidemicus, as will be discussed below. Instead of using streptococci for hyaluronan production, 
the number of fermentation studies using safe recombinant hosts has been increased the last five 
years, and will also be reviewed. 
Hyaluronan synthesis is a costly process for bacteria in terms of carbon and energy resources. 
To construct one hyaluronan disaccharide unit, five ATP equivalents, two NAD+ cofactors, and one 
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acetyl-CoA group are used in addition to the disaccharide backbone (Chong et al. 2005), as is shown in 
Figure 7. Therefore, hyaluronan production is likely to compete with bacterial growth for glucose to use 
as energy provider and the formation of the needed precursors. As will be discussed in a later section, 
suboptimal growth seem to enhance hyaluronan synthesis because, when cells are growing slowly, the 
carbon and energy resource are available for other processes (Armstrong et al. 1997). The effect of 
energy and carbon resources on hyaluronan synthesis is further discussed below. 
Regulation within bacterial cells
The high hyaluronan productivity observed for S. zooepidemicus can partially be explained by the two 
fold higher conversion rates observed for SeHAS compared to SpHAS (Tlapak-Simmons et al. 1999a). 
In addition, hyaluronan synthesis in Group C streptococci differs from Group A streptococci in regulatory 
system and precursor synthesis. First, a two-component regulatory system has been identified in S. 
pyogenes that influences expression of the capsule synthesis genes of the has operon (Levin et al. 
1998), consisting of a capsule synthesis regulator component (csrR) and a sensor component (csrS). 
Inactivation of one of these genes reverts unencapsulated cells into the hyaluronan producing strain 
(Levin et al. 1998). Although S. zooepidemicus does seem to encode similar regulator genes, there is 
no difference in expression of the csrRS operon observed between encapsulated and unencapsulated 
strains (Blank et al. 2005). Since encapsulated and unencapsulated S. zooepidemicus strains both 
contain identical has operon genes, it suggests that other factors are involved in the regulation of 
hyaluronan synthesis in S. zooepidemicus.
Second, it has been recently discovered that S. zooepidemicus contains a has operon on which four 
of the enzymes involved in UDP-sugar synthesis are mutually expressed with the hyaluronan synthase 
gene (hasA) (Blank et al. 2008). These include UDP-glucose dehydrogenase (hasB), UDP-glucose 
pyrophosphorylase (hasC), a glmU paralog encoding for a dual function enzyme acetyltransferase and 
pyrophosphorylase activity (hasD), and a pgi paralog encoding for phosphoglucoisomerase (hasE). In 
Figure 7 is shown that hasB and hasC are involved in UDP-GlcUA synthesis, while hasD and hasE are 
involved in UDP-GlcNAc synthesis. Other streptococci strains have has operons that contain, besides 
hyaluronan synthase, only the hasB and hasC genes. This suggests that the superior hyaluronan 
biosynthesis observed for S. zooepidemicus relates to UDP-sugar availability. 
Energy resources
Under aerobic fermentation conditions, streptococci change their metabolism of producing lactate 
into producing acetate, formate and ethanol, which generates  four ATP per hexose for the acetate 
production instead of the two ATP formed in lactate production (Chong et al. 2003a). Consequently, 
hyaluronan productivity is increased under aerobic conditions by 50% resulting in raised yields and 
molecular weight, whereas cell growth is unaffected (Armstrong et al. 1997; Cooney et al. 1999; Huang 
et al. 2006). These results suggested that the increased levels of ATP were the reason for the increase 
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in hyaluronan yield and molecular weight. However, studies designed to improve ATP formation by 
increased acetate production through maltose metabolism (Chong et al. 2003a) or by metabolic 
engineering increasing NADH oxidase levels (Chong et al. 2003b) revealed that hyaluronan synthesis 
was not limited by energy resources. 
Recently, it has been shown that only a critical level of dissolved oxygen of 5% is needed to increase 
the hyaluronan yield on cell growth, after which the yield is constant (Huang et al. 2006). Interestingly, 
the expression of hyaluronan synthase in S. zooepidemicus is nine times higher under aerobic 
conditions than under anaerobic conditions (Duan et al. 2009), explaining the increase of hyaluronan 
synthesis. Furthermore, oxygen induces enzymes involved in the production of UDP-GlcNAc (hasD) 
and acetoin recycling, which offers an additional ATP molecule and acetyl-CoA that can be used in 
hyaluronan production (Wu et al. 2009). Based on these results, I can conclude that elevated HAS 
concentrations and UDP-GlcNAc availability seem to be the main reason for the increase in hyaluronan 
synthesis under aerobic conditions.
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Carbon resources
Since glucose is needed to synthesize the precursors of hyaluronan, its availability has an substantial 
effect on hyaluronan yield and molecular weight (Armstrong et al. 1997). The yield of hyaluronan on 
glucose varies between 5 and 10% (Chong et al. 2005; Gao et al. 2006b; Duan et al. 2009), which is 
significantly higher than typical yields for complex polysaccharides in lactic acid bacteria (Chong et al. 
2005). Under glucose-limited growth, these yields are maintained, implying that the overall glucose 
distribution to hyaluronan biosynthesis pathway in S. zooepidemicus was relatively constant despite the 
differences in cultivation conditions (Cooney et al. 1999). As long as growth inhibition is not caused by a 
reduced glucose uptake rate, it will benefit hyaluronan production. If glucose uptake rate is decreased, 
first hyaluronan productivity and then molecular weight declines (Chong et al. 2005).
Metabolic engineering in S. zooepidemicus and in recombinant hosts have demonstrated that the 
ratio between UDP-GlcNAc and UDP-GlcUA and the ratio between HAS and substrates are of greatest 
importance for hyaluronan molecular weight. Chen et al. (2009) has overexpressed each of the five 
genes in the has operon in S. zooepidemicus individually. They discovered that overexpression of 
hasA, involved in hyaluronan biosynthesis, and hasB and hasC, involved in UDP-GlcUA biosynthesis, 
decreased molecular weight, while overexpression of hasE, involved in UDP-GlcNAc biosynthesis, 
greatly enhanced molecular weight (see Figure 7). Overexpression of hasD had no effect, but 
molecular weight was further increased when combined with hasE overexpression (Chen et al. 2009). 
Upregulation of hasD in S. zooepidemicus has been observed under aerobic conditions (Wu et al. 
2009) and at the presence of an empty plasmid within the cell (Marcellin et al. 2010), which is why 
I assume that overexpression of hasD alone had no effect. In summary, the results above indicate 
that, with a proper balance between the synthesis pathways to UDP-GlcNAc and UDP-GlcUA, the 
hyaluronan molecular weight can be further increased and controlled (Chen et al. 2009). 
In addition to the ratio between the two precursors, the ratio between precursor UDP-GlcUA and 
hyaluronan synthase also influences hyaluronan molecular weight  (Sheng et al. 2009). In this study, 
two plasmids were constructed for heterologous host Lactococcus lactis, containing either hasA or 
hasB of S. zooepidemicus with inducible expression promoters, respectively NICE system and lacA. 
Hyaluronan molecular weight increased significantly at hasA/hasB ratios below 2, indicating that higher 
UDP-GlcUA availability per hyaluronan synthase enhances hyaluronan molecular weight (Sheng et al. 
2009). 
Without overexpression of hasB or an analog encoding for UDP-glucose dehydrogenase, 
UDP-GlcUA levels are often limiting in heterologous hosts (DeAngelis et al. 1993a; Widner et al. 2005; 
Chien et al. 2007; Mao et al. 2009), whereas UDP-GlcNAc seems to be adequately available in the 
hosts since it is a main component for bacterial cell wall synthesis. Attempts to overexpress both 
synthetic pathways to UDP-GlcNAc and UDP-GlcUA in heterologous hosts were so far unsuccessful, 
but overexpression of hasA, hasB and hasC has led to considerable increases in hyaluronan synthesis 
varying between 200 and 800 % depending on the host (Yu et al. 2008; Prasad et al. 2010). 
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Influence of reaction conditions on molecular weight
Streptococcal fermentation to produce hyaluronan is, like other fermentations, influenced by medium 
composition, pH, temperature, aeration and agitation. Especially aerobic conditions and the initial 
glucose concentration had a large influence on hyaluronan yield and molecular weight, as was 
discussed above. Both agitation and fermentation modus have a rather complex effect on hyaluronan 
production and are, therefore, in greater detail described, below.
In general, optimum pH was observed around 7.0, where cell growth, hyaluronan yield and 
molecular weight were at their maximum levels (Johns et al. 1994; Kim et al. 1996; Armstrong et 
al. 1997; Kim et al. 2006). Temperatures below 38°C favored higher hyaluronan yield and molecular 
weight, whereas the cell growth rate decreased considerably (Armstrong et al. 1997; Kim et al. 2006). 
This effect indicated that suboptimal growth benefits hyaluronan production, as was already discussed 
above. 
Agitation
Most studies agree that increasing agitation increases hyaluronan yield under both anaerobic and 
aerobic conditions (Johns et al. 1994; Armstrong et al. 1997; Hasegawa et al. 1999; Huang et al. 2006), 
but the reports on the effect on molecular weight are contradictory (Kim et al. 1996; Armstrong et al. 
1997; Hasegawa et al. 1999; Duan et al. 2008; Zhang et al. 2010). The increasing hyaluronan yield 
is explained by the enhanced mass transfer because increased agitation reduces the viscosity of the 
broth (Johns et al. 1994). Since shedding of hyaluronan synthase from the cell wall into the culture 
medium was observed during the exponential growth phase of Group C streptococci (Mausolf et al. 
1990), it was suggested that a higher shear rate may be required to release the hyaluronan capsule 
from the bacterial cell wall into the medium (Johns et al. 1994). However, no increase in hyaluronan 
yield has been observed in fermentations where agitation was increased from 150 to 1000 rpm (Duan 
et al. 2008).
In addition, it was recently shown that hyaluronan molecular weight increases at moderate impeller 
speed due to mass transfer enhancement, but decreases due to degradation by reactive oxygen species 
that are formed under aerobic conditions at high impeller speed (Zhang et al. 2010). Concentration 
levels of reactive oxygen species were significantly higher during exponential growth phase than during 
the stationary phase. Therefore, the critical value at which agitation decreases hyaluronan molecular 
weight will most likely depend on the dissolved oxygen saturation (Duan et al. 2009), the cellular phase 
(Zhang et al. 2010), the impeller type (Kim et al. 1996), and impeller speed (Zhang et al. 2010).
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Batch versus chemostat cultivation 
In thirty years of intermittent research, hyaluronan yields synthesized in batch fermentation of 
streptococci increased from 300-400 mg/ml (Holmstrom et al. 1967) to 6-7 g/l (Kim et al. 1996), which 
is, because of the high viscosity of the broth, the practical limit due to mass transfer limitations (Chong 
et al. 2005). Further improvement of the hyaluronan yield is therefore not possible through high-cell-
density fermentation or through a high-yield strain. 
Continuous culture is the best strategy to improve volumetric productivity of hyaluronan synthesis for 
several reasons. First, cell growth of streptococci can be maintained at exponential phase, preventing 
the excretion of the hyaluronan synthase and other cell wall proteins in the stationary phase (Mausolf et 
al. 1990). Since hyaluronan synthesis stops in stationary phase (van de Rijn 1983; Crater et al. 1995), 
extension of the exponential phase could lead to increased amount of hyaluronan. Second, suboptimal 
growth conditions can be imposed by nutrient limitation to decrease the resource competition between 
cell growth and hyaluronan synthesis (Ellwood et al. 1996; Armstrong et al. 1997). Third, a turnaround 
phase is avoided by using a continuous culture (Huang et al. 2008). And last, the viscosity of the broth 
can be controlled by controlling the hyaluronan concentration within the reactor. 
On the other hand, chemostat cultures have long been thought to be impossible due to phenotype 
instability, causing a decreased efficiency of hyaluronan synthesis during prolonged operation (Blank 
et al. 2005). Stable continuous culture processes for hyaluronan synthesis by streptococci was at first 
only achieved at dilution rates below 0.12 h-1 (Ellwood et al. 1996; Stahl 2000). A major breakthrough in 
this field was the realization that chemostat cultures were not hampered by phenotype instability, but by 
competition between encapsulated and unencapsulated S. zooepidemicus strains (Blank et al. 2005). 
Through the addition of horse serum, selective pressure was provided in favor for encapsulated cells. 
This resulted in a stable chemostat process that could be maintained for more than 150 h of production 
at high dilution rates of 0.4 h-1 for both chemically defined and complex media (Blank et al. 2005). In 
later studies, it was shown that prolonged cultivation of S. zooepidemicus was also possible without 
horse serum by controlling the medium conditions (Zhang et al. 2006b; Huang et al. 2008).
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Overview of regulating aspects in hyaluronan production
All aspects, reviewed in Part 2 of this chapter, that influence hyaluronan molecular weight, yield 
or polydispersity are shown in Figure 8. Interestingly, UDP-GlcNAc regulation is observed for all 
HAS enzymes. Several conditions are found on cell and reactor level that increase UDP-GlcNAc 
concentrations within the bacterial cell and thus higher molecular weight and yields are obtained.
Figure 8.   Regulating aspects in hyaluronan production and their effect on HA molecular weight, yield and poly-
dispersity.
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PART 3 - Producing hyaluronan of a desired length using hyaluronan synthases
Now that the many factors influencing hyaluronan synthesis in bacterial fermentation and in enzymatic 
in vitro systems have been reviewed, the status quo of hyaluronan synthesis in existing production 
systems will be described. New production methods to generate high molecular weight (Mw) hyaluronan 
with narrow polydispersity or monodisperse hyaluronan oligosaccharides will be reviewed. In addition, I 
will indicate how these processes can be further improved using the knowledge on hyaluronan synthesis 
regulation described above. Moreover, suggestions for improved PmHAS performance will be given.
Quest for high Mw products with narrow polydispersity 
The quest for high molecular weight hyaluronan production already started in the 60’s when the 
viscoelastic properties of hyaluronan and its multiple applications became apparent. An interesting 
example of high molecular weight hyaluronan production is through the fermentation of nonhemolytic 
and hyaluronidase-free mutants that were obtained through random mutagenesis of streptococci 
strains. Since hyaluronan degradation by hyaluronidase is avoided, these mutants are able to produce 
hyaluronan with a molecular weight varying from 3.5 to 5.9 MDa and yields around 6-7 g/l (Kim et al. 
1996; Park et al. 1996; Han et al. 2004; Im et al. 2009). Random mutagenesis has also resulted in 
streptococci strains that produce hyaluronan of extraordinary high molecular weight ranging from 6 to 
9 MDa and with moderate yields from 100 to 800 mg/l (Stahl 2000). 
Interestingly, UDP-GlcNAc concentrations seem to regulate the activity of HAS enzymes by the 
elevated KmNAc value and, in some HASs, allosteric regulation. Therefore, increased UDP-GlcNAc 
concentration, whether caused by reaction conditions or metabolic engineering, enhance molecular 
weight. This finding is crucial for future fermentation processes, which should take UDP-GlcNAc 
concentration into account to control the molecular weight of the product. 
To avoid the risk of exotoxin contamination in hyaluronan products, safe organisms have been 
genetically engineered into hyaluronan producers, such as Enterococcus faecalis (DeAngelis et al. 
1993a), Escherichia coli (DeAngelis et al. 1993a; DeAngelis et al. 1998; Yu et al. 2008; Mao et al. 
2009), Bacillus subtilis (Widner et al. 2005), Agrobacterium sp. (Mao et al. 2007), and Lactococcus 
lactis (Chien et al. 2007; Prasad et al. 2010; Sheng et al. 2009), by introducing hyaluronan synthase 
enzymes of either streptococci or Pasteurella multocida. The additional advantage of using these 
heterologous hosts is that for most of them a wide array of tools for genetic manipulation is readily 
available to increase hyaluronan yields through metabolic engineering. 
At this moment, gram-scale production has been achieved using recombinant hosts, although not 
yet at the same levels as for S. zooepidemicus. For instance, a hyaluronan concentration of 2-3.8 
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g/l was accomplished using PmHAS expressed in E. coli after 24h of fedbatch fermentation in a 1 l 
bioreactor (Mao et al. 2009). Highest hyaluronan concentration obtained using a Class I HAS (SzHAS) 
in recombinant L. lactis is 1.8 g/l with an average molecular weight of 2.8 MDa after 16h of batch 
fermentation in a 2.4 l bioreactor (Prasad et al. 2010). In time, these production processes will be 
optimized and probably become the major source of hyaluronan products.
For certain applications, polydispersity of the hyaluronan product has to be especially narrow to 
induce the desired reaction within the mammalian body. In these cases, hyaluronan synthesis using 
PmHAS in in vitro systems may become relevant. Polydispersity can be controlled using PmHAS at 
saturating substrate concentrations, as is evident from the results presented in Chapter 4 and the 
discussions above. Narrow polydispersity in PmHAS elongations using templates can be achieved up 
to 2.5 MDa, after which size distribution starts to broaden (Jing et al. 2006). An important requirement 
for large-scale production will be the removal of UDP and, preferably, the regeneration of UDP-GlcNAc 
and UDP-GlcUA, which will be further discussed in the next section.
Quest for short, monodisperse HA oligosaccharides
At this moment, the only company that commercially provides monodisperse hyaluronan 
oligosaccharides up to 20 sugar residues on mg-scale is Hyalose, L.L.C. (Oklahoma City, USA). Their 
founders, Paul DeAngelis and Paul Weigel, have developed a two-column production process, where 
two PmHAS mutants successively elongate UDP-GlcNAc and UDP-GlcUA on a hyaluronan template 
(DeAngelis et al. 2003). In this way, the hyaluronan chain is step-wise elongated and product chain 
length is controlled. However, this process will, at increasing chain length, endure inhibition caused by 
the increasing concentrations of released UDP. As is shown in Figure 7, each elongation step releases 
an UDP moiety in the reaction medium. In my studies, UDP inhibition has been observed starting from 
5 mM (data not shown), thus, for a large-scale process, UDP removal is essential. Preferably, the 
removed UDP will be regenerated into the required UDP-sugars, reducing the costs of starting material. 
Furthermore, preliminary results of PmHAS elongations using template concentrations above 6 mM 
indicated that PmHAS activity was inhibited at high hyaluronan oligosaccharide concentrations (data 
not shown). In this section, different possibilities to address these issues are discussed.
PmHAS is, up to now, the only HAS enzyme that is able to elongate pre-existing hyaluronan 
oligosaccharides stepwise and is, therefore, the most suited HAS enzyme for monodisperse hyaluronan 
oligosaccharide production. Single-step elongations can be imposed by using PmHAS mutants 
that are only able to transfer one of the UDP-sugars, as was developed by the group of DeAngelis. 
Alternatively, hyaluronan oligosaccharides can be fixated on a carrier system, such as a glycan array, 
after which it is exposed to solutions containing either PmHAS1-703 and UDP-GlcUA or PmHAS1-703 
and UDP-GlcNAc. Glycan arrays are becoming increasingly important for oligosaccharide synthesis, 
where several glycosyltransferases are involved (Seeberger et al. 2007; Laurent et al. 2008). If PmHAS 
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mutants with only one transferase activity cannot be used in combination with the glycan array, washing 
steps are required after each elongation step. Production through fixed oligosaccharides is likely to 
prevent substrate inhibition, since oligosaccharides are unable to compete for the same binding site on 
PmHAS. However, literature has shown that conversion rates and product yields are generally lower 
for enzymes, when solid-phase arrays are used (Laurent et al. 2008). By selecting the right solid-
phase material and linkers to fixate the oligosaccharides, yields and conversion rates can be improved 
(Halling et al. 2005; Basso et al. 2006). 
Whether hyaluronan oligosaccharides are produced by immobilized enzymes or through glycan 
arrays, UDP concentrations will increase after each elongation step. Specific degradation of UDP is 
possible by adding alkaline phosphates into the reaction medium (Baggenstoss et al. 2006), which will 
hydrolyze UDP into uridine and phosphate. This will reduce the UDP inhibition, but regeneration of the 
UDP-sugars using the released UDP is the best solution. There are several possibilities explored in 
literature, such as enzymatic cascade reactions (De Luca et al. 1995; Nahalka et al. 2003), coupling 
of metabolically engineered bacteria (Endo et al. 2000), and a mutant nucleotidyltransferase (Williams 
et al. 2008). The most promising and relatively simplest method is exploiting the reversibility of 
glycosyltransferase-catalyzed reactions (Zhang et al. 2006a).
Improving PmHAS performance
Chapter 4 and 5 of this thesis showed that there are important similarities in predicted structure and 
kinetic mechanism between PmHAS and glycosyltransferases of the GT-A fold. Knowledge gained 
in mutation studies of these glycosyltransferases may also be applicable to PmHAS. In theory, 
increased binding properties of substrates may lead to faster conversion rates, higher yields and higher 
molecular weights. The structural model of PmHAS can also be used to pinpoint amino acids that are 
involved in substrate specificity or that are involved in closing the flexible loops. Alteration of substrate 
specificity may lead to new products, and alterations in the flexible loops may increase rates. In Table 
1, suggestions are made for mutation studies in PmHAS.
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Desired 
effect
Target 
residue(s) Function Change (into) Effect observed in literature
Increasing 
UDP-
GlcNAc 
affinity
T165TFN Uracil ring bind-ing site IPAY
UA-transferase site of PmHAS and 
Class I HASs contain IXXY motif, 
and have better affinity, see discus-
sion earlier this chapter
His-tag at 
C-terminus
Purification of 
PmHAS
Change to N-
terminus
To ensure that high Km NAc value is 
not caused by unexpected interac-
tion with His-tag 
(no reference available)
Increasing 
conversion 
rate
NAc-site
Flexible loop 
Pro397-Thr413
Loop acts 
probably as a 
lid over UDP-
GlcNAc binding 
site (Chapter 5)
Change bulky 
residues in loop, 
such as R406 and 
K411, or in loop 
environment into 
smaller residues
Change of residue Arg176 into Gly, a 
residue located as hinge of the flex-
ible loop in human blood Group A 
glycosyltransferase increases kcat 
3-fold. Crystal structures indicate 
that increase in kcat is caused by in-
creased flexibility of the loop. (Alfaro 
et al. 2008)
Alterations in charged residues with-
in loop considerably decreases rates 
(Zhang et al. 2003)
UA-site
Flexible loop 
His639-Val658
Loop acts 
probably as a 
lid over UDP-
GlcUA binding 
site (Chapter 5)
Change bulky 
residues in loop, 
such as K653, or 
in loop environ-
ment into smaller 
residues
Changing 
UDP-sugar 
specificity
NAc-site
His394 Unknown Lys or Arg
Specificity of GlcAT-1, which in wild 
type uses UDP-GlcUA, was changed 
by His308Arg mutation, transferring 
UDP-glucose, UDP-mannose, and 
UDP-N-acetyl-glucosamine at high 
rates. (Ouzzine et al. 2002)
A positive charged residue at the 
same location as His308 is for several 
glycosyltransferases conserved.
UA-site
Arg636 Unknown Lys or His
Identification 
of roles of 
aromatic 
hydrophobic 
residues
NAc-site
Trp320, Trp366,
Tyr425
Putative 
oligosaccharide 
binding site
To be determined
See section about ‘Hyaluronan oligo-
saccharide affinity’UA-site
Tyr571, Trp573, 
Phe676, Tyr685, 
Phe687
Putative 
oligosaccharide 
binding site
To be determined
Identification 
of catalytic 
residues
NAc-site
Asp370
Putative cata-
lytic residue To be determined
These Asp residues are conserved in 
GT-A fold glycosyltransferases.
Mutation of Asp370 has already been 
investigated, resulting in the loss of 
NAc-transferase activity in PmHAS. 
(Jing et al. 2003)
UA-site
Asp613
Putative cata-
lytic residue To be determined
Table 1 Suggestions for PmHAS mutation studies
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In conclusion
In this thesis, I have focused on the polymerization mechanism of Pasteurella multocida hyaluronan 
synthase (PmHAS). This enzyme is the single member of the Class II HAS group and is considered 
to be fundamentally different from Class I HASs. In this chapter, I have discussed the differences 
and similarities between Class I and Class II HAS enzymes and come to the conclusion that their 
polymerization mechanisms are actually quite similar.
Hyaluronan synthesis is a complex reaction that is influenced by many factors outside the cell, 
inside the cell and on enzyme level. Surprisingly, UDP-GlcNAc concentration is of great importance 
in regulating hyaluronan synthases by high KmNAc values and in some cases by allosteric behavior. 
Several reaction conditions stimulate UDP-GlcNAc biosynthesis by increasing the expression of 
enzymes involved in that pathway. Factors that increase or decrease hyaluronan molecular weight and 
yield have been discussed.
Hyaluronan, with its multiple and diverse applications, seem to be the holy grail for pharmaceutical 
and cosmetic companies, but producing only the desired length is difficult to achieve. In the last part of 
this chapter, the latest accomplishments in hyaluronan production are reviewed. I expect that bacterial 
fermentation using heterologous hosts will become the main source of high hyaluronan molecular 
weight, and metabolic engineering will be used to improve molecular weight. Enzymatic in vitro systems 
using PmHAS may provide specialized hyaluronan products with predetermined polydispersity, but 
can only be made economically successful through an integrated system with UDP recovery and 
UDP-sugar regeneration. 
For monodisperse hyaluronan oligosaccharide synthesis, step-wise additions to hyaluronan 
oligosaccharides can be imposed by using immobilized PmHAS mutants or by using glycan arrays. 
Furthermore, I have selected candidate amino acid residues within PmHAS that through mutation 
studies may provide PmHAS with improved hyaluronan production abilities. Most important, hyaluronan 
research have revealed for the last 100 years many interesting, sometimes puzzling aspects of 
hyaluronan and hyaluronan synthesis and will most likely continue to do so in the coming years.
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Appendix I
Sequence alignment of Class I HAS enzymes. The sequences are color coded to show family resem-
blances. Streptococcus equisimilis (Se) HAS is here used as a model (black shade), since it is the 
smallest gene (417 residues) encoding for a complete HAS enzyme and conserved residues found in 
this gene may be involved in binding substrates or the catalytic triad. Other color codes are based on 
the mammalian isozymes: HAS1 (dark gray shade, white letters), HAS2 (light gray shade, dark gray 
letters) and HAS3 (light gray letters). 
Sz = Streptococcus equi subspecies zooepidemicus; Su = Streptococcus uberis; Sp = Streptococcus 
pyogenes; Hs = Homo sapiens (human); Mm = Mus musculus (mouse); Xl = Xenopus laevis (frog); Cv 
= Chlorella virus
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SeHAS              MR---------------TLK------NLITVVAFSIFWVLLI---YVNVYLFGA----KG 32
SzHAS              MR---------------TLK------NLITVVAFSIFWVLLI---YVNVYLFGA----KG 32
SuHAS              ME---------------KLK------NLITFMTFIFLWLIII---GLNVFVFGT----KG 32
SpHAS              MP--------------IFKK------TLIVLS-FIFLISILI---YLNMYLFGT----S- 31
HsHAS1             MRQQDAPKPTPAACRCSGLAR------RVLTIAFALLILGLMTWAYAAGVPLASDRYGLL 54
MmHAS1             MR-QDMPKPSEAARCCSGLAR------RALTIIFALLILGLMTWAYAAGVPLASDRYGLL 53
XlHAS1             MKEKAAETMEIPEGIPKDLEPKHPTLWRIIYYSFGVVLLATITAAYVAEFQVLKHEAILF 60
HsHAS2             ---MHCERFLCILRIIG-------------TTLFGVSLLLGITAAYIVGYQFIQTDNYYF 44
MmHAS2             ---MHCERFLCVLRIIG-------------TTLFGVSLLLGITAAYIVGYQFIQTDNYYF 44
XlHAS2             ---MHCERFICILRIIG-------------TTLFGVSLLLGISAAYIVGYQFIQTDNYYF 44
HsHAS3             ----MPVQLTTALRVVG-------------TSLFALAVLGGILAAYVTGYQFIHTEKHYL 43
MmHAS3             ----MPVQLTTALRVVG-------------TSLFALVVLGGILAAYVTGYQFIHTEKHYL 43
XlHAS3             ----MPGKFQTGLRVLA-------------TCLFALLVLGGILVAYVTGYQFIHTDRHHL 43
CvHAS              -MGKNIIIMVSWYTIITSN---------LIAVGGASLILAPAITGYVLHWNIALST--IW 48
     
                                                                         
SeHAS              SLSIYGFLLIAYLLVKMSLSFFYKPFKGRAG----------------QYKVAAIIPSYNE 76
SzHAS              SLSIYGFLLIAYLLVKMSLSFFYKPFKGRAG----------------QYKVAAIIPSYNE 76
SuHAS              SLTVYGIILLTYLSIKMGLSFFYRPYKGSVG----------------QYKVAAIIPSYNE 76
SpHAS              TVGIYGVILITYLVIKLGLSFLYEPFKGKPH----------------DYKVAAVIPSYNE 75
HsHAS1             AFGLYGAFLSAHLVAQSLFAYLEHRRVAAAAR-----GPLDAAT---ARSVALTISAYQE 106
MmHAS1             AFGLYGAFLSAHLVAQSLFAYLEHRRVAAAARRSLAKGPLDAAT---ARSVALTISAYQE 110
XlHAS1             SLGLYGLAMLLHLMMQSLFAFLEIRRVN--------KSELPCSF---KKTVALTIAGYQE 109
HsHAS2             SFGLYGAFLASHLIIQSLFAFLEHRKMKKS-----LETPIKLN-----KTVALCIAAYQE 94
MmHAS2             SFGLYGAFLASHLIIQSLFAFLEHRKMKKS-----LETPIKLN-----KTVALCIAAYQE 94
XlHAS2             SFGLYGAILALHLIIQSLFAFLEHRKMKRS-----LETPIKLN-----KSVALCIAAYQE 94
HsHAS3             SFGLYGAILGLHLLIQSLFAFLEHRRMRR------AGQALKLPSPRRG-SVALCIAAYQE 96
MmHAS3             SFGLYGAILGLHLLIQSLFAFLEHRRMRR------AGRPLKLHCSQRSRSVALCIAAYQE 97
XlHAS3             SFGLYGAILGLHLLSQSLFAFLEHRKMR------GGGR-----CPSGKSTVVLCIAAYQE 92
CvHAS              GVSAYGIFVFGFFLAQVLFSELNRKRLRKWIS----LRPKGWN----DVRLAVIIAGYRE 100
                                                                              
SeHAS              DAESLLETLKSVQQQTYPL---AEIYVVDDGSADETGIKRIEDYVRDTGDLSSNVIVHR- 132
SzHAS              DAESLLETLKSVQQQTYPL---AEIYVVDDGSADETGIKRIEDYVRDTGDLSSNVIVHR- 132
SuHAS              DGVGLLETLKSVQQQTYPL---AEIFVIDDGSVDKTGIKLVEDYVKLNG-FGDQVIVHQ- 131
SpHAS              DAESLLETLKSVLAQTYPL---SEIYIVDDGSSNTDAIQLIEEYVNREVDICRNVIVHR- 131
HsHAS1             DPAYLRQCLASARALLYPRARLRVLMVVDGNRAEDLYMVDMFREVFA-DEDPATYVWDGN 165
MmHAS1             DPAYLRQCLTSARALLYPHTRLRVLMVVDGNRAEDLYMVDMFREVFA-DEDPATYVWDGN 169
XlHAS1             NPEYLIKCLESCKYVKYPKDKLKIILVIDGNTEDDAYMMEMFKDVFH-GEDVGTYVWKGN 168
HsHAS2             DPDYLRKCLQSVKRLTYPG--IKVVMVIDGNSEDDLYMMDIFSEVMG-RDKSATYIWKNN 151
MmHAS2             DPDYLRKCLQSVKRLTYPG--IKVVMVIDGNSDDDLYMMDIFSEVIG-RDKSATYIWKNN 151
XlHAS2             DEDYLRKCLLSVKRLTYPG--MKVIMVIDGNSDDDLYMMNIFREIMG-NDSCATYVWKNN 151
HsHAS3             DPDYLRKCLRSAQRISFPD--LKVVMVVDGNRQEDAYMLDIFHEVLGGTEQAGFFVWRSN 154
MmHAS3             DPEYLRKCLRSAQRIAFPN--LKVVMVVDGNRQEDTYMLDIFHEVLGGTEQAGFFVWRSN 155
XlHAS3             DPEYLRKCLRSVRRLSYPH--LRVIMVVDGNTEEDRYMMDIFREVMG-SEGTCCYIWDKN 149
CvHAS              DPYMFQKCLESVRDSDYGN-VARLICVIDGDEDDDMRMAAVYKAIYNDNIKKPEFVLCE- 158
SeHAS              --------------------------------------------SEKNQGKRHAQAWAFE 148
SzHAS              --------------------------------------------SEKNQGKRHAQAWAFE 148
SuHAS              --------------------------------------------MPENVGKRHAQAWAFE 147
SpHAS              --------------------------------------------SLVNKGKRHAQAWAFE 147
HsHAS1             YHQPWEPAAA-GAVGAGAYREVEAEDPGRLAVEALVRTRRCVCVAQRWGGKREVMYTAFK 224
MmHAS1             YHQPWEPAEATGAVGEGAYREVEAEDPGRLAVEALVRTRRCVCVAQRWGGKREVMYTAFK 229
XlHAS1             YHTVKKPEETNKGSCPEVSKPLN-EDEGINMVEELVRNKRCVCIMQQWGGKREVMYTAFQ 227
HsHAS2             FHEK------------GPGETDESHKESSQHVTQLVLSNKSICIMQKWGGKREVMYTAFR 199
MmHAS2             FHEK------------GPGETEESHKESSQHVTQLVLSNKSICIMQKWGGKREVMYTAFR 199
XlHAS2             FHMK------------GPNETDETHRESMQHVTQMVLSNRNVCIMQKWGGKREVMYTAFK 199
HsHAS3             FHEA------------GEGETEASLQEGMDRVRDVVRASTFSCIMQKWGGKREVMYTAFK 202
MmHAS3             FHEA------------GEGETEASLQEGMERVRAVVWASTFSCIMQKWGGKREVMYTAFK 203
XlHAS3             YHES------------EEGG-----QEGERGVQEMVKNFQYVCIMQKWGGKREVTYTAFR 192
CvHAS              ----------------------SDDKEGERIDSDFS---RDICVLQPHRGKRECLYTGFQ 193
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SeHAS              ----RSDADVFLTVDSDTYIYPDALEELLKTFN-DPTVFAATGHLNVRNRQTNLLTRLTD 203
SzHAS              ----RSDADVFLTVDSDTYIYPDALEELLKTFN-DPTVFAATGHLNVRNRQTNLLTRLTD 203
SuHAS              ----RSDADVFLTVDSDTYIYPDALEELLKTFN-DPEVYAATGHLNARNRQTNLLTRLTD 202
SpHAS              ----RSDADVFLTVDSDTYIYPNALEELLKSFN-DETVYAATGHLNARNRQTNLLTRLTD 202
HsHAS1             --ALGDSVDYVQVCDSDTRLDPMALLELVRVLDEDPRVGAVGGDVRILNPLDSWVSFLSS 282
MmHAS1             --ALGDSVDYVQVCDSDTRLDPMALLELVRVLDEDPRVGAVGGDVRILNPLDSWVSFLSS 287
XlHAS1             --AIGTSVDYVQVCDSDTKLDELATVEMVKVLESNDMYGAVGGDVRILNPYDSFISFMSS 285
HsHAS2             --ALGRSVDYVQVCDSDTMLDPASSVEMVKVLEEDPMVGGVGGDVQILNKYDSWISFLSS 257
MmHAS2             --ALGRSVDYVQVCDSDTMLDPASSVEMVKVLEEDPMVGGVGGDVQILNKYDSWISFLSS 257
XlHAS2             --ALGRSVDYVQVCDSDTVLDPASSVEMVKVLEEDIMVGGVGGDVQILNKYDSWISFLSS 257
HsHAS3             --ALGDSVDYIQVCDSDTVLDPACTIEMLRVLEEDPQVGGVGGDVQILNKYDSWISFLSS 260
MmHAS3             --ALGNSVDYIQVCDSDTVLDPACTIEMLRVLEEDPQVGGVGGDVQILNKYDSWISFLSS 261
XlHAS3             --ALGDSVAYVQVCDSDTVLDPACTAEMLRILEEDPEVGGVGGDVQILNKYESWISFLSS 250
CvHAS              LAKMDPSVNAVVLIDSDTVLEKDAILEVVYPLACDPEIQAVAGECKIWN-TDTLLSLLVA 252       
SeHAS              IRYDNAFGVERAAQSVTGNILVCSGPLSVYRREVVVPNIDRYINQTFLGIPVSIGDDRCL 263
SzHAS              IRYDNAFGVERAAQSVTGNILVCSGPLSVYRREVVVPNIDRYINQTFLGIPVSIGDDRCL 263
SuHAS              IRYDNAFGVERAAQSVTGNILVCSGPLSIYRRSVGIPNLERYTSQTFLGVPVSIGDDRCL 262
SpHAS              IRYDNAFGVERAAQSLTGNILVCSGPLSIYRREVIIPNLERYKNQTFLGLPVSIGDDRCL 262
HsHAS1             LRYWVAFNVERACQSYFHCVSCISGPLGLYRNNLLQQFLEAWYNQKFLGTHCTFGDDRHL 342
MmHAS1             LRYWVAFNVERACQSYFHCVSCISGPLGLYRNNLLQQFLEAWYNQKFLGTHCTFGDDRHL 347
XlHAS1             LRYWMAFNVERACQSYFDCVSCISGPLGMYRNNILQVFLEAWYRQKFLGTYCTLGDDRHL 345
HsHAS2             VRYWMAFNIERACQSYFGCVQCISGPLGMYRNSLLHEFVEDWYNQEFMGNQCSFGDDRHL 317
MmHAS2             VRYWMAFNIERACQSYFGCVQCISGPLGMYRNSLLHEFVEDWYNQEFMGNQCSFGDDRHL 317
XlHAS2             VRYWMAFNIERACQSYFGCVQCISGPLGMYRNSLLHEFIEDWYNQEFMGSQCSFGDDRHL 317
HsHAS3             VRYWMAFNVERACQSYFGCVQCISGPLGMYRNSLLQQFLEDWYHQKFLGSKCSFGDDRHL 320
MmHAS3             VRYWMAFNVERACQSYFGCVQCISGPLGMYRNSLLQQFLEDWYHQKFLGSKCSFGDDRHL 321
XlHAS3             FRYWMAFNVERACQSYFGCVQCISGPLGMYRNSLLQYFLEDWYHQTFLGQKCSFGDDRHL 310
CvHAS              WRYYSAFCVERSAQSFFRTVQCVGGPLGAYKIDIIKEIKDPWISQRFLGQKCTYGDDRRL 312
SeHAS              TNYATDLG-KTVYQSTAKCITDVPDKMSTYLKQQNRWNKSFFRESIISVKKIMNNPFVAL 322
SzHAS              TNYATDLG-KTVYQSTAKCITDVPDKMSTYLKQQNRWNKSFFRESIISVKKIMNNPFVAL 322
SuHAS              TNYATDLG-KTVYQSTARCDTDVPDKFKVFIKQQNRWNKSFFRESIISVKKLLATPSVAV 321
SpHAS              TNYAIDLG-RTVYQSTARCDTDVPFQLKSYLKQQNRWNKSFFRESIISVKKILSNPIVAL 321
HsHAS1             TNRMLSMGYATKYTSRSRCYSETPSSFLRWLSQQTRWSKSYFREWLYNALWWHRH---HA 399
MmHAS1             TNRMLSMGYATKYTSRSRCYSETPSSFLRWLSQQTRWSKSYFREWLYNALWWHRH---HA 404
XlHAS1             TNRVLSMGYRTKYTHKSRAFSETPSLYLRWLNQQTRWTKSYFREWLYNAQWWHKH---HI 402
HsHAS2             TNRVLSLGYATKYTARSKCLTETPIEYLRWLNQQTRWSKSYFREWLYNAMWFHKH---HL 374
MmHAS2             TNRVLSLGYATKYTARSKCLTETPIEYLRWLNQQTRWSKSYFREWLYNAMWFHKH---HL 374
XlHAS2             TNRVLSLGYATKYTARSKCLTETPTEYLRWLNQQTRWSKSYFREWLYNSLWFHKH---HL 374
HsHAS3             TNRVLSLGYRTKYTARSKCLTETPTKYLRWLNQQTRWSKSYFREWLYNSLWFHKH---HL 377
MmHAS3             TNRVLSLGYRTKYTARSKCLTETPTRYLRWLNQQTRWSKSYFREWLYNSLWFHKH---HL 378
XlHAS3             TNRVLSMGFRTKYTARSKCLTETPTRYLRWLNQQTRWSKSYFREWLYNALWFHKH---HL 367
CvHAS              TNEILMRGKKVVFTPFAVGWSDSPTNVFRYIVQQTRWSKSWCREIWYTLFAAWKHGLSGI 372
SeHAS              WTILEVSMFMMLVYSVVDFFVGNVREFDWLRVLAFLVIIFIVALCRN-IHYMLKHPLSFL 381
SzHAS              WTILEVSMFMMLVYSVVDFFVGNVREFDWLRVLAFLVIIFIVALCRN-IHYMLKHPLSFL 381
SuHAS              WTITEVSMFIMLVYSIFSLLIGEAQEFNLIKLVAFLVIIFIVALCRN-VHYMVKHPFAFL 380
SpHAS              WTIFEVVMFMMLIVAIGNLLFNQAIQLDLIKLFAFLSIIFIVALCRN-VHYMVKHPASFL 380
HsHAS1             WMTYEAVVSGLFPFFVAATVLRLFYAGRPWALLWVLLCVQGVALAKAAFAAWLRGCLRMV 459
MmHAS1             WMTYEAVVSGLFPFFVAATVLRLFYAGRPWALLWVLLCVQGVALAKAAFAAWLRGCVRMV 464
XlHAS1             WMTYESVVSFIFPFFITATVIRLIYAGTIWNVVWLLLCIQIMSLFKSIYACWLRGNFIML 462
HsHAS2             WMTYEAIITGFFPFFLIATVIQLFYRGKIWNILLFLLTVQLVGLIKSSFASCLRGNIVMV 434
MmHAS2             WMTYEAVITGFFPFFLIATVIQLFYRGKIWNILLFLLTVQLVGLIKSSFASCLRGNIVMV 434
XlHAS2             WMTYEAVITGFFPFFLIATVIQLFYRGKIWNILLFLLTVQLVGLIKSSFASALRGNIVMV 434
HsHAS3             WMTYESVVTGFFPFFLIATVIQLFYRGKIWNILLFLLTVQLVGIIKATYACFLRGNAEMI 437
MmHAS3             WMTYESVVTGFFPFFLIATVIQLFYRGKIWNILLFLLTVQLVGIIKATYACFLRGNAEMI 438
XlHAS3             WMTYESVVTGFFPFFLVATVVQLFYRGKVWNILLFLLTVQLVGILKATYACILRGNAEMI 427
CvHAS              WLAFECLYQITYFFLVIYLFSRLAVEADPRAQTATVIVSTTVALIKCGYFSFRAKDIRAF 432
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SeHAS              LSPFYGVLHLFVLQPLKLYSLFTIRNADWGTRKKLL------------------------ 417
SzHAS              LSPFYGVLHLFVLQPLKLYSLFTIRNADWGTRKKLL------------------------ 417
SuHAS              LSPFYGLIHLFVLQPLKIYSLFTIRNATWGTRKKTSK----------------------- 417
SpHAS              LSPLYGILHLFVLQPLKLYSLCTIKNTEWGTRKKVTIFK--------------------- 419
HsHAS1             LLSLYAPLYMCGLLPAKFLALVTMNQSGWGTSGRR-------KLAANYVPLLPLALWALL 512
MmHAS1             LLSLYAPLYMCGLLPAKFLALVTMNQSGWGTSGRK-------KLAANYVPVLPLALWALL 517
XlHAS1             LMSLYSMLYMTGLLPSKYFALLTLNKTGWGTSGRK-------KIVGNYMPILPLSIWAAV 515
HsHAS2             FMSLYSVLYMSSLLPAKMFAIATINKAGWGTSGRK-------TIVVNFIGLIPVSVWFTI 487
MmHAS2             FMSLYSVLYMSSLLPAKMFAIATINKAGWGTSGRK-------TIVVNFIGLIPVSVWFTI 487
XlHAS2             FMSFYSVLYMSSLLPAKMFAIATINKAGWGTSGRK-------TIVVNFIGLIPITVWFTI 487
HsHAS3             FMSLYSLLYMSSLLPAKIFAIATINKSGWGTSGRK-------TIVVNFIGLIPVSIWVAV 490
MmHAS3             FMSLYSLLYMSSLLPAKIFAIATINKSGWGTSGRK-------TIVVNFIGLIPVSIWVAV 491
XlHAS3             FMSLYSLLYMTSLLPAKIFAVITINKSGWGTSGRK-------KLVVNFMGMVPVSVWFCI 480
CvHAS              YFVLYTFVYFFCMIPARITAMMTLWDIGWGTSGGNEKPSVGTRVALWAKQYLIAYMWWAA 492
SeHAS              ------------------------------------------------------------
SzHAS              ------------------------------------------------------------
SuHAS              ------------------------------------------------------------
SpHAS              ------------------------------------------------------------
HsHAS1             LLGGLVRSVAHEARADWSGPSRAAEAYHLAAGAGAYVGYWVAMLTLYWVGVRRLCR--RR 570
MmHAS1             LLGGLARSVAQEARADWSGPSRAAEAYHLAAGAGAYVAYWVVMLTIYWVGVRRLCR--RR 575
XlHAS1             LCGGVGYSIYMDCQNDWSTPEKQKEMYHLLYGCVGYVMYWVIMAVMYWVWVKRCCR--KR 573
HsHAS2             LLGGVIFTIYKESKRPFS----ESKQTVLIVGTLLYACYWVMLLTLYVVLIN-KCGRRKK 542
MmHAS2             LLGGVIFTIYKESKKPFS----ESKQTVLIVGTLIYACYWVMLLTLYVVLIN-KCGRRKK 542
XlHAS2             LLGGVCYTIWRETKKPFS----ESEKIVLAVGAILYACYWVMLLTMYVSLVM-KCGRRRK 542
HsHAS3             LLGGLAYTAY--CQDLFS----ETELAFLVSGAILYGCYWVALLMLYLAIIARRCG--KK 542
MmHAS3             LLGGLAYTAY--CQDLFS----ETELAFLVSGAILYGCYWVALLMLYLAIIARRCG--KK 543
XlHAS3             LLGGLVYTAY--CQSHDP--FTETELLFLLTGAILYGCYWVALLSLYLALIARRCG--KR 534
CvHAS              VVGAGVYSIVHNWMFDWN----SLSYRFALVGICSYIVFIVIVLVVYFTGKITTWNFTKL 548
                                                                                
SeHAS              -----------------------
SzHAS              -----------------------
SuHAS              -----------------------
SpHAS              -----------------------
HsHAS1             TGGYRVQV--------------- 578
MmHAS1             SGGYRVQV--------------- 583
XlHAS1             SQTVTLVHDIPDMCV-------- 588
HsHAS2             GQQYDMVLDV------------- 552
MmHAS2             GQQYDMVLDV------------- 552
XlHAS2             EPQHDLVLA-------------- 551
HsHAS3             PEQYSLAFAEV------------ 553
MmHAS3             PEQYSLAFAEV------------ 554
XlHAS3             QELYNLALEEVSEPEPAAKAIKP 557
CvHAS              QKELIEDRVLYDATTNAQSV--- 568
General discussion 
132
Chapter 6
Appendix II
Sequence alignment of Domain A1 and Domain A2 of PmHAS with Class I HAS enzymes. The se-
quences are color coded to show family resemblances: SeHAS (grey shade) and PmHAS (red shade). 
Asterisks indicate conserved amino acids in Class I. The conserved areas known to interact with an 
UDP-sugar in PmHAS are in green boxes. Blue boxes indicate predicted membrane domains in Class 
I enzymes.
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Hyaluronan oligo- and polysaccharides are abundant in the human body. Depending on the chain 
length, hyaluronan is an important structural component or is involved in influencing cell responses 
during embryonic development, healing processes, inflammation and cancer. Due to these diverse 
roles of hyaluronan, there are multiple applications already in use or in development, such as 
supplementation of fluid in eyes and joints, cosmetic tissue augmentation, enhancing wound healing, 
tissue engineering, cancer treatment, controlled drug release and targeted drug delivery. State-of-
the-art hyaluronan production techniques include bacterial fermentation to produce long hyaluronan 
polymers with a small chain length distribution and in vitro enzymatic systems to produce hyaluronan 
oligosaccharides of one chain length.  Both production strategies make use of hyaluronan synthase 
(HAS), an enzyme that elongates UDP-glucuronic acid (UDP-GlcUA) and UDP-N-acetylglucosamine 
(UDP-GlcNAc) into hyaluronan.
The main question in hyaluronan production today is how the chain length of the products can be 
controlled. Since most production processes use hyaluronan synthases, the aim of this thesis was to 
elucidate the polymerization mechanism of Pasteurella multocida hyaluronan synthase (PmHAS) from 
a biochemical point of view. In addition, the acquired knowledge is used for improving the control on 
hyaluronan chain length in polymerization reactions using PmHAS. Valuable information important 
for production processes on the intrinsic properties of the enzyme, such as substrate affinity, can 
be obtained by kinetic studies using single-step elongations. Kinetic studies also provide insights 
on how polymerization is achieved and, combined with structural studies, the identification of amino 
acid residues that are important for polymerization. This knowledge can be used for improving the 
hyaluronan synthesis performance of the enzyme.
Kinetic studies require purified substrates in quantities of mg-scale. Hyaluronan (HA) oligosaccharides 
were obtained through stepwise hyaluronan cleavage using hyaluronidase and consecutive separation 
of the reaction mixture by flash-chromatography (Chapter 2). The enzymatic hydrolysis was optimized 
by experimental design studies with pH, enzyme concentration and reaction time as parameters. 
Empirical models were developed for the yield of each individual target HA oligosaccharide using the 
results from a central composite design. Selective production of short HA oligomers (HA ≤ 10) or longer 
oligosaccharides (HA > 10) was made possible through implementation of the reaction conditions 
indicated by the empirical models. Separated HA oligomers were characterized by a combination of 
anion exchange chromatography and matrix-assisted laser desorption/ionization mass spectrometry 
with time-off-flight analysis. Using these techniques, the desired quantities of purified target HA 
oligosaccharides (n = 4, 6, 8 and 10) were obtained and used in further studies.
Besides the single-step elongations assessed in kinetic studies, full polymerization studies with both 
UDP-sugars available were used to investigate the influence of substrate concentrations on the chain 
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length distribution of the hyaluronan products. In order to quantify all oligosaccharides formed during 
PmHAS polymerization in μl-scale reactions, HA templates consisting of a fluorophore-labeled HA 
tetrasaccharide (HA4) were generated (Chapter 3). A fast, simple and sensitive assay was developed 
based on fluorophore-assisted carbohydrate electrophoresis (FACE) that was used for quantification 
and characterization of PmHAS polymerization products.
The individual β1,3-glucuronyl-transferase (UA-transferase) and β1,4-N-acetylglucosamine-
transferase (NAc-transferase) activities of PmHAS were investigated separately using kinetic 
studies, where the reaction of an HA oligosaccharide was followed with, respectively, UDP-GlcUA 
or UDP-GlcNAc in single-step elongations. In Chapter 4, the influence of HA oligosaccharide length 
(n = 4, 5, 6, 7, 8 and 9) on the polymerization reaction was investigated by one-substrate kinetics, 
varying only the HA oligosaccharide concentration at saturating UDP-sugar concentration. These 
reactions followed Michaelis Menten kinetics, although HA oligosaccharides may become inhibiting 
at elevated concentrations above 6 mM. The observed kcat values increased with increasing HA 
oligosaccharide length to a constant value at HA6 and HA7. The specificity constant kcat/Km values 
for HA oligosaccharides in the UA-transferase domain increased at increasing oligosaccharide length, 
whereas in the NAc-transferase domain kcat/Km values were  constant at a low value. This indicates 
that there are two separate oligosaccharide binding sites of different lengths, one in each transferase 
domain of PmHAS. In Chapter 4, it was demonstrated that the chain-lenght distribution in PmHAS 
polymerization reactions can be decreased, and thus improved, by using saturating concentrations of 
both HA oligosaccharides and UDP-sugars. 
Chapter 5 describes two-substrate kinetic studies, where in single-step elongations both HA 
oligosaccharide and one of the UDP-sugars were varied, to investigate the polymerization mechanism 
of each individual transferase domain in PmHAS. Dead-end inhibition studies and goodness-of-fit 
parameters were used to distinguish between two-substrate models. From this analysis follows that 
both transferase domains elongate the UDP-sugar through a sequential mechanism, which is most 
likely an ordered one. In this proposed mechanism, the UDP-sugar is first bound followed by binding of 
the HA oligosaccharide, after which first the elongated HA oligosaccharide and then UDP is released. 
Large differences between Km values for UDP-GlcNAc and UDP-GlcUA, also found in Class I HAS 
enzymes, suggest that UDP-GlcNAc concentration is involved in the regulation of HAS activity and thus 
the chain length of hyaluronan products.
Structural studies were used to evaluate the results obtained with kinetic studies. In Chapter 
4, a structural homology model of PmHAS was built based on crystal structure K4CP chondroitin 
polymerase in E. coli, which has a high sequence identity of 62% and high sequence homology of 
78% with PmHAS. The active sites of PmHAS are structurally related to other glycosyltransferases 
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and this provided information on where the oligosaccharide binding sites could be located. These 
putative oligosaccharide binding sites differ in size, as was predicted by kinetic studies (Chapter 4). 
Furthermore, structural similarities between PmHAS, α1,3-galactosyltransferase (α3GT) and β1,4-
galactosyltransferase (β4Gal-T1) demonstrated that PmHAS contains in each transferase domain one 
flexible loop that forms a bridge over the active site. In crystal structures of α3GT and β4Gal-T1, 
these flexible loops have been shown to change conformation upon binding the UDP-sugar. Based 
on similarities in kinetic mechanisms and structures between PmHAS, α3GT and β4Gal-T1, it is likely 
that the flexible loops in PmHAS follow a similar conformational change, which makes the proposed 
ordered mechanism the only possible mechanism (Chapter 5).
In Chapter 6, the knowledge on the PmHAS polymerization mechanism gained in earlier chapters 
is reviewed and used to create new insights in the polymerization mechanism of Class I HAS enzymes. 
Both Class I HASs and PmHAS are used in hyaluronan production, and, therefore, the differences and 
similarities are discussed in Chapter 6. During hyaluronan production, there are many different aspects, 
such as intrinsic properties of the enzyme, cell metabolism and fermentation reaction conditions, that 
influence hyaluronan chain length and yield (Chapter 6). Moreover, hyaluronan production systems that 
are able to produce hyaluronan of desired length are discussed in Chapter 6 and a personal view of 
how these systems can be improved is presented.
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Hyaluronan oligo- and polysachariden zijn in overvloed aanwezig in het menselijk lichaam. Afhankelijk 
van de ketenlengte is hyaluronan een belangrijk structureel component of beïnvloedt  hyaluronan 
reacties van cellen gedurende embryonale ontwikkeling, wondhelingsprocessen, ontstekingen en 
kanker. Vanwege deze diverse rollen zijn er meerdere pharmaceutische toepassingen van hyaluronan 
al in gebruik of in ontwikkeling, zoals het aanvullen van vloeistof in ogen en gewrichten, het cosmetisch 
corrigeren van weefsel, het versnellen van wondheling, tissue engineering, het behandelen van kanker, 
gecontroleerde en doelgerichte medicijn afgifte. Moderne hyaluronan productie technieken omvatten 
bacteriële fermentatie om lange hyaluronan polymeren met een kleine ketendistributie te produceren 
en in vitro enzymatische systemen om hyaluronan oligosachariden van één ketenlengte te maken. 
Beide productie strategieën maken gebruik van hyaluronan synthase (HAS), een enzym dat UDP-
glucuronzuur (UDP-GlcUA) en UDP-N-acetylglucosamine (UDP-GlcNAc) met elkaar verbindt en zo 
hyaluronan vormt.
De belangrijkste vraag binnen hyaluronan productie vandaag de dag is hoe de ketenlengte van 
de producten gecontroleerd kan worden. Aangezien in de meeste productieprocessen hyaluronan 
synthases gebruikt worden, is het doel van dit proefschrift om het verlengingsmechanisme van het 
Pasteurella multocida hyaluronan synthase (PmHAS) op te helderen vanuit een biochemisch standpunt. 
Vervolgens wordt de verworven kennis toegepast om de controle over de hyaluronan ketenlengte te 
verbeteren in PmHAS reacties. Waardevolle informatie over de intrinsieke eigenschappen van het 
enzym, zoals substraataffiniteit, die van belang zijn voor productieprocessen kan verkregen worden 
via kinetische studies via één-stap verlengingen. Kinetische studies geven ook inzicht hoe de 
verlengingsreactie tot stand wordt gebracht en, in combinatie met structurele studies, kunnen tot de 
identificatie van aminozuren leiden die belangrijk zijn voor de verlengingsreactie. Deze kennis kan 
benut worden ter verbetering van het hyaluronan producerend vermogen van het enzym. 
Voor kinetische studies zijn zuivere substraten nodig in mg-schaal hoeveelheden. Hyaluronan (HA) 
oligosachariden werden verkregen door stapsgewijs afbreken van hyaluronan met hyaluronidase en 
vervolgens het reactiemengsel te scheiden via flash chromatografie (Hoofdstuk 2). De enzymatische 
hydrolyse werd geoptimaliseerd via experimenteel ontwerp studies met pH, enzym concentratie 
en reactietijd als parameters. Empirische modellen werden ontwikkeld voor de opbrengst van 
elk individueel gewenste HA oligosacharide gebruik makend van de uitkomsten van een central 
composite design. Selectieve productie van korte HA oligomeren (HA ≤ 10) of langere oligosachariden 
(HA > 10) was mogelijk door implementatie van de reactiecondities aangeduid door de empirische 
modellen. Gescheiden HA oligomeren werden gekarakteriseerd door een combinatie van anion 
uitwisselingschromatografie en massaspectrometrie (MALDI-TOF). Met behulp van deze technieken 
konden de benodigde hoeveelheden van de gewenste zuivere HA oligosachariden (n = 4, 6, 8, en 10) 
worden verkregen en gebruikt in verdere studies.
Samenvatting
161
Naast het bestuderen van één-stap verlengingen in kinetische studies zijn ook volledige polymerisatie 
studies uitgevoerd in aanwezigheid van beide UDP-suikers om de invloed van substraatconcentraties 
op de ketendistributie van de hyaluronan producten te bepalen. Om alle oligosachariden, die gevormd 
zijn tijdens de polymerisatie met PmHAS, te kunnen kwantificeren in μl-schaal reacties werden er 
fluorofoor-gelabelde HA tetrasachariden (HA4), ook wel HA templates genoemd, gesynthetiseerd 
(Hoofdstuk 3). Een snelle, simpele en gevoelige assay werd ontwikkeld gebaseerd op het scheiden 
van fluorofoor-gelabelde oligosachariden met electrophorese (FACE). Deze methode werd toegepast 
voor het kwantificeren en karakteriseren van PmHAS polymerisatie producten.
De individuele β1,3-glucuronyl-transferase (UA-transferase) en β1,4-N-acetylglucosamine-
transferase (NAc-transferase) activiteiten van PmHAS werden afzonderlijk van elkaar onderzocht 
via kinetische studies, waarbij de reactie van een HA oligosacharide met respectievelijk UDP-GlcUA 
of UDP-GlcNAc in één-stap verlengingen werd gevolgd. In Hoofdstuk 4 werd de invloed van de HA 
oligosacharide ketenlengte (n = 4, 5, 6, 7, 8, en 9)  op de polymerisatie reactie onderzocht via één-substraat 
kinetiek, waarbij alleen de HA oligosacharide concentratie gevarieerd werd bij verzadigde UDP-suiker 
concentratie. Deze reacties worden het best beschreven met de Michaelis Menten vergelijking, alhoewel 
de HA oligosachariden bij concentraties hoger dan 6 mM de reactie zouden kunnen gaan remmen. De 
geobserveerde kcat waarden stegen met de ketenlengte van HA oligosachariden tot een constante 
waarde bij HA6 en HA7. De specificiteitsconstante kcat/Km was groter bij langere oligosachariden in 
het UA-transferase domein, terwijl in het NAc-transferase domain de kcat/Km waarden een constante 
lage waarde hadden. Dit geeft aan dat er twee afzonderlijke oligosacharide-bindingsplaatsen zijn van 
verschillende lengte, één in elk transferase domein in PmHAS. In Hoofdstuk 4 werd aangetoond dat 
de ketendistributie in PmHAS polymerisatie reacties verkleind, en dus verbeterd, kon worden door 
verzadigde concentraties van zowel HA oligosachariden als UDP-suikers te hanteren.
In Hoofdstuk 5 worden twee-substraat kinetiek studies toegelicht, waarin de concentraties van 
zowel HA oligosachariden als één van de UDP-suikers worden gevarieerd in één-stap verlengingen, 
om het verlengingsmechanisme van de individuele transferase domeinen in PmHAS te onderzoeken. 
Dead-end inhibitie studies en statistische parameters (goodness-of-fit) werden bestudeert om twee-
substraat modellen te kunnen onderscheiden. Uit deze analyse volgt dat beide transferase domainen 
via een sequentieel mechanisme verlengen, die meest waarschijnlijk een geordend mechanisme is. In 
dit voorgedragen mechanisme wordt eerst de UDP-suiker gebonden gevolgd door de binding van de 
HA oligosacharide, waarna eerst de verlengde HA oligosacharide vrijkomt en vervolgens UDP. Grote 
verschillen in Km waarden voor UDP-GlcNAc en UDP-GlcUA, die ook waargenomen zijn voor Klasse 
I HAS enzymen, suggereert dat de UDP-GlcNAc concentratie betrokken is in de regulatie van HAS 
activiteit en dus de ketenlengte van hyaluronan producten. 
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Structurele studies werden uitgevoerd om de verkregen resultaten uit de kinetiek studies te 
evalueren. In Hoofdstuk 4 was een structureel homologie model van PmHAS gebouwd gebaseerd op 
een kristalstructuur van K4CP chondroitin polymerase in E. coli, die ten opzichte van PmHAS een hoge 
sequentie-identiteit heeft van 62% en een hoge sequentie-homologie van 78%. De twee domeinen 
binnen PmHAS waar de reacties plaats vinden, active sites genoemd, zijn structureel gerelateerd aan 
andere glycosyltransferases en dit leverde informatie op waar de oligosacharide-bindingsplaatsen 
mogelijk gelegen zijn. Deze mogelijke oligosacharide-bindingsplaatsen verschillen in grootte, zoals 
voorspelt was door de kinetische studies (Hoofdstuk 4). Daarnaast demonstreerden structurele 
overeenkomsten tussen PmHAS, α1,3-galactosyltransferase (α3GT) en β1,4-galactosyltransferase 
(β4Gal-T1) dat PmHAS in elk transferase domein een flexibele lus heeft die een brug vormt boven 
de active site. In de kristalstructuren van α3GT and β4Gal-T1 veranderen deze flexibele lussen 
van conformatie na de binding van een UDP-suiker. Gebaseerd op overeenkomsten in kinetische 
mechanismen en structuren tussen PmHAS, α3GT and β4Gal-T1, is het waarschijnlijk dat de flexibele 
lussen in PmHAS een vergelijkbare conformatieverandering ondergaan, waardoor het voorgedragen 
geordend mechanisme het enige mogelijke overgebleven mechanisme is (Hoofdstuk 5).
In Hoofdstuk 6 wordt de kennis over het PmHAS verlengingsmechanisme, die verworven is in de 
vorige hoofdstukken, samengevat en benut om nieuwe inzichten te creëren in het verlengingsmechanisme 
van Klasse I HAS enzymen. Zowel Klasse I HAS enzymen als PmHAS worden in hyaluronan productie 
gebruikt, en daarom worden de verschillen en overeenkomsten in Hoofdstuk 6 bediscussieerd. Tijdens 
hyaluronan productie zijn er veel verschillende aspecten, zoals de intrinsieke eigenschappen van het 
enzym, celmetabolisme en fermentatie reactiecondities, die de hyaluronan ketenlengte en opbrengst 
beïnvloeden (Hoofdstuk 6). Daarnaast worden in Hoofdstuk 6 hyaluronan productie systemen 
besproken die in staat zijn om hyaluronan met een gewenste ketenlengte te produceren en een eigen 
visie gepresenteerd over hoe deze systemen verbeterd kunnen worden.
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